Staff Publications Received in April, 2022

1.        Akpan I.N., Taskin T., Wheldon C.W., Rossheim M.E., Thompson E.L., Human papillomavirus vaccination uptake among 27-to-45-year-olds in the United States. Prev Med. 182: 107951, 2024. PMID38604575.

2.        Atkins M.B., Jegede O.A., Haas N.B., McDermott D.F., Bilen M.A., Stein M., Sosman J., Alter R., Plimack E.R., Ornstein M.C., Hurwitz M., Peace D.J., Einstein D., Catalano P.J., Hammers H., Regan M.M., Treatment-free survival outcomes from the phase ii study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (hcrn gu16-260-cohort a). J Immunother Cancer. 12(4)2024. PMID38604810. PMC11015345.

3.        Bagnyukova T., Egleston B.L., Pavlov V.A., Serebriiskii I.G., Golemis E.A., Borghaei H., Synergy of EGFR and AURKA inhibitors in KRAS-mutated non-small cell lung cancers. Cancer Res Commun, 2024. PMID38639476.

4.        Balbach M.L., Neely G., Yorke A., Figueroa-Medina E., Paly J., Shulman R.M., Dempsey C., Shulman A., Biancia C.D., Cutrer W.B., Li B.C., Developing an educational “hub”: Impact of a distance-learning curriculum in a multinational cohort. BMC Med Educ. 24(1): 406, 2024. PMID38610008. PMC11010438.

5.        Bamgbose G., Bordet G., Lodhi N., Tulin A., Mono-methylated histones control parp-1 in chromatin and transcription. Elife. 132024. PMID38690995.

6.        Barata P., Gulati S., Elliott A., Hammers H.J., Burgess E.F., Gartrell B.A., Darabi S., Bilen M.A., Basu A., Geynisman D.M., Dawson N.A., Zibelman M.R., Zhang T., Wei S., Ryan C.J., Heath E.I., Poorman K.A., Nabhan C., McKay R.R., Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles. J Clin Invest, 2024. PMID38652565.

7.        Bremner R.M., Ungerleider R.M., Ungerleider J., Wolf A.S., Erkmen C.P., Luc J.G.Y., Litle V.R., Cerfolio R.J.,Cooke D.T., Well-being of cardiothoracic surgeons in the time of covid-19: A survey by the wellness committee of the American association for thoracic surgery. Semin Thorac Cardiovasc Surg. 36(1): 129-136, 2024. PMID36244627.PMC9561391.

8.        Budagyan K., Cannon A.C., Chernoff J., A facile method to append a bio-id tag to endogenous mutant kras alleles. Methods Mol Biol. 2797: 351-362, 2024. PMID38570472.

9.        Bychkov I., Deneka A., Topchu I., Pangeni R., Ismail A., Lengner C., Karanicolas J., Golemis E., Makhov P., Boumber Y., Musashi-2 (msi2) regulation of DNA damage response in lung cancer. Res Sq, 2024. PMID38659828.PMC11042440. [Preprint]

10.      Carril-Ajuria L., Lavaud P., Dalban C., Negrier S., Gravis G., Motzer R.J., Chevreau C., Tannir N.M., Oudard S., McDermott D.F., Laguerre B., Hammers H.J., Barthelemy P., Plimack E.R., Borchiellini D., Gross-Goupil M., Jiang R., Lee C.W., de Silva H., Rini B.I., Escudier B., Albigès L., Validation of the lung immune prognostic index (lipi) as a prognostic biomarker in metastatic renal cell carcinoma. Eur J Cancer. 204: 114048, 2024. PMID38653033.

11.      Chen-Yost H.I., Bammert C., Hao W., Heymann J.J., Lin D.M., Marotti J., Waraksa-Deutsch T., Huang M., Krishnamurti U., Lin O., Ly A., Moatamed N., Pantanowitz L., Roy-Chowdhuri S., Changing digital and telecytology practices post COVID-19 comparing ASC survey results from 2016 to 2023. J Am Soc Cytopathol, 2024. PMID38582697.

12.      Chiba M., Shimono J., Suto K., Ishio T., Endo T., Goto H., Hasegawa H., Maeda M., Teshima T., Yang Y., Nakagawa M., Whole-genome CRISPR screening identifies molecular mechanisms of pd-l1 expression in adult t-cell leukemia/lymphoma. Blood. 143(14): 1379-1390, 2024. PMID38142436. PMC11033594.

13.      Covington E.L., Suresh K., Anderson B.M., Barker M., Dess K., Price J.G., Moncion A., Vaccarelli M.J., Santanam L., Xiao Y., Mayo C., Perceptions on and roadblocks to implementation of standardized nomenclature in radiation oncology: A survey from tg-263u1. J Appl Clin Med Phys: e14359, 2024. PMID38689502.

14.      Ditonno F., Veccia A., Montanaro F., Pettenuzzo G., Franco A., Manfredi C., Triggiani L., De Nunzio C., De Sio M., Cerruto M., Crivellaro S., Kutikov A., Autorino R., Antonelli A.  Trimodal therapy vs radical cystectomy in patients with muscle-invasive bladder cancer: A systematic review and meta-analysis of comparative studies. BJU Int, 2024. PMID38622957.

15.      Donovan B., Wiese D., Henry K.A., Wu J., Rae L. ,Anderson J., Evaluating the effects of food deserts and food swamps in an urban burn patient population. J Burn Care Res, 2024. PMID38630546.

16.      Drevik J.A., Dalimov Z., Lucas J., Simhan J., Cohn J.A., Factors associated with postoperative urinary retention in patients undergoing penile prosthesis implantation. Int J Impot Res. 36(3): 201-205, 2024. PMID36198809.

17.      Elkins M., Jain N., Tükel Ç., The menace within: Bacterial amyloids as a trigger for autoimmune and neurodegenerative diseases. Curr Opin Microbiol. 79: 102473, 2024. PMID38608623.

18.      Fried W., Tyagi M., Minakhin L., Chandramouly G., Tredinnick T., Ramanjulu M., Auerbacher W., Calbert M., Rusanov T., Hoang T., Borisonnik N., Betsch R., Krais J.J., Wang Y., Vekariya U.M., Gordon J., Morton G., Kent T., Skorski T., Johnson N., Childers W., Chen X.S., Pomerantz R.T., Discovery of a small-molecule inhibitor that traps polθ on DNA and synergizes with parp inhibitors. Nat Commun. 15(1): 2862, 2024. PMID38580648.PMC10997755.

19.      Gautam A., Boyd D.F., Nikhar S., Zhang T., Siokas I., Van de Velde L.A., Gaevert J., Meliopoulos V., Thapa B., Rodriguez D.A., Cai K.Q., Yin C., Schnepf D., Beer J., DeAntoneo C., Williams R.M., Shubina M., Livingston B., Zhang D., Andrake M.D., Lee S., Boda R., Duddupudi A.L., Crawford J.C., Vogel P., Loch C., Schwemmle M., Fritz L.C., Schultz-Cherry S., Green D.R., Cuny G.D., Thomas P.G., Degterev A., Balachandran S., Necroptosis blockade prevents lung injury in severe influenza. Nature. 628(8009): 835-843, 2024. PMID38600381.

20.      Gerber D.E., Wang Y., Ramalingam S.S., Bhalla S., Sun Z., Borghaei H., Brahmer J.R., Schiller J.H., Incidence, correlates, and prognostic significance of mixed response in advanced non-small cell lung cancer. Oncologist. 29(4): 342-349, 2024. PMID38207008. PMC10994259.

21.      Hall M.J., D’Avanzo P.A., Chertock Y., Kelly P.J.A., Brajuha J., Singley K., Luck C.C., Bass S.B., Oncologists’ perceptions of tumor genomic profiling and barriers to communicating secondary hereditary risks to African American cancer patients. BMC Cancer. 24(1): 412, 2024. PMID38566032. PMC10988900.

22.      Hayakawa K., Zhou Y., Shinton S.A., B-1 derived anti-thy-1 b cells in old aged mice develop lymphoma/leukemia with high expression of cd11b and hamp2 that different from tcl1 transgenic mice. Immun Ageing. 21(1): 22, 2024. PMID38570827. PMC10988983.

23.      Hayek H., Rehbini O., Kosmider B., Brandt T., Chatila W., Marchetti N., Criner G.J., Bolla S., Kishore R., Bowler R.P., Bahmed K., The regulation of fatty acid synthase by exosomal mir-143-5p and mir-342-5p in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 70(4): 259-282, 2024. PMID38117249.

24.      Hildebrand E.M., Polovnikov K., Dekker B., Liu Y., Lafontaine D.L., Fox A.N., Li Y., Venev S.V., Mirny L.A., Dekker J., Mitotic chromosomes are self-entangled and disentangle through a topoisomerase-ii-dependent two-stage exit from mitosis. Mol Cell. 84(8): 1422-1441.e14, 2024. PMID38521067.

25.      Hussen A.S., Kravitz H.L., Freudenthal B.D., Whitaker A.M., Oxidative DNA damage on the VEGF G-quadruplex forming promoter is repaired via long-patch BER. Environ Mol Mutagen. 65 Suppl 1(Suppl 1): 25-39, 2024. PMID37606505. PMC10984112.

26.      Im E.O., Chee W., Paul S., Choi M.Y., Kim S.Y., Yeo S., Ulrich C.M., Schapira M.M., Nguyen G.T., Meghani S., Mao J.J., Ma G., Inouye J., Deatrick J.A., Shin D., Bao T.  Five dimensions of needs for help: The efficacy of a technology-based intervention among Asian American breast cancer survivors. J Cancer Educ, 2024. PMID38594385.

27.      Ioffe D., McSweeny M., Hall M.J., Precision medicine in the era of genetic testing: Microsatellite instability evolved. Clin Colon Rectal Surg. 37(3): 157-171, 2024. PMID38617845. PMC11007599.

28.      Jain S., Bakolitsa C., Brenner S.E., Radivojac P., Moult J., Repo S., Hoskins R.A., Andreoletti G., Barsky D., Chellapan A., Chu H.Y., Dabbiru N., Kollipara N.K., Ly M., Neumann A.J., Pal L.R., Odell E., Pandey G., Peters-Petrulewicz R.C., Srinivasan R., Yee S.F., Yeleswarapu S.J., Zuhl M., Adebali O., Patra A., Beer M.A., Hosur R., Peng J., Bernard B.M., Berry M., Dong S.C., Boyle A.P., Adhikari A., Chen J.Q., Hu Z.Q., Wang R., Wang Y.Q., Miller M., Wang Y.R., Bromberg Y., Turina P., Capriotti E., Han J.J., Ozturk K., Carter H., Babbi G., Bovo S., Di Lena P., Martelli P.L., Savojardo C., Casadio R., Cline M.S., De Baets G., Bonache S., Díez O., Gutiérrez-Enríquez S., Fernández A., Montalban G., Ootes L., Özkan S., Padilla N., Riera C., De la Cruz X., Diekhans M., Huwe P.J., Wei Q., Xu Q.F., Dunbrack R.L., Gotea V., Elnitski L., Margolin G., Fariselli P., Kulakovskiy I.V., Makeev V.J., Penzar D.D., Vorontsov I.E., Favorov A.V., Forman J.R., Hasenahuer M., Fornasari M.S., Parisi G., Avsec Z., Celik M.H., Nguyen T.Y.D., Gagneur J., Shi F.Y., Edwards M.D., Guo Y.C., Tian K., Zeng H.Y., Gifford D.K., Göke J., Zaucha J., Gough J., Ritchie G.R.S., Frankish A., Mudge J.M., Harrow J., Young E.L., Yu Y., Huff C.D., Murakami K., Nagai Y., Imanishi T., Mungall C.J., Jacobsen J.O.B., Kim D., Jeong C.S., Jones D.T., Li M.J., Guthrie V.B., Bhattacharya R., Chen Y.C., Douville C., Fan J., Kim D., Masica D., Niknafs N., Sengupta S., Tokheim C., Turner T.N., Yeo H.T.G., Karchin R., Shin S., Welch R., Keles S., Li Y., Kellis M., Corbi-Verge C., Strokach A.V., Kim P.M., Klein T.E., Mohan R., Sinnott-Armstrong N.A., Wainberg M., Kundaje A., Gonzaludo N., Mak A.C.Y., Chhibber A., Lam H.Y.K., Dahary D., Fishilevich S., Lancet D., Lee I., Bachman B., Katsonis P., Lua R.C., Wilson S.J., Lichtarge O., Bhat R.R., Sundaram L., Viswanath V., Bellazzi R., Nicora G., Rizzo E., Limongelli I., Mezlini A.M., Chang R., Kim S., Lai C., O’Connor R., Topper S., van den Akker J., Zhou A.Y., Zimmer A.D., Mishne G., Bergquist T.R., Breese M.R., Guerrero R.F., Jiang Y.X., Kiga N., Li B., Mort M., Pagel K.A., Pejaver V., Stamboulian M.H., Thusberg J., Mooney S.D., Teerakulkittipong N., Cao C., Kundu K., Yin Y.Z., Yu C.H., Kleyman M., Lin C.F., Stackpole M., Mount S.M., Eraslan G., Mueller N.S., Naito T., Rao A.R., Azaria J.R., Brodie A., Ofran Y., Garg A., Pal D., Hawkins-Hooker A., Kenlay H., Reid J., Mucaki E.J., Rogan P.K., Schwarz J.M., Searls D.B., Lee G.R., Seok C., Kramer A., Shah S., Huang C.V., Kirsch J.F., Shatsky M., Cao Y., Chen H.R., Karimi M., Moronfoye O., Sun Y.F., Shen Y., Shigeta R., Ford C.T., Nodzak C., Uppal A., Shi X.H., Joseph T., Kotte S., Rana S., Rao A., Saipradeep V.G., Sivadasan N., Sunderam U., Stanke M., Su A., Adzhubey I., Jordan D.M., Sunyaev S., Rousseau F., Schymkowitz J., Van Durme J., Tavtigian S.V., Carraro M., Giollo M., Tosatto S.C.E., Adato O., Carmel L., Cohen N.E., Fenesh I., Holtzer I., Juven-Gershon T., Unger R., Niroula A., Olatubosun A., Valiaho J., Yang Y., Vihinen M., Wahl M.E., Chang B., Chong K.C., Hu I., Sun R., Wu W.K.K., Xia X.X., Zee B.C., Wang M.H., Wang M., Wu C.L., Lu Y.T., Chen K., Yang Y.D., Yates C.M., Kreimer A., Yan Z.X., Yosef N., Zhao H.Y., Wei Z.P., Yao Z.M., Zhou F.F., Folkman L., Zhou Y.Q., Daneshjou R., Altman R.B., Inoue F., Ahituv N., Arkin A.P., Lovisa F., Bonvini P., Bowdin S., Gianni S., Mantuano E., Minicozzi V., Novak L., Pasquo A., Pastore A., Petrosino M., Puglisi R., Toto A., Veneziano L., Chiaraluce R., Ball M.P., Bobe J.R., Church G.M., Consalvi V., Mort M., Cooper D.N., Buckley B.A., Sheridan M.B., Cutting G.R., Scaini M.C., Cygan K.J., Fredericks A.M., Glidden D.T., Neil C., Rhine C.L., Fairbrother W.G., Alontaga A.Y., Fenton A.W., Matreyek K.A., Starita L.M., Fowler D.M., Löscher B.S., Franke A., Adamson S.I., Graveley B.R., Gray J.W., Malloy M.J., Kane J.P., Kousi M., Katsanis N., Schubach M., Kircher M., Tang P.L.F., Kwok P.Y., Lathrop R.H., Clark W.T., Yu G.Y.K., LeBowitz J.H., Benedicenti F., Bettella E., Bigoni S., Cesca F., Mammi I., Marino-Bus-Ije C., Milani D., Peron A., Polli R., Sartori S., Stanzial F., Ioldo I., Turolla L., Aspromonte M.C., Bellini M., Leonardi E., Liu X.M., Marshall C., McCombie W.R., Elefanti L., Menin C., Meyn M.S., Murgia A., Nadeau K.C.Y., Neuhausen S.L., Nussbaum R.L., Pirooznia M., Potash J.B., Dimster-Denk D.F., Rine J.D., Sanford J.R., Snyder M., Tavtigian S.V., Cole A.G., Sun S., Verby M.W., Weile J., Roth F.P., Tewhey R., Sabeti P.C., Campagna J., Refaat M.M., Wojciak J., Grubb S., Schmitt N., Shendure J., Spurdle A.B., Stavropoulos D.J., Walton N.A., Zandi P.P., Ziv E., Burke W., Chen F., Carr L.R., Martinez S., Paik J., Harris-Wai J., Yarborough M., Fullerton S.M., Koenig B.A., McInnes G., Shigaki D., Chandonia J.M., Furutsuki M., Kasak L., Yu C.H., Chen R., Cline M.S., Pandey G., Friedberg I., Getz G.A., Cong Q., Kinch L.N., Zhang J., Grishin N.V., Voskanian A., Kann M.G., Clark W.T., Tran E., Ioannidis N.M., Hunter J.M., Udani R., Cai B.H., Morgan A.A., Sokolov A., Stuart J.M., Tavtigian S.V., Minervini G., Monzon A.M., Batzoglou S., Butte A.J., Church G.M., Greenblatt M.S., Hart R.K., Hernandez R., Hubbard T.J.P., Kahn S., O’Donnell-Luria A., Ng P.C., Shon J., Tavtigian S.V., Veltman J., Zook J.M.,Critical Assessment G., Cagi, the critical assessment of genome interpretation, establishes progress and prospects for computational genetic variant interpretation methods. Genome Biology. 25(1): 53, 2024. PMC10882881.

29.      Jermakowicz A.M., Kurimchak A.M., Johnson K.J., Bourgain-Guglielmetti F., Kaeppeli S., Affer M., Pradhyumnan H., Suter R.K., Walters W., Cepero M., Duncan J.S., Ayad N.G., RAPID resistance to bet inhibitors is mediated by FGFR1 in glioblastoma. Sci Rep. 14(1): 9284, 2024. PMID38654040.PMC11039727.

30.      Jog A., Strauss Starling A.L., Kaur I., Um K., Keele L.J., Triggs J.R., Altieri M.S., Shao J.M., Paraesophageal hernia recurrence following repair: Making the case for reoperative surgery in a propensity-matched cohort. Surg Endosc, 2024. PMID38627258.

31.      Johnson N., Surviving without brca2: Mlh1 gets r-looped in to curtail genomic instability. Journal of Clinical Investigation. 134(7)2024.  WOS:001198702600004. PMC10977974.

32.      Kadariya Y., Sementino E., Ruan M., Cheung M., Hadikhani P., Osmanbeyoglu H.U., Klein-Szanto A.J., Cai K.,Testa J.R., Low exposures to amphibole or serpentine asbestos in germline bap1-mutant mice induce mesothelioma characterized by an immunosuppressive tumor microenvironment. Cancer Res Commun. 4(4): 1004-1015, 2024. PMID38592450. PMC11000687.

33.      Kakish H., Sun J., Ammori J.B., Hoehn R.S., Rothermel L.D., First-line immunotherapy for metastatic merkel cell carcinoma: Analysis of real-world survival data and practice patterns. Am J Clin Oncol, 2024. PMID38587336.

34.      Lu Q., Kou D., Lou S., Ashrafizadeh M., Aref A.R., Canadas I., Tian Y., Niu X., Wang Y., Torabian P., Wang L., Sethi G., Tergaonkar V., Tay F., Yuan Z., Han P., Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy. J Hematol Oncol. 17(1): 16, 2024. PMID38566199. PMC10986145.

35.      Mischley V., Maier J., Chen J., Karanicolas J., Ppiscreenml: Structure-based screening for protein-protein interactions using alphafold. bioRxiv 2024. PMID38559274. PMC10979958. [Preprint]

36.      Neal J.W., Minichiello K., Brennick R., Huang R.S.P., Hiemenz M.C., Amler C., Patel J., Herbst R., Reckamp K.L., Borghaei H., Highleyman L., Redman M.W., Pasquina L.W., Kozono D.E., A process to reanalyze clinical DNA sequencing data for biomarker matching in the lung-map master protocol. Oncologist, 2024. PMID38597608.

37.      Nguyen T., Carrieri F.A., Connis N., Lafargue A., Chang J., Chan A., Shetty A.C., Song Y., Hoang T., Jagtap S., Chowdhury D.D., Khan M.A., Gabrielson K.L., Rezaee M., Torres-Ayuso P., Brognard J., Hann C.L., Tran P.T., TNIK inhibition sensitizes TNIK-overexpressing lung squamous cell carcinoma to radiotherapy. Mol Cancer Ther, 2024. PMID38670554.

38.      Punjabi A., Araya S., Amadio G., Webster T., Mutyala S., Wu M., Zhao H., Roth S., Walchak A., Patel S.A., Chimeric versus multiple flaps for composite oral cavity defects: A systematic review and meta-analysis. Laryngoscope, 2024. PMID38689522.

39.      Purdue M.P., Dutta D., Machiela M.J., Gorman B.R., Winter T., Okuhara D., Cleland S., Ferreiro-Iglesias A., Scheet P., Liu A., Wu C., Antwi S.O., Larkin J., Zequi S.C., Sun M., Hikino K., Hajiran A., Lawson K.A., Cárcano F., Blanchet O., Shuch B., Nepple K.G., Margue G., Sundi D., Diver W.R., Folgueira M., van Bokhoven A., Neffa F., Brown K.M., Hofmann J.N., Rhee J., Yeager M., Cole N.R., Hicks B.D., Manning M.R., Hutchinson A.A., Rothman N., Huang W.Y., Linehan W.M., Lori A., Ferragu M., Zidane-Marinnes M., Serrano S.V., Magnabosco W.J., Vilas A., Decia R., Carusso F., Graham L.S., Anderson K., Bilen M.A., Arciero C., Pellegrin I., Ricard S., Scelo G., Banks R.E., Vasudev N.S., Soomro N., Stewart G.D., Adeyoju A., Bromage S., Hrouda D., Gibbons N., Patel P., Sullivan M., Protheroe A., Nugent F.I., Fournier M.J., Zhang X., Martin L.J., Komisarenko M., Eisen T., Cunningham S.A., Connolly D.C., Uzzo R.G., Zaridze D., Mukeria A., Holcatova I., Hornakova A., Foretova L., Janout V., Mates D., Jinga V., Rascu S., Mijuskovic M., Savic S., Milosavljevic S., Gaborieau V., Abedi-Ardekani B., McKay J., Johansson M., Phouthavongsy L., Hayman L., Li J., Lungu I., Bezerra S.M., Souza A.G., Sares C.T.G., Reis R.B., Gallucci F.P., Cordeiro M.D., Pomerantz M., Lee G.M., Freedman M.L., Jeong A., Greenberg S.E., Sanchez A., Thompson R.H., Sharma V., Thiel D.D., Ball C.T., Abreu D., Lam E.T., Nahas W.C., Master V.A., Patel A.V., Bernhard J.C., Freedman N.D., Bigot P., Reis R.M., Colli L.M., Finelli A., Manley B.J., Terao C., Choueiri T.K., Carraro D.M., Houlston R., Eckel-Passow J.E., Abbosh P.H., Ganna A., Brennan P., Gu J.,Chanock S.J., Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. Nat Genet, 2024. PMID38671320.

(Read the NIH news release here: https://www.nih.gov/news-events/news-releases/analysis-identifies-50-new-genomic-regions-associated-kidney-cancer-risk

40.      Quinteros S.L., Snyder N.W., Chatoff A., Ryan F., O’Brien B.,Donnelly S., The helminth-derived peptide, fhhdm-1, reverses the trained phenotype of nod bone-marrow-derived macrophages and regulates proinflammatory responses. Eur J Immunol: e2350643, 2024. PMID38581085.

41.      Reese J.B., Bauman J.R., Sorice K.A., Frederick N., Bober S.L., Reply to S.S. Coughlin et al. JCO Oncol Pract: Op2400202, 2024. PMID38608216.

42.      Rodrigues G., Higgins K.A., Rimner A., Amini A., Chang J.Y., Chun S.G., Donington J., Edelman M.J., Gubens M.A., Iyengar P., Movsas B., Ning M.S., Park H.S., Wolf A., Simone C.B., 2nd, American radium society appropriate use criteria for unresectable locally advanced non-small cell lung cancer. JAMA Oncol, 2024. PMID38602670.

43.      Rodriguez A.L., Cappelletti L., Kurian S.M., Passio C., Rux S. Transitional care navigation. Semin Oncol Nurs. 40(2): 151580, 2024. PMID38290928.

44.      Sadeghi J.K., Reza J.A., Miller C., Cooke D.T., Erkmen C., Death by a thousand delays. JTCVS Open. 18: 353-359, 2024. PMID38690410. PMC11056460.

45.      Sedrak M.S., Sun C.L., Bae M., Freedman R.A., Magnuson A., O’Connor T., Moy B., Wildes T.M., Klepin H.D., Chapman A.E., Tew W.P., Dotan E., Fenton M.A., Kim H., Katheria V., Muss H.B., Cohen H.J., Gross C.P., Ji J., Functional decline in older breast cancer survivors treated with and without chemotherapy and non-cancer controls: Results from the hurria older patients (hope) prospective study. J Cancer Surviv, 2024. PMID38678525.

46.      Siminoff L.A., Wilson-Genderson M., Chwistek M.,Thomson M., The cancer caregiving burden trajectory over time: Varying experiences of perceived versus objectively measured burden. Oncologist, 2024. PMID38652165.

47.      Skiendzielewski K., Forke C.M., Sarwer D.B., Noll J.G., Wheeler D.C., Henry K.A., Schroeder K., The intersection of adverse childhood experiences and neighborhood determinants of health: An exploratory spatial analysis. Psychol Trauma. 16(Suppl 1): S125-s132, 2024. PMID35834220. PMC9839886.

48.      Stutzmann G.E., Soboloff J.  Channelling calcium signals to therapeutics. J Physiol. 602(8): 1445-1447, 2024. PMID38578234.

49.      Tangudu N.K., Buj R., Wang H., Wang J., Cole A.R., Uboveja A., Fang R., Amalric A., Yang B., Chatoff A., Crispim C.V., Sajjakulnukit P., Lyons M.A., Cooper K., Hempel N., Lyssiotis C.A., Chandran U.R., Snyder N.W., Aird K.M., De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression. Cancer Res Commun, 2024. PMID38626341.

50.      Thomas K.K., Francescatti A.B., Vreeland T.J., Teshome M.K., Morris A.M., Hunt K.K., Katz M.H.G., Villano A.M., Correction: Standardization of colon resection for cancer: An overview of the American College of Surgeons commission on cancer standard 5.6. Ann Surg Oncol, 2024. PMID38662097.

51.      Tiger Y.K.R., Jain S., Barta S.K., Tolu S., Estrella B., Sawas A., Lue J.K., Francescone M.M., Pro B., Amengual J.E., Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature t-cell lymphoma. Leukemia & Lymphoma: 1-10, 2024. WOS:001189458100001.

52.      Wasik M.A., Kim P.M., Nejati R. Diverse and reprogrammable mechanisms of malignant cell transformation in lymphocytes: Pathogenetic insights and translational implications. Front Oncol. 14: 1383741, 2024. PMID38638855. PMC11024630.

53.      Wei S., Pei J., Belser P., Lee T., Farma J.M., Patchefsky A.S., Flieder D.B., Montgomery E.A., Novel mir143hg::Plag1 gene fusion identified in a rectal myxoid leiomyosarcoma. Genes Chromosomes Cancer. 63(4): e23239, 2024. PMID38656544.

54.      Wheldon C.W., Skurka C., Eng N., Inoculating Black/African American and LGBTQ communities against the tobacco industry: The role of community connectedness and tobacco denormalization beliefs. Health Promot Pract. 25(3): 445-454, 2024. PMID36648060.

55.      Xiang A., Braun A.E., Chang C., Swerdloff D., Gross M.S., Simhan J., Penoscrotal inflatable penile prosthesis recipients often fully recover from pain at two weeks following placement. Int J Impot Res, 2024. PMID38561424.

56.      Yang S., Li Y., Wheldon C.W., Prosperi M., George T.J., Shenkman E.A., Wang F., Bian J.,Guo Y., The burden of cancer and pre-cancerous conditions among transgender individuals in a large healthcare network. medRxiv, 2024. PMID38585849. PMC10996763. [Preprint]

57.      Yankey H., Ruth K.J., Dotan E., Reddy S., Meyer J.E., Survival and toxicity in patients with unresectable or inoperable biliary tract cancers with ablative radiation therapy versus nonablative chemoradiation. Advances in Radiation Oncology. 9(4)2024. WOS:001188630500001.

58.      Zarrabi K.K., Miron B., Geynisman D.M., Contemporary role of avelumab first-line maintenance in advanced urothelial carcinoma with consideration of the javelin bladder 100 comprehensive clinical subgroup analyses. Transl Androl Urol. 13(3): 463-466, 2024. PMID38590958. PMC10999025.

59.      Zhao J., Reese J.B., Han X., Yabroff K.R. Loneliness and mortality risk among cancer survivors in the United States: A retrospective, longitudinal study. J Natl Compr Canc Netw: 1-5, 2024. PMID38663443.

Staff Publications Received in March, 2024

1.        Abu-Rustum N.R., Yashar C.M., Arend R., Barber E., Bradley K., Brooks R., Campos S.M., Chino J., Chon H.S., Crispens M.A., Damast S., Fisher C.M., Frederick P., Gaffney D.K., Gaillard S., Giuntoli R., II, Glaser S., Holmes J., Howitt B.E., Kendra K., Lea J., Lee N., Mantia-Smaldone G., Mariani A., Mutch D., Nagel C., Nekhlyudov L., Podoll M., Rodabaugh K., Salani R., Schorge J., Siedel J., Sisodia R., Soliman P., Ueda S., Urban R., Wethington S.L., Wyse E., Zanotti K., McMillian N.,Espinosa S., Vulvar cancer, version 3.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 22(2): 117-135, 2024. PMID38503056.

2.        Anderson E.C., DiPalazzo J., Lucas F.L., Hall M.J., Antov A., Helbig P., Bourne J., Graham L., Gaitor L., Lu-Emerson C., Bradford L.S., Inhorn R., Sinclair S.J., Brooks P.L., Thomas C.A., Rasmussen K., Han P.K.J., Liu E.T., Rueter J., Genome-matched treatments and patient outcomes in the Maine Cancer Genomics Initiative (mcgi). NPJ Precis Oncol. 8(1): 67, 2024. PMID38461318. PMC10924947.

3.        Barham D.W., Pyrgidis N., Amini E., Hammad M., Miller J., Andrianne R., Burnett A.L., Gross K., Hatzichristodoulou G., Hotaling J., Hsieh T.C., Jenkins L.C., Jones J.M., Lentz A., Modgil V., Osmonov D., Park S.H., Pearce I., Perito P., Sadeghi-Nejad H., Sempels M., Suarez-Sarmiento A., Simhan J., van Renterghem K., Warner J.N., Ziegelmann M., Yafi F.A., Gross M.S., Does climate impact inflatable penile prosthesis infection (ipp) risk? Assessment of temperature and dew point on ipp infections. J Sex Med, 2024. PMID38481017.

4.        Barnes D.R., Tyrer J.P., Dennis J., Leslie G., Bolla M.K., Lush M., Aeilts A.M., Aittomäki K., Andrieu N., Andrulis I.L., Anton-Culver H., Arason A., Arun B.K., Balmaña J., Bandera E.V., Barkardottir R.B., Berger L.P.V., de Gonzalez A.B., Berthet P., Białkowska K., Bjørge L., Blanco A.M., Blok M.J., Bobolis K.A., Bogdanova N.V., Brenton J.D., Butz H., Buys S.S., Caligo M.A., Campbell I., Castillo C., Claes K.B.M., Colonna S.V., Cook L.S., Daly M.B., Dansonka-Mieszkowska A., de la Hoya M., deFazio A., DePersia A., Ding Y.C., Domchek S.M., Dörk T., Einbeigi Z., Engel C., Evans D.G., Foretova L., Fortner R.T., Fostira F., Foti M.C., Friedman E., Frone M.N., Ganz P.A., Gentry-Maharaj A., Glendon G., Godwin A.K., González-Neira A., Greene M.H., Gronwald J., Guerrieri-Gonzaga A., Hamann U., Hansen T.V.O., Harris H.R., Hauke J., Heitz F., Hogervorst F.B.L., Hooning M.J., Hopper J.L., Huff C.D., Huntsman D.G., Imyanitov E.N., Izatt L., Jakubowska A., James P.A., Janavicius R., John E.M., Kar S., Karlan B.Y., Kennedy C.J., Kiemeney L., Konstantopoulou I., Kupryjanczyk J., Laitman Y., Lavie O., Lawrenson K., Lester J., Lesueur F., Lopez-Pleguezuelos C., Mai P.L., Manoukian S., May T., McNeish I.A., Menon U., Milne R.L., Modugno F., Mongiovi J.M., Montagna M., Moysich K.B., Neuhausen S.L., Nielsen F.C., Noguès C., Oláh E., Olopade O.I., Osorio A., Papi L., Pathak H., Pearce C.L., Pedersen I.S., Peixoto A., Pejovic T., Peng P.C., Peshkin B.N., Peterlongo P., Powell C.B., Prokofyeva D., Pujana M.A., Radice P., Rashid M.U., Rennert G., Richenberg G., Sandler D.P., Sasamoto N., Setiawan V.W., Sharma P., Sieh W., Singer C.F., Snape K., Sokolenko A.P., Soucy P., Southey M.C., Stoppa-Lyonnet D., Sutphen R., Sutter C., Teixeira M.R., Terry K.L., Thomsen L.C.V., Tischkowitz M., Toland A.E., Van Gorp T., Vega A., Velez Edwards D.R., Webb P.M., Weitzel J.N., Wentzensen N., Whittemore A.S., Winham S.J., Wu A.H., Yadav S., Yu Y., Ziogas A., Berchuck A., Couch F.J., Goode E.L., Goodman M.T., Monteiro A.N., Offit K., Ramus S.J., Risch H.A., Schildkraut J.M., Thomassen M., Simard J., Easton D.F., Jones M.R., Chenevix-Trench G., Gayther S.A., Antoniou A.C., Pharoah P.D.P. Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk. medRxiv, 2024. PMID38496424. PMC10942532. [Preprint]

5.        Beltrán-Visiedo M., Balachandran S., Galluzzi L., Mre11 mobilizes cgas and drives zbp1-dependent necroptosis. Cell Res, 2024. PMID38443562.

6.        Berman E., Shah N.P., Deninger M., Altman J.K., Amaya M., Begna K., Bhatia R., Chan O., Collins R., Curtin P., DeAngelo D.J., Drazer M., Maness L., Metheny L., Mohan S., Moore J., Oehler V., Pratz K., Pusic I., Rose M., Shomali W., Smith B.D., Styler M., Sweet K., Talpaz M., Tanaka T., Tantravahi S., Tsai S., Vaughn J., Welborn J., Yang D., Mauro M., Cortes J., Radich J.,Druker B., CML and the WHO: Why? J Clin Oncol. 42(9): 984-986, 2024. PMID38086008. [Comment]

7.        Budyagan K., Cannon A.C., Chatoff A., Snyder N.W., Kurimchak A.M., Duncan J.S., Chernoff J., Kras mutation-selective requirement for acss2 in colorectal adenoma formation. Res Sq, 2024. PMID38464238. PMC10925460. [Pre-print]

8.        Cannon A.C., Budagyan K., Uribe-Alvarez C., Kurimchak A.M., Araiza-Olivera D., Cai K.Q., Peri S., Zhou Y., Duncan J.S. Chernoff J., Unique vulnerability of rac1-mutant melanoma to combined inhibition of cdk9 and immune checkpoints. Oncogene. 43(10): 729-743, 2024. PMID38243078.

9.        Chen N., McGrath C.B., Ericsson C.I., Vaselkiv J.B., Rencsok E.M., Stopsack K.H., Guard H.E., Autio K.A., Rathkopf D.E., Enting D., Bitting R.L., Mateo J., Githiaka C.W., Chi K.N., Cheng H.H., Davis I.D., Anderson S.G., Badal S.A.M., Bjartell A., Russnes K.M., Heath E.I., Pomerantz M.M., Henegan J.C., Hyslop T., Esteban E., Omlin A., McDermott R., Fay A.P., Popoola A.A., Ragin C., Nowak J., Gerke T., Kantoff P.W., George D.J., Penney K.L.,Mucci L.A., Marital status, living arrangement, and survival among individuals with advanced prostate cancer in the international registry for men with advanced prostate cancer. Cancer Epidemiol Biomarkers Prev. 33(3): 419-425, 2024. PMID38189661. PMC10922505.

10.      Chwistek M. Mitigating the risk of aberrant use of opioids in patients with cancer pain. Journal of the National Comprehensive Cancer Network. 21(11): 1212-1213, 2023. PMIDWOS:001171227400013.

11.      Deni W.H., Gao T., Wu J., Protocol for reconstituting peptides/peptidomimetics from DMSO to aqueous buffers for circular dichroism analyses. STAR Protoc. 5(1): 102850, 2024. PMID38285735. PMC10839526.

12.      Hildebrand E.M., Polovnikov K., Dekker B., Liu Y., Lafontaine D.L., Fox A.N., Li Y., Venev S.V., Mirny L.A., Dekker J., Mitotic chromosomes are self-entangled and disentangle through a topoisomerase-ii-dependent two-stage exit from mitosis. Mol Cell, 2024. PMID38521067.

13.      Hutchings H., Behinaein P., Enofe N., Brue K., Tam S., Chang S., Movsas B., Poisson L., Wang A.,Okereke I., Association of social determinants with patient-reported outcomes in patients with cancer. Cancers (Basel). 16(5)2024. PMID38473374. PMC10930456.

14.      Iyer S.P., Johnston P.B., Barta S.K., Pralatrexate injection combined with CHOP for treatment of PTCL: Results from the Fol-CHOP dose-finding phase 1 trial. Blood Advances. 8(2): 353-364, 2024. WOS:001166650400001.

15.      Johnson C.K., Leung M.M., Ma G.X., Ogunwobi O.O., Effective recruitment strategies utilized to examine dietary practices of Blacks in New York City in the midst of the covid-19 pandemic. J Racial Ethn Health Disparities. 11(2): 764-772, 2024. PMID36929490.PMC10019415.

16.      Juric D., Barve M., Vaishampayan U., Roda D., Calvo A., Jañez N.M., Trigo J., Greystoke A., Harvey R.D., Olszanski A.J., Opyrchal M., Spira A., Thistlethwaite F., Jiménez B., Sappal J.H., Kannan K., Riley J., Li C., Li C., Gregory R.C., Miao H.,Wang S., A phase Ib study evaluating the recommended phase II dose, safety, tolerability, and efficacy of mivavotinib in combination with nivolumab in advanced solid tumors. Cancer Med. 13(5)2024. PMID38501219. PMC10949085.

17.      Kanefsky J., Basse M., Sokei J., di Martino O., Valin L., Jaspers Y., Martinez E., Huhn J., Di Marcantonio D., Magee J.A., Goldman A.R., Tang H.Y., Ferraro F., Kemp S., Wiest D.L., Sykes S.M., Disruption of polyunsaturated fatty acid biosynthesis drives sting-dependent acute myeloid leukemia cell maturation and death. J Biol Chem: 107214, 2024. PMID38522521.

18.      Klochkova A., Karami A.L., Fuller A.D., Parham L.R., Panchani S.R., Natarajan S., Jackson J.L., Mu A., Tan Y., Cai K.Q., Klein-Szanto A.J., Muir A.B., Tétreault M.P., Graña X., Hamilton K.E., Whelan K.A., Autophagy contributes to homeostasis in esophageal epithelium where high autophagic vesicle level marks basal cells with limited proliferation and enhanced self-renewal potential. Cell Mol Gastroenterol Hepatol, 2024. PMID38452871.

19.      Mell L.K., Pugh S.L., Jones C.U., Nelson T.J., Zakeri K., Rose B.S., Zeitzer K.L., Gore E.M., Bahary J.P., Souhami L., Michalski J.M., Hartford A.C., Mishra M.V., Roach M., 3rd, Parliament M.B., Choi K.N., Pisansky T.M., Husain S.M., Malone S.C., Horwitz E.M., Feng F.  Effects of androgen deprivation therapy on prostate cancer outcomes according to competing event risk: Secondary analysis of a phase 3 randomised trial. Eur Urol. 85(4): 373-381, 2024. PMID36710205.PMC10372191.

20.      Muquith M., Espinoza M., Elliott A., Xiu J., Seeber A., El-Deiry W., Antonarakis E.S., Graff S.L., Hall M.J., Borghaei H., Hoon D.S.B., Liu S.V., Ma P.C., McKay R.R., Wise-Draper T., Marshall J., Sledge G.W., Spetzler D., Zhu H., Hsiehchen D., Tissue-specific thresholds of mutation burden associated with anti-pd-1/l1 therapy benefit and prognosis in microsatellite-stable cancers. Nat Cancer, 2024. PMID38528112.

21.      Murayama T., Nakayama J., Jiang X., Miyata K., Morris A.D., Cai K.Q., Prasad R.M., Ma X., Efimov A., Belani N., Gerstein E.R., Tan Y., Zhou Y., Kim W., Maruyama R., Campbell K.S., Chen L., Yang Y., Balachandran S., Cañadas I., Targeting dhx9 triggers tumor-intrinsic interferon response and replication stress in small cell lung cancer. Cancer Discov. 14(3): 468-491, 2024. PMID38189443. PMC10905673.

22.      Naia Fioretto M., Colombelli K.T., da Silva C.L.F., Dos Santos S.A.A., Camargo A.C.L., Constantino F.B., Portela L.M.F., Aquino A.M., Barata L.A., Mattos R., Scarano W.R., Zambrano E., Justulin L.A., Maternal malnutrition associated with postnatal sugar consumption increases inflammatory response and prostate disorders in rat offspring. Mol Cell Endocrinol: 112223, 2024. PMID38556160.

23.      Ninmer E.K., Zhu H., Chianese-Bullock K.A., von Mehren M., Haas N.B., Ross M.I., Dengel L.T., Slingluff C.L., Jr.  Multipeptide vaccines for melanoma in the adjuvant setting: Long-term survival outcomes and post-hoc analysis of a randomized phase II trial. Nat Commun. 15(1): 2570, 2024. PMID38519525. PMC10959948.

24.      Omil-Lima D.,Kutikov A. Reply by authors. Urology Practice. 11(1): 48-48, 2024. WOS:001163787500066.

25.      Omil-Lima D., Tracy C.R., Steinberg R.L., Re: Predictors of excellent urology residents at the time of the urology match. Urology, 2024. PMID38518994.

26.      Parikh M., Tangen C., Hussain M.H.A., Gupta S., Callis S., Jo Y., Harzstark A., Paller C.J., George S., Zibelman M.R., Cheng H.H., Maughan B.L., Zhang J., Pachynski R.K., Bryce A.H., Lin D.W., Quinn D.I., Lerner S.P., Thompson I.M., Dorff T.B., Lara P.N., Agarwal N., Three- and seven-month prostate-specific antigen levels as prognostic markers for overall survival in metastatic hormone-sensitive prostate cancer: Results from SWOG s1216, a phase 3 randomized trial of androgen deprivation plus orteronel or bicalutamide. Eur Urol Oncol, 2024. PMID38523017.

27.      Plimack E.R., Powles T., Stus V., Gafanov R., Nosov D., Waddell T., Alekseev B., Pouliot F., Melichar B., Soulières D., Borchiellini D., McDermott R.S., Vynnychenko I., Chang Y.H., Tamada S., Atkins M.B., Molife L.R., Li C.X., Perini R., Bedke J., Rini B.I. Pembrolizumab plus axitinib versus sunitinib as first-line treatment of advanced renal cell carcinoma: 43-month follow-up of the phase 3 keynote-426 study” eur urol 84(5) (2023) 449-454. European Urology. 85(2): e58-e59, 2024. PMIDWOS:001167642100001.

28.      Pratt-Chapman M.L., Tredway K., Wheldon C.W., Streed C.G., Jr., Scout N.F.N., Ose J.,Jackson S.S., Strategies for advancing sexual orientation and gender identity data collection in cancer research. JCO Oncol Pract: Op2300629, 2024. PMID38547426.

29.      Reinhardt M.E., Mutyala S., Gerald M., Zhao H., Nova V., Araya Cambronero S., Patel S., Baltodano P.A., The critical blood-sparing effect of tranexamic acid (txa) in liposuction: A systematic review and meta-analysis. JPRAS Open. 40: 48-58, 2024. PMID38425698. PMC10904189.

30.      Richardson D.L., Moore K.N., Vergote I., Gilbert L., Martin L.P., Mantia-Smaldone G.M., Castro C.M., Provencher D., Matulonis U.A., Stec J., Wang Y., Method M., O’Malley D.M., Phase 1b study of mirvetuximab soravtansine, a folate receptor alpha (frα)-targeting antibody-drug conjugate, in combination with carboplatin and bevacizumab in patients with platinum-sensitive ovarian cancer. Gynecol Oncol. 185: 186-193, 2024. PMID38447347.

31.      Rini B.I., Plimack E.R., Stus V., Gafanov R., Waddell T., Nosov D., Pouliot F., Alekseev B., Soulieres D., Melichar B., Vynnychenko I.O., Azevedo S.J., Borchiellini D., McDermott R.S., Bedke J., Tamada S., Wu S., Burgents J., Molife L.R.,Powles T., Pembrolizumab plus axitinib versus sunitinib as first-line therapy for advanced clear cell renal cell carcinoma: 5-year analysis of keynote-426. Journal of Clinical Oncology. 41(17_SUPPL): LBA4501-LBA4501, 2023. PMIDWOS:001182783300026.

32.      Ryu Tiger Y.K., Jain S., Barta S.K., Tolu S., Estrella B., Sawas A., Lue J.K., Francescone M.M., Pro B.,Amengual J.E., Phase ii study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature t-cell lymphoma. Leuk Lymphoma: 1-10, 2024. PMID38517235.

33.      Schuetze S.M., Ballman K.V., Heise R., Ganjoo K.N., Davis E.J., George S., Burgess M.A., Choy E., Shepard D.R., Tinoco G., Hirbe A., Kelly C.M., Attia S., Deshpande H.A., Schwartz G.K., Siontis B.L., Riedel R.F., von Mehren M., Kozlowski E., Chen H.X., Astbury C.,Rubin B.P., A single arm phase 2 trial of trametinib in patients with locally advanced or metastatic epithelioid hemangioendothelioma. Clin Cancer Res, 2024. PMID38446990.

34.      Shulman R.M., Deng M., Handorf E.A., Meyer J.E., Lynch S.M.,Arora S., Factors associated with racial and ethnic disparities in locally advanced rectal cancer outcomes. JAMA Netw Open. 7(2): e240044, 2024. PMID38421650. PMC10905315.

35.      Siegel S.D., Zhang Y., Lynch S.M., Rowland J., Curriero F.C. A novel approach for conducting a catchment area analysis of breast cancer by age and stage for a community cancer center. Cancer Epidemiol Biomarkers Prev, 2024. PMID38451180.

36.      Sterling J., Simhan J., Flynn B.J., Rusilko P., França W.A., Ramirez E.A., Angulo J.C., Martins F.E., Patel H.V., Higgins M., Swerdloff D., Nikolavsky D., Multi-institutional outcomes of dorsal onlay buccal mucosal graft urethroplasty in patients with postprostatectomy, postradiation anastomotic stenosis. J Urol. 211(4): 596-604, 2024. PMID38275201.

37.      Stevenson J., Ettinger D.S., Wood D.E., Aisner D.L., Akerley W., Bauman J.R., Bharat A., Bruno D.S., Chang J.Y., Chirieac L.R., DeCamp M., Desai A., Dilling T.J., Dowell J., Durm G.A., Garassino M.C., Gettinger S., Grotz T.E., Gubens M.A., Lackner R.P., Lanuti M., Lin J., Loo B.W., Jr., Lovly C.M., Maldonado F., Massarelli E., Morgensztern D., Mullikin T.C., Ng T., Otterson G.A., Owen D., Patel S.P., Patil T., Polanco P.M., Riely G.J., Riess J., Shapiro T.A., Singh A.P., Tam A., Tanvetyanon T., Yanagawa J., Yang S.C., Yau E., Gregory K., Hang L. Mesothelioma: Pleural, version 1.2024. J Natl Compr Canc Netw. 22(2): 72-81, 2024. PMID38503043.

38.      Sun L., Handorf E.A., Zhou Y., Borghaei H., Aggarwal C., Bauman J. Outcomes in patients treated with frontline immune checkpoint inhibition (ici) for advanced nsclc with kras mutations and stk11/keap1 comutations across pd-l1 levels. Lung Cancer. 190: 107510, 2024. PMID38432028.

39.      Thompson C.L., Buchanan A.H., Myers R., Weinberg D.S., Integrating primary care, shared decision making, and community engagement to facilitate equitable access to multi-cancer early detection clinical trials. Front Oncol. 13: 1307459, 2023. PMID38486933. PMC10937460.

40.      Topchu I., Bychkov I., Roshchina E., Makhov P., Boumber Y. Pip4k2b protein regulation by nsd1 in hpv-negative head and neck squamous cell carcinoma. Cancers (Basel). 16(6)2024. PMID38539515. PMC10968846.

41.      Tseng M., Walton E., Egleston B.L., Fang C.Y., Pandemic effects on social capital in residents and non-residents of Chinese immigrant enclaves in Philadelphia. Wellbeing Space and Society. 62024. WOS:001175379900001.

42.      Weinberg D.S., Barkun A., Liquid biopsy for colorectal cancer screening: Not so bloody fast. Gastroenterology, 2024. PMID38555972.

43.      Whitehead R.A., Patel E.A., Liu J.C., Bhayani M.K. Racial disparities in head and neck cancer: It’s not just about access. Otolaryngol Head Neck Surg. 170(4): 1032-1044, 2024. PMID38258967.

44.      Xirou V., Moutafi M., Bai Y., Nwe Aung T., Burela S., Liu M., Kimple R.J., Shabbir Ahmed F., Schultz B., Flieder D., Connolly D.C., Psyrri A., Burtness B., Rimm D.L. An algorithm for standardization of tumor infiltrating lymphocyte evaluation in head and neck cancers. Oral Oncol. 152: 106750, 2024. PMID38547779.

45.      Yang J.Y., Liu C., Deng W.Y., Wu D., Weng C.H., Zhou Y.Y., Wang K., Enhancing phenotype recognition in clinical notes using large language models: Phenobcbert and phenogpt. Patterns. 5(1)2024. WOS:001165274200001.

Staff Publications Received in February, 2024

1.         Ajmal N., Lallas C.D., McCue P., Li L., Succinate dehydrogenase deficient renal cell carcinoma with sarcomatoid and rhabdoid features-a diagnostic dilemma. Int J Surg Pathol: 10668969241229333, 2024. PMID38311902.

2.         Arai H., Yang Y., Baca Y., Millstein J., Denda T., Ou F.S., Innocenti F., Takeda H., Kubota Y., Doi A., Horie Y., Umemoto K., Izawa N., Wang J., Battaglin F., Jayachandran P., Algaze S., Soni S., Zhang W., Goldberg R.M., Hall M.J., Scott A.J., Hwang J.J., Lou E., Weinberg B.A., Marshall J., Goel S., Xiu J., Michael Korn W., Venook A.P., Sunakawa Y.,Lenz H.J., Predictive value of cdc37 gene expression for targeted therapy in metastatic colorectal cancer. Eur J Cancer. 201: 113914, 2024. PMID38359495.

3.         Araya S., Chang A.H., Moss C., Gubara S.M., Gebreyesus M.T., Jordan K., Ruth K.J., Baltodano P., Patel S.A. Contemporary prophylactic antibiotic practices and adjunct therapies in autologous fat grafting procedures: A survey of the aesthetic society members. Aesthetic Surgery Journal Open Forum. 62024. WOS:001157816200001.

4.         Bai Y., Zhang X., Li Y., Qi F., Liu C., Ai X., Tang M., Szeto C., Gao E., Hua X., Xie M., Wang X., Tian Y., Chen Y., Huang G., Zhang J., Xiao W., Zhang L., Liu X., Yang Q., Houser S.R., Chen X., Protein kinase a is a master regulator of physiological and pathological cardiac hypertrophy. Circ Res. 134(4): 393-410, 2024. PMID38275112.

5.         Bartel M.J. Endoscopic resection of t1 colorectal cancer with unfavorable histologic features: What shall we do next? Gastrointest Endosc. 99(3): 417-418, 2024. PMID38368043.Editorial.

6.         Beckermann K.E., Bestvina C.M., El Osta B., Sanborn R.E., Borghaei H., Lammers P.E., Selvaggi G., Whisenant J.G., Heimann-Nichols E., Berry L., Hsu C.Y., Shyr Y., Horn L., Wakelee H. A phase 1/2 study to evaluate the safety and activity of nivolumab in combination with vorolanib, a vascular endothelial growth factor tyrosine kinase inhibitor, in patients with refractory thoracic tumors. JTO Clin Res Rep. 5(2): 100619, 2024. PMID38328473.PMC10847019.

7.         Begum T.F., Patil V.S., Zhu L., Yeh M.C., González E., Fraser M.A., Lu W.Y., Zhu S., Rubio-Torio N., Ma G.X., Tan Y.  Assessing physicians’ recommendations for hepatitis b virus (hbv) and hepatitis c virus (hcv) testing among minority populations in greater Philadelphia and New York City. Journal of Community Health, 2024. WOS:001150463000001.

8.         Bukavina L., Davis L., Helstrom E., Magee D., Ponsky L., Uzzo R., Calaway A., Abbosh P., Kutikov A., Population estimates of ovarian cancer risk in a cohort of patients with bladder cancer. Eur Urol Focus, 2024. PMID38326120.

9.         Chen J., Bearz A., Kim D.W., Mamdani H., Bauman J., Chiari R., Ou S.I., Solomon B.J., Soo R.A., Felip E., Shaw A.T., Thurm H., Clancy J.S., Lee K., O’Gorman M., Tanski C., Pithavala Y.K., Evaluation of the effect of lorlatinib on cyp2b6, cyp2c9, ugt, and p-glycoprotein substrates in patients with advanced non-small cell lung cancer. Clin Pharmacokinet. 63(2): 171-182, 2024. PMID38079095.PMC10847213.

10.       Chioccioli M., Liu S., Magruder S., Tata A., Borriello L., McDonough J.E., Konkimalla A., Kim S.H., Nouws J., Gonzalez D.G., Traub B., Ye X., Yang T., Entenberg D.R., Krishnaswamy S., Hendry C.E., Kaminski N., Tata P.R., Sauler M. Stem cell migration drives lung repair in living mice. Dev Cell, 2024. PMID38377991.

11.       Clarke L.M., Jones R.M., Hiremath S.V., Franklin C., Wright W.G., Tucker C.A. The effects of age and height on gait smoothness in adolescent athletes. Children (Basel). 11(2)2024. PMID38397335.PMC10887815.

12.       D’Avella C., Whooley P., Milano E., Egleston B., Helstrom J., Patrick K., Edelman M., Bauman J. The impact of an oncology urgent care center on healthcare utilization. JNCI Cancer Spectr, 2024. PMID38377387.

13.       Dotan E., Lynch S.M., Ryan J.C., Mitchell E.P. Disparities in care of older adults of color with cancer: A narrative review. Cancer Medicine, 2024. WOS:001143858100001.

14.       Emiloju O.E., Yin J., Koubek E., Reid J.M., Borad M.J., Lou Y., Seetharam M., Edelman M.J., Sausville E.A., Jiang Y., Kaseb A.O., Posey J.A., Davis S.L., Gores G.J., Roberts L.R., Takebe N., Schwartz G.K., Hendrickson A.E.W., Kaufmann S.H., Adjei A.A., Hubbard J.M., Costello B.A.  Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort. Invest New Drugs. 42(1): 127-135, 2024. PMID38270822.

15.       Enke T., Keswani R., Triggs J., Gannavarapu B., Mittal C., Sinha J., Kwasny M.J., Komanduri S. Adherence to quality indicators and best practices in surveillance endoscopy of barrett’s esophagus: A video-based assessment. Endoscopy International Open. 12(01): E90-E96, 2024. WOS:001145872800006.

16.       Fazliyeva R., Makhov P., Uzzo R.G., Kolenko V.M. Targeting npc1 in renal cell carcinoma. Cancers (Basel). 16(3)2024. PMID38339268.PMC10854724.

17.       Gaines T., Simhan J.  Adult hypospadias outcomes for the pediatric urologist. Curr Urol Rep, 2024. PMID38319558.

18.       Gharzai L.A., Morris E., Suresh K., Nguyen-Tân P.F., Rosenthal D.I., Gillison M.L., Harari P.M., Garden A.S., Koyfman S., Caudell J.J., Jones C.U., Mitchell D.L., Krempl G., Ridge J.A., Gensheimer M.F., Bonner J.A., Filion E., Dunlap N.E., Stokes W.A., Le Q.T., Torres-Saavedra P., Mierzwa M., Schipper M.J. Surrogate endpoints in clinical trials of p16-positive squamous cell carcinoma of the oropharynx: An individual patient data meta-analysis. Lancet Oncol. 25(3): 366-375, 2024. PMID38423050.

19.       Harmange G., Hueros R.A.R., Schaff D.L., Emert B., Saint-Antoine M., Kim L.C., Niu Z.J., Nellore S., Fane M.E., Alicea G.M., Weeraratna A.T., Simon M.C., Singh A., Shaffer S.M., Disrupting cellular memory to overcome drug resistance. Nature Communications. 14(1)2023.  WOS:001142811000001.

20.       Heinrich M.C., Jones R.L., George S., Gelderblom H., Schöffski P., von Mehren M., Zalcberg J.R., Kang Y.K., Razak A.A., Trent J., Attia S., Le Cesne A., Siontis B.L., Goldstein D., Boye K., Sanchez C., Steeghs N., Rutkowski P., Druta M., Serrano C., Somaiah N., Chi P., Reichmann W., Sprott K., Achour H., Sherman M.L., Ruiz-Soto R., Blay J.Y.,Bauer S., Ripretinib versus sunitinib in gastrointestinal stromal tumor: Ctdna biomarker analysis of the phase 3 intrigue trial. Nat Med. 30(2): 498-506, 2024. PMID38182785.PMC10878977.

21.       Henderson T.O., Allen M.A., Mim R., Egleston B., Fleisher L., Elkin E., Oeffinger K., Krull K., Ofidis D., McLeod B., Griffin H., Wood E., Cacioppo C., Weinberg M., Brown S., Howe S., McDonald A., Vukadinovich C., Alston S., Rinehart D., Armstrong G.T., Bradbury A.R. The engage study: A 3-arm randomized hybrid type 1 effectiveness and implementation study of an in-home, collaborative pcp model of remote telegenetic services to increase uptake of cancer genetic services in childhood cancer survivors. BMC Health Serv Res. 24(1): 253, 2024. PMID38414045.PMC10900774.

22.       Hermida-Prado F., Xie Y.T., Sherman S., Nagy Z., Russo D., Akhshi T., Chu Z.T., Feit A., Campisi M., Chen M.Y., Nardone A., Guarducci C., Lim K., Font-Tello A., Lee I., García-Pedrero J., Cañadas I., Agudo J., Huang Y., Sella T., Jin Q.C., Tayob N., Mittendorf E.A., Tolaney S.M., Qiu X.T., Long H.Y., Symmans W.F., Lin J.R., Santagata S., Bedrosian I., Yardley D.A., Mayer I.A., Richardson E.T., Oliveira G., Wu C.J., Schuster E.F., Dowsett M., Welm A.L., Barbie D., Metzger O., Jeselsohn R. Endocrine therapy synergizes with smac mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer. Cancer Research. 83(19): 3284-3304, 2023. PMIDWOS:001083040500015.

23.       Howell K.J., Jain A. Endometrial cancer treatment: Long-term engagement strategies. International Journal of Radiation Oncology Biology Physics. 118(2): 321-321, 2024. WOS:001164953000001. Editorial.

24.       Isali I., Helstrom E.K., Uzzo N., Lakshmanan A., Nandwana D., Valentine H., Sindhani M., Abbosh P., Bukavina L.  Current trends and challenges of microbiome research in bladder cancer. Curr Oncol Rep, 2024. PMID38376627.

25.       Joshi K., Luisi B., Wunderlin G., Saleh S., Lilly A., Okusolubo T., Farabaugh P.J. An evolutionarily conserved phosphoserine-arginine salt bridge in the interface between ribosomal proteins us4 and us5 regulates translational accuracy in saccharomyces cerevisiae. Nucleic Acids Research, 2024. WOS:001160158300001.

26.       Keating M., Ferrada P., O’Halloran P.J., Perry W., Potter S., Reddy S.S., Wilder F.G., Reynolds I.S., Tips for early career academic surgeons. Am J Surg, 2024. PMID38302367.

27.       Kehm R.D., Knight J.A., Houghton L.C., McDonald J.A., Schwartz L.A., Goldberg M., Chung W.K., Frost C.J., Wei Y., Bradbury A.R., Keegan T.H.M., Daly M.B., Buys S.S., Andrulis I.L., John E.M., Terry M.B. Childhood physical activity and pubertal timing: Findings from the legacy girls study. Int J Epidemiol. 53(1)2024. PMID38205889.PMC10859159.

28.       Khushman M.M., Toboni M.D., Xiu J., Manne U., Farrell A., Lou E., Shields A.F., Philip P.A., Salem M.E., Abraham J., Spetzler D., Marshall J., Jayachandran P., Hall M.J., Lenz H.J., Sahin I.H., Seeber A., Powell M.A.  Differential responses to immune checkpoint inhibitors are governed by diverse mismatch repair gene alterations. Clin Cancer Res, 2024. PMID38350001.

29.       Kuter B.J., Brien K., Anderson S., Bass S.B., Gutierrez L., Winters S., Eichenlaub B., Whitfield C., Faig W. Covid-19 vaccine perspectives and uptake among university students three years into the pandemic. Vaccine, 2024. PMID38365478.

30.       Lazim A., Mackrides N., Nasibli J., Pei J., Nejati R. ,Mansoor N. A t(14;18) negative nodal diffuse follicular lymphoma with 1p36/tnfrsf14 loh detected by cytogenomic microarray analysis. American Journal of Clinical Pathology. 160: S68-S68, 2023. WOS:001117683500001.

31.       Luck C.C., Bass S.B., Chertock Y., Kelly P.J.A., Singley K., Hoadley A., Hall M.J. Understanding perceptions of tumor genomic profile testing in Black/African American cancer patients in a qualitative study: The role of medical mistrust, provider communication, and family support. J Community Genet, 2024. PMID38366313.

32.       Mak K.S., Scannell Bryan M., Dignam J.J., Shipley W.U., Lin Y., Peters C.A., Gore E.M., Rosenthal S.A., Zeitzer K.L., D’Souza D.P., Horwitz E.M., Pisansky T.M., Maier J.M., Chafe S.M., Robin T.P., Roach M., 3rd, Tran P.T., Souhami L., Michalski J.M., Hartford A.C., Feng F.Y., Sandler H.M., Efstathiou J.A. Cardiovascular mortality and duration of androgen deprivation in locally advanced prostate cancer: Long-term update of nrg/rtog 9202. Eur Urol Focus, 2024. PMID38307806.

33.       Masuda M.Y., Pyon G.C., Luo H., LeSuer W.E., Putikova A., Dao A., Ortiz D.R., Schulze A.R., Fritz N., Kobayashi T., Iijima K., Klein-Szanto A.J., Shimonosono M., Flashner S., Morimoto M., Pai R.K., Rank M.A., Nakagawa H., Kita H., Wright B.L., Doyle A.D. Epithelial overexpression of il-33 induces eosinophilic esophagitis dependent on il-13. J Allergy Clin Immunol, 2024. PMID38310974.

34.       Morgan T.M., Boorjian S.A., Buyyounouski M.K., Chapin B.F., Chen D.Y.T., Cheng H.H., Chou R., Jacene H.A., Kamran S.C., Kim S.K., Kirkby E., Luckenbaugh A.N., Nathanson B.J., Nyame Y.A., Posadas E.M., Tran P.T., Chen R.C. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part i: Introduction and treatment decision-making at the time of suspected biochemical recurrence after radical prostatectomy. J Urol: 101097ju0000000000003892, 2024. PMID38421253.

35.       Morgan T.M., Boorjian S.A., Buyyounouski M.K., Chapin B.F., Chen D.Y.T., Cheng H.H., Chou R., Jacene H.A., Kamran S.C., Kim S.K., Kirkby E., Luckenbaugh A.N., Nathanson B.J., Nyame Y.A., Posadas E.M., Tran P.T., Chen R.C. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part iii: Salvage therapy after radiotherapy or focal therapy, pelvic nodal recurrence and oligometastasis, and future directions. J Urol: 101097ju0000000000003890, 2024. PMID38421252.

36.       Morgan T.M., Boorjian S.A., Buyyounouski M.K., Chapin B.F., Chen D.Y.T., Cheng H.H., Chou R., Jacene H.A., Kamran S.C., Kim S.K., Kirkby E., Luckenbaugh A.N., Nathanson B.J., Nyame Y.A., Posadas E.M., Tran P.T., Chen R.C. Salvage therapy for prostate cancer: AUA/ASTRO/SUO guideline part ii: Treatment delivery for non-metastatic biochemical recurrence after primary radical prostatectomy. J Urol: 101097ju0000000000003891, 2024. PMID38421243.

37.       Moulton N., Abbasi M., Ahmad D., Burks A., Chenna P., Haas K., Loiselle A., Mekhaiel E., Pilli S., Sadoughi A., Lydon B., Patel T., Chen A.C. Inter- and intra-observer variability of radial-endobronchial ultrasound image interpretation for peripheral pulmonary lesions. J Thorac Dis. 16(1): 450-456, 2024. PMID38410559.PMC10894385.

38.       Mühlenberg T., Falkenhorst J., Schulz T., Fletcher B.S., Teuber A., Krzeciesa D., Klooster I., Lundberg M., Wilson L., Lategahn J., von Mehren M., Grunewald S., Tüns A.I., Wardelmann E., Sicklick J.K., Brahmi M., Serrano C., Schildhaus H.U., Sievers S., Treckmann J., Heinrich M.C., Raut C.P., Ou W.B., Marino-Enriquez A., George S., Rauh D., Fletcher J.A., Bauer S. Kit atp-binding pocket/activation loop mutations in gi stromal tumor: Emerging mechanisms of kinase inhibitor escape. J Clin Oncol: Jco2301197, 2024. PMID38408285.

39.       Muir A.B., Karakasheva T., Whelan K.A. Epithelial-fibroblast crosstalk in eosinophilic esophagitis. Cell Mol Gastroenterol Hepatol, 2024. PMID38316214.

40.       Nakata J.A., Arif A., Chai L.F., Su S. First report of a post-pneumonectomy nocardia empyema. J Surg Case Rep. 2024(1): rjae002, 2024. PMID38304314.PMC10832585.

41.       Naqash A.R., Floudas C.S., Aber E., Maoz A., Nassar A.H., Adib E., Choucair K., Xiu J., Baca Y., Ricciuti B., Alessi J.V., Awad M.M., Kim C., Judd J., Raez L.E., Lopes G., Nieva J.J., Borghaei H., Takebe N., Ma P.C., Halmos B., Kwiatkowski D.J., Liu S.V. ,Mamdani H.  Influence of tp53 comutation on the tumor immune microenvironment and clinical outcomes with immune checkpoint inhibitors in stk11-mutant non-small-cell lung cancer. JCO Precis Oncol. 8: e2300371, 2024. PMID38330261.PMC10860998.

42.       Neelapu S.S., Chavez J.C., Sehgal A.R., Epperla N., Ulrickson M., Bachy E., Munshi P.N., Casulo C., Maloney D.G., de Vos S., Reshef R., Leslie L.A., Oluwole O.O., Yakoub-Agha I., Khanal R., Rosenblatt J., Korn R., Peng W., Lui C., Wulff J., Shen R., Poddar S., Jung A.S., Miao H., Beygi S., Jacobson C.A. Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-hodgkin lymphoma (zuma-5). Blood. 143(6): 496-506, 2024. PMID37879047.

43.       Parham L.R., Williams P.A., Katada K., Nettleford S.K., Chatterji P., Acheampong K.K., Danan C.H., Ma X., Simon L.A., Naughton K.E., Mizuno R., Karakasheva T., McMillan E.A., Whelan K.A., Brady D.C., Shaffer S.M., Hamilton K.E. Igf2bp1/imp1 deletion enhances a facultative stem cell state via regulation of map1lc3b. Cell Mol Gastroenterol Hepatol. 17(3): 439-451, 2024. PMID38081361.PMC10835461.

44.       Parker C.S., Zhou L.L., Prabhu V.V., Lee S., Miner T.J., Ross E.A., El-Deiry W.S.  Onc201/tic10 plus tly012 anti-cancer effects via apoptosis inhibitor downregulation, stimulation of integrated stress response and death receptor dr5 in gastric adenocarcinoma. American Journal of Cancer Research. 13(12): 6290-6312, 2023. WOS:001143926000003.

45.       Poloyac S.M., Daugherty K.K., DeVilliers M.M., Farrell D.F., Malhotra A., Nolin T.D., Panyam J., Perumal O., Sheaffer E.A., Swaan P.W. Report of the 2023 aacp council of deans taskforce on pharmacy research and scholarship. Am J Pharm Educ. 88(2): 100641, 2024. PMID38185465.

46.       Preston K.J., Kawai T., Torimoto K., Kuroda R., Nakayama Y., Akiyama T., Kimura Y., Scalia R., Autieri M.V., Rizzo V., Hashimoto T., Osei-Owusu P., Eguchi S.  Mitochondrial fission inhibition protects against hypertension induced by angiotensin ii. Hypertens Res, 2024. PMID38383894.

47.       Reese J.B., Bauman J.R., Sorice K.A., Frederick N., Bober S.L., Hematology and oncology fellow education about sexual and reproductive health: A survey of program directors in the united states. JCO Oncol Pract: Op2300499, 2024. PMID38320223.

48.       Saaoud F., Lu Y., Xu K., Shao Y., Praticò D., Vazquez-Padron R.I., Wang H., Yang X., Protein-rich foods, sea foods, and gut microbiota amplify immune responses in chronic diseases and cancers – targeting perk as a novel therapeutic strategy for chronic inflammatory diseases, neurodegenerative disorders, and cancer. Pharmacol Ther. 255: 108604, 2024. PMID38360205.

49.       Sasaki M., Hara T., Wang J.X., Zhou Y., Kennedy K.V., Umeweni N.N., Alston M.A., Spergel Z.C., Ishikawa S., Teranishi R., Nakagawa R., McMillan E.A., Whelan K.A., Karakasheva T.A., Hamilton K.E., Ruffner M.A., Muir A.B. Lysyl oxidase regulates epithelial differentiation and barrier integrity in eosinophilic esophagitis. Cell Mol Gastroenterol Hepatol, 2024. PMID38340809.

50.       Sherry D.R., Patell R., Han H.J., Dodge L.E., Braun I.M., Buss M.K., Palliative medicine fellows’ discussions, perceptions, and training regarding medical cannabis. J Pain Symptom Manage, 2024. PMID38417464.

51.       Simons M., Sharaiha R.Z., Updates in metabolic bariatric endoscopy. Dig Endosc. 36(2): 107-115, 2024. PMID37405807.

52.       Sterling J., Simhan J., Flynn B.J., Rusilko P., França W.A., Ramirez E.A., Angulo J.C., Martins F.E., Patel H.V., Higgins M., Swerdloff D., Nikolavsky D., Reply by authors. J Urol: 101097ju0000000000003888, 2024. PMID38382012.

53.       Strother M., Barlotta R., Uzzo R., Bloom E., Jazayeri S.B., Bigalli A.C., Schober J., Lee J., Bernstein A., Ginsburg K., Handorf E., Chen D.Y., Correa A., Greenberg R., Smaldone M., Viterbo R., Kutikov A. Symptomatic and functional recovery after transurethral resection of bladder tumor: Data from ecological momentary symptom assessment. Urol Oncol, 2024. PMID38369443.

54.       Sun J., Karasaki K.M., Farma J.M. The use of gene expression profiling and biomarkers in melanoma diagnosis and predicting recurrence: Implications for surveillance and treatment. Cancers (Basel). 16(3)2024. PMID38339333.PMC10854922.

55.       Sun Y., Young M.C., Woodward C.H., Danon J.N., Truong H., Gupta S., Winters T.J., Font-Burgada J., Burslem G.M., Sgourakis N.G. Universal open mhc-i molecules for rapid peptide loading and enhanced complex stability across hla allotypes. Proceedings of the National Academy of Sciences of the United States of America. 120(25)2023. WOS:001041283500001.

56.       Topchu I., Bychkov I., Gursel D., Makhov P., Boumber Y. Nsd1 supports cell growth and regulates autophagy in hpv-negative head and neck squamous cell carcinoma. Cell Death Discov. 10(1): 75, 2024. PMID38346948.PMC10861597.

57.       Torres-Ayuso P., Katerji M., Mehlich D., Lookingbill S.A., Sabbasani V.R., Liou H., Casillas A.L., Chauhan S.S., Serwa R., Rubin M.R., Marusiak A.A., Swenson R.E., Warfel N.A., Brognard J. Pim1 targeted degradation prevents the emergence of chemoresistance in prostate cancer. Cell Chem Biol. 31(2): 326-337.e11, 2024. PMID38016478.

58.       Trujillo M.N., Jennings E.Q., Hoffman E.A., Zhang H., Phoebe A.M., Mastin G.E., Kitamura N., Reisz J.A., Megill E., Kantner D., Marcinkiewicz M.M., Twardy S.M., Lebario F., Chapman E., McCullough R.L., D’Alessandro A., Snyder N.W., Cusanovich D.A., Galligan J.J. Lactoylglutathione promotes inflammatory signaling in macrophages through histone lactoylation. Mol Metab. 81: 101888, 2024. PMID38307385.PMC10869261.

59.       Uboveja A., Huang Z., Buj R., Amalric A., Wang H., Tangudu N.K., Cole A.R., Megill E., Kantner D., Chatoff A., Ahmad H., Marcinkiewicz M.M., Disharoon J.A., Graff S., Dahl E.S., Hempel N., Stallaert W., Sidoli S., Bitler B.G., Long D.T., Snyder N.W., Aird K.M. Αkg-mediated carnitine synthesis promotes homologous recombination via histone acetylation. bioRxiv, 2024. PMID38370789.PMC10871207 (Pre-Print).

60.       Wang Y., He S., Calendo G., Bui T., Tian Y.Y., Lee C.Y., Zhou Y., Zhao X., Abraham C., Mo W.B., Chen M.M., Sanders-Braggs R., Madzo J., Issa J.P., Hexner E.O., Wiest D.L., Reshef R., Xue H.H., Zhang Y. Tissue-infiltrating alloreactive t cells require id3 to deflect pd-1-mediated immune suppression during gvhd. Blood. 143(2): 166-177, 2024. WOS:001155837900001.

61.       Wei S., Krause H.B., Geynisman D.M., Elliott A., Kutikov A., Uzzo R.G., Pei J., Barata P., Carneiro B., Heath E., Ryan C., Farrell A., Nabhan C., Ali-Fehmi R., Naqash A.R., Argani P.,McKay R.R., Molecular characterization of tfe3-rearranged renal cell carcinoma: A comparative study with papillary and clear cell renal cell carcinomas. Mod Pathol. 37(2): 100404, 2024. PMID38104891.

62.       Yang Y., Liu L., Tian Y., Gu M., Wang Y., Ashrafizadeh M., Reza Aref A., Cañadas I., Klionsky D.J., Goel A., Reiter R.J., Wang Y., Tambuwala M.,Zou J., Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics. Cancer Lett. 587: 216659, 2024. PMID38367897.

63.       Yong V., Rostmeyer K., Erkmen C.P. Reply from authors: Reading between the lines: Guidance for applicants and authors of letters of recommendation. J Thorac Cardiovasc Surg. 167(3): e61-e62, 2024. PMID37768259.

64.       Zabransky D.J., Chhabra Y., Fane M.E., Kartalia E., Leatherman J.M., Hüser L., Zimmerman J.W., Delitto D., Han S., Armstrong T.D., Charmsaz S., Guinn S., Pramod S., Thompson E.D., Hughes S.J., O’Connell J., Egan J.M., Jaffee E.M., Weeraratna A.T. Fibroblasts in the aged pancreas drive pancreatic cancer progression. Cancer Res, 2024. PMID38330147.

Learn More

• Talbot Library Staff Publications Guide
• Staff Publications Database

Getting Full Text Articles

There are four easy ways to get access to full text articles.  This post will briefly go over each option so you can decide the best way to get your articles. 

But first some general information to keep in mind.  Going directly to the publisher’s website, googling an article, or using a site like Google Scholar or Research Gate won’t get you access to the library’s paid subscriptions, you’ll always need to authenticate to get access to subscription journals.  The best way to get an article is through the library’s website.

Use PubMed

PubMed is a great resource for finding full text articles.  Using the Talbot Research Library’s special PubMed link will get you access to all the subscriptions held by the library while are searching in PubMed, you’ll easily see which articles are available and which one’s you’ll need to request an interlibrary loan for. 

Here are some basic instructions for using the Talbot Library’s PubMed Link to get articles:

• Go to the Talbot Research Library’s PubMed Link and copy the article title into the search bar.
• Once you find the article you want click on the title.
• On the right-hand side of the page, you will see a row of buttons.  Click on the teal-colored button that says Online Full Text (this is the Talbot button holdings button) you should see a login in screen.
• Use your Fox Chase login (the same one you use to access the Hub) this will take you to the publisher’s website where you can download the article as a pdf.
• If the library doesn’t hold the journal you need you’ll see a page to request an interlibrary loan.  Fill out the form and submit it to the library.  We will fill find the request and send the article to you via email.
• This subject Guide about finding full text has instructions outlining how to use PubMed to get full text articles, scroll to the bottom of the page.

Use the Talbot Library’s A to Z Journal Page

If you want to access an article directly from a publisher’s website, or you want to browse a journal title the best way to get full text access is to access the library’s journal A to Z list.  This list will show you the active subscriptions from the library as well as the range of dates held for each title.  The list will give you a link to the publisher’s website where you can authenticate and get access to the journal holdings directly.

Here are some instructions on accessing the library’s journal holdings list:

• Go the Talbot Library website and click on the Find Journals link on the main page.
• Search for the journal title you want to access in the search box.
• Find the title you want and click on the link to the publisher’s website.
• Use your Fox Chase login (the same one you use to access the Hub) you’ll now be able download the article as a pdf.

If the library doesn’t offer access to the title you need please use the article/book request form on library’s website to request a copy.

Find articles in a database

If you are searching in a database such as Web of Science or Cinahl and you find an article you want, you can usually access the full text article in the database.  Look for buttons or links that say Find Full Text, or Access full Text.  Once you select full text you should be asked to authenticate and if the library subscribes to the title you will get access to the article.  Each database is different but all of them have some type of full text access.  If you don’t see a link or you can’t access the article use the article/book request form on library’s website to request a copy.  A full list of library databases can be found here.

Find Open Access articles

More and more articles are being published as open access.  Sites like PubMed Central and browser extensions like UnpayWall can help you find open access articles available for free use.  You may also various versions of open access articles on preprint archives such as bioRxiv.

Another option is to search for open access journals on sites such as the Directory of Open Access Journals.

Finally, if you use either Browzine or Read by QxMD (both available free from the Talbot Research Library) you can get access to both paid subscriptions and open access articles in these apps.  Learn more about using them in our Current Awareness Subject Guide.

Finding the articles you need should be easy.  Remember if you need any assistance with articles or searches you can always reach out to the Talbot Librarians.  We are happy to help with all your research needs.  Call, email, or stop by Reimann 224 for assistance.

Learn More

• Talbot Library Homepage
• Talbot Library’s PubMed Link
• Talbot Library Article Request Form
• Find Full Text Subject Guide
• PubMed Central
• Talbot Library’s UnPaywall Guide
• Talbot Library Preprint Guide
• Talbot Library’s Browzine Guide
• Talbot Library’s Read by QxMD Guide

Staff Publications Received in January, 2024

1.        Andreeva T.V., Maluchenko N.V., Efremenko A.V., Lyubitelev A.V., Korovina A.N., Afonin D.A., Kirpichnikov M.P., Studitsky V.M., Feofanov A.V., Epigallocatechin gallate affects the structure of chromatosomes, nucleosomes and their complexes with parp1. Int J Mol Sci. 24(18)2023. PMID37762491. PMC10532227.

2.        Araya S., Hackley M., Amadio G.M., Deng M., Moss C., Reinhardt E., Walchak A., Tecce M.G., Patel S.A. Survey of surgeon-reported postoperative protocols for deep inferior epigastric perforator flap in breast reconstruction. Plast Reconstr Surg Glob Open. 11(11): e5402, 2023. PMID38025610. PMC10653572.

3.        Bai Y., Zhang X., Li Y., Qi F., Liu C., Ai X., Tang M., Szeto C., Gao E., Hua X., Xie M., Wang X., Tian Y., Chen Y., Huang G., Zhang J., Xiao W., Zhang L., Liu X., Yang Q., Houser S.R., Chen X., Protein kinase a is a master regulator of physiological and pathological cardiac hypertrophy. Circ Res, 2024. PMID38275112.

4.        Balderson B., Fane M., Harvey T.J., Piper M., Smith A., Bodén M. Systematic analysis of the transcriptional landscape of melanoma reveals drug-target expression plasticity. Brief Funct Genomics, 2024. PMID38183207.

5.        Barham D.W., Gross M.S., Lentz A.C., Simhan J., Yafi F.A.  AUA-recommended antibiotic prophylaxis for primary penile implantation results in a higher, not lower, risk for postoperative infection: A multicenter analysis. Reply. Journal of Urology. 209(5): 850-851, 2023. WOS:001144475200016.

6.        Barta J.A., Erkmen C.P., Shusted C.S., Myers R.E., Saia C., Cohen S., Wainwright J., Zeigler-Johnson C., Dako F., Wender R., Kane G.C., Vachani A., Rendle K.A., The Philadelphia lung cancer learning community: A multi-health-system, citywide approach to lung cancer screening. JNCI Cancer Spectr. 7(5)2023. PMID37713466. PMC10588937.

7.        Begum T.F., Patil V.S., Zhu L., Yeh M.C., González E., Fraser M.A., Lu W., Zhu S., Rubio-Torio N., Ma G.X., Tan Y.  Assessing physicians’ recommendations for hepatitis b virus (hbv) and hepatitis c virus (hcv) testing among minority populations in greater Philadelphia and New York City. J Community Health, 2024. PMID38286964.

8.        Borghaei H., O’Byrne K.J., Paz-Ares L., Ciuleanu T.E., Yu X., Pluzanski A., Nagrial A., Havel L., Kowalyszyn R.D., Valette C.A., Brahmer J.R., Reck M., Ramalingam S.S., Zhang L., Ntambwe I., Rabindran S.K., Nathan F.E., Balli D.,Wu Y.L., Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: Results of the phase III checkmate 227 part 2 trial. ESMO Open. 8(6): 102065, 2023. PMID37988950. PMC10774956.

9.        Burdo T.H., Chen C., Kaminski R., Sariyer I.K., Mancuso P., Donadoni M., Smith M.D., Sariyer R., Caocci M., Liao S., Liu H., Huo W., Zhao H., Misamore J., Lewis M.G., Simonyan V., Thompson E.E., Xu E.Y., Cradick T.J., Gordon J., Khalili K., Correction: Preclinical safety and biodistribution of crispr targeting siv in non-human primates. Gene Ther, 2024. PMID38212405.

10.      Cannon A.C., Budagyan K., Uribe-Alvarez C., Kurimchak A.M., Araiza-Olivera D., Cai K.Q., Peri S., Zhou Y., Duncan J.S., Chernoff J. Unique vulnerability of rac1-mutant melanoma to combined inhibition of cdk9 and immune checkpoints. Oncogene, 2024. PMID38243078.

11.      Chang C., Barham D.W., Dalimov Z., Swerdloff D., Sadeghi-Nejad H., Andrianne R., Sempels M., Hsieh T.C., Hatzichristodoulou G., Hammad M., Miller J., Osmonov D., Lentz A., Perito P., Suarez-Sarmiento A., Hotaling J., Gross K., Jones J.M., van Renterghem K., Park S.H., Nicholas Warner J., Ziegelmann M., Modgil V., Jones A., Pearce I., Gross M.S., Yafi F.A., Simhan J. Single dilation in primary inflatable penile prosthesis placement is associated with fewer corporal complications than sequential dilation. Urology. 181: 150-154, 2023. PMID37574145.

12.      Chen N., McGrath C.B., Ericsson C.I., Vaselkiv J.B., Rencsok E.M., Stopsack K.H., Guard H.E., Autio K.A., Rathkopf D.E., Enting D., Bitting R.L., Mateo J., Githiaka C.W., Chi K.N., Cheng H.H., Davis I.D., Anderson S.G., Badal S.A.M., Bjartell A., Russnes K.M., Heath E.I., Pomerantz M.M., Henegan J.C., Hyslop T., Esteban E., Omlin A., McDermott R., Fay A.P., Popoola A.A., Ragin C., Nowak J., Gerke T., Kantoff P.W., George D.J., Penney K.L.,Mucci L.A., Marital status, living arrangement, and survival among individuals with advanced prostate cancer in the international registry for men with advanced prostate cancer. Cancer Epidemiol Biomarkers Prev, 2024. PMID38189661.

13.      Deni W.H., Gao T., Wu J., Protocol for reconstituting peptides/peptidomimetics from dmso to aqueous buffers for circular dichroism analyses. STAR Protoc. 5(1): 102850, 2024. PMID38285735.

14.      Dotan E., Lynch S.M., Ryan J.C., Mitchell E.P.  Disparities in care of older adults of color with cancer: A narrative review. Cancer Med, 2024. PMID38234214.

15.      Emiloju O.E., Yin J., Koubek E., Reid J.M., Borad M.J., Lou Y., Seetharam M., Edelman M.J., Sausville E.A., Jiang Y., Kaseb A.O., Posey J.A., Davis S.L., Gores G.J., Roberts L.R., Takebe N., Schwartz G.K., Hendrickson A.E.W., Kaufmann S.H., Adjei A.A., Hubbard J.M., Costello B.A., Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort. Invest New Drugs, 2024. PMID38270822.

16.      Enke T., Keswani R., Triggs J., Gannavarapu B., Mittal C., Sinha J., Kwasny M.J., Komanduri S.  Adherence to quality indicators and best practices in surveillance endoscopy of Barrett’s esophagus: A video-based assessment. Endosc Int Open. 12(1): E90-e96, 2024. PMID38250164.PMC10798847.

17.      Gerber D.E., Wang Y., Ramalingam S.S., Bhalla S., Sun Z., Borghaei H., Brahmer J.R., Schiller J.H. Incidence, correlates, and prognostic significance of mixed response in advanced non-small cell lung cancer. Oncologist, 2024. PMID38207008.

18.      Hanna G.J., Chang S.S., Siddiqui F., Bain P.A., Takiar V., Ward M.C., Shukla M.E., Hu K.S., Robbins J., Witek M.E., Bakst R., Chandra R.A., Galloway T. ,Margalit D.N.  Imaging and biomarker surveillance for head and neck squamous cell carcinoma: A systematic review and appropriate use criteria document. Int J Radiat Oncol Biol Phys, 2023. PMID38168554.

19.      Harmange G., Hueros R.A.R., Schaff D.L., Emert B., Saint-Antoine M., Kim L.C., Niu Z., Nellore S., Fane M.E., Alicea G.M., Weeraratna A.T., Simon M.C., Singh A., Shaffer S.M., Disrupting cellular memory to overcome drug resistance. Nat Commun. 14(1): 7130, 2023. PMID37932277. PMC10628298.

20.      Heinrich M.C., Jones R.L., George S., Gelderblom H., Schöffski P., von Mehren M., Zalcberg J.R., Kang Y.K., Razak A.A., Trent J., Attia S., Le Cesne A., Siontis B.L., Goldstein D., Boye K., Sanchez C., Steeghs N., Rutkowski P., Druta M., Serrano C., Somaiah N., Chi P., Reichmann W., Sprott K., Achour H., Sherman M.L., Ruiz-Soto R., Blay J.Y., Bauer S., Ripretinib versus sunitinib in gastrointestinal stromal tumor: Ctdna biomarker analysis of the phase 3 intrigue trial. Nat Med, 2024. PMID38182785.

21.      Howell K.J., Jain A.  Endometrial cancer treatment: Long-term engagement strategies. Int J Radiat Oncol Biol Phys. 118(2): 321, 2024. PMID38220253.

22.      Iyer S.P., Johnston P.B., Barta S.K., Pralatrexate injection combined with chop for treatment of ptcl: Results from the fol-chop dose-finding phase 1 trial. Blood Adv. 8(2): 353-364, 2024. PMID38029357. PMC10788850.

23.      Kashyap D., Tanwar M., Rani C., Bagde P.H., Singh S., Varshney N., Saini V., Mishra A., Kumar R., Jha H.C.  Spectroscopic assessment of biomolecular changes in <i>helicobacter pylori</i> and epstein-barr virus co-infected gastric epithelial cells. Journal of Raman Spectroscopy, 2024. WOS:001146330500001.

24.      Kasper G., Momen M., Sorice K.A., Mayhand K.N., Handorf E.A., Gonzalez E.T., Devlin A., Brownstein K., Esnaola N., Fisher S.G.,Lynch S.M., Effect of neighborhood and individual-level socioeconomic factors on breast cancer screening adherence in a multi-ethnic study. BMC Public Health. 24(1): 63, 2024. PMID38166942. PMC10763410.

25.      Kehm R.D., Knight J.A., Houghton L.C., McDonald J.A., Schwartz L.A., Goldberg M., Chung W.K., Frost C.J., Wei Y., Bradbury A.R., Keegan T.H.M., Daly M.B., Buys S.S., Andrulis I.L., John E.M., Terry M.B., Childhood physical activity and pubertal timing: Findings from the legacy girls study. Int J Epidemiol, 2024. PMID38205889.

26.      Kumar S.K., Callander N.S., Adekola K., Anderson L.D., Jr., Baljevic M., Baz R., Campagnaro E., Castillo J.J., Costello C., D’Angelo C., Derman B., Devarakonda S., Elsedawy N., Garfall A., Godby K., Hillengass J., Holmberg L., Htut M., Huff C.A., Hultcrantz M., Kang Y., Larson S., Lee H., Liedtke M., Martin T., Omel J., Robinson T., Rosenberg A., Sborov D., Schroeder M.A., Sherbenou D., Suvannasankha A., Valent J., Varshavsky-Yanovsky A.N., Snedeker J., Kumar R., Waldenström macroglobulinemia/lymphoplasmacytic lymphoma, version 2.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 22(1d): e240001, 2024. PMID38244272.

27.      Li Y., He X., Wheldon C., Wu Y., Prosperi M., Shenkman E.A., Jaffee M.S., Guo J., Wang F., Guo Y., Bian J., A computable phenotype for the identification of sexual and gender minorities in electronic health records. AMIA Annu Symp Proc. 2023: 1057-1066, 2023. PMID38222414. PMC10785915.

28.      Liao R.S., Ruan H.T., Jang A., Huynh M., Nadal Rios R., Hoffman-Censits J.H., Wei S., Mian O.Y., Barata P.C , Emerging insights in small-cell carcinoma of the genitourinary tract: From diagnosis to novel therapeutic horizons. Am Soc Clin Oncol Educ Book. 44: e430336, 2024. PMID38176691.

29.      Lukez A., Handorf E., Mendenhall N.P., Henderson R.H., Stish B.J., Davis B.J., Hallman M., Horwitz E.M., Vapiwala N., Wong J.K., A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancer. Prostate. 84(4): 395-402, 2024. PMID38108113.

30.      Magee D.E., Bukavina L. ,Correa A., Reply: Taking a stand: No conferences in anti-abortion states. J Urol. 211(2): 324-325, 2024. PMID38193407.

31.      Murayama T., Nakayama J., Jiang X., Miyata K., Morris A.D., Cai K.Q., Prasad R.M., Ma X., Efimov A., Belani N., Gerstein E.R., Tan Y., Zhou Y., Kim W., Maruyama R., Campbell K.S., Chen L., Yang Y., Balachandran S., Canadas I., Targeting dhx9 triggers tumor-intrinsic interferon response and replication stress in small cell lung cancer. Cancer Discov, 2024. PMID38189443.

32.      Najafali D., Reiche E., Araya S., Camacho J.M., Liu F.C., Johnstone T., Patel S.A., Morrison S.D., Dorafshar A.H.,Fox P.M., Bard versus the 2022 American Society of Plastic Surgeons in-service examination: Performance on the examination in its intern year. Aesthetic Surgery Journal Open Forum. 6: ojad066, 2024. WOS:001138526600001. PMC10776237.

33.      Parker C.S., Zhou L., Prabhu V.V., Lee S., Miner T.J., Ross E.A., El-Deiry W.S., Onc201/tic10 plus tly012 anti-cancer effects via apoptosis inhibitor downregulation, stimulation of integrated stress response and death receptor dr5 in gastric adenocarcinoma. Am J Cancer Res. 13(12): 6290-6312, 2023. PMID38187068.PMC10767330.

34.      Purev E., Bahmed K.,Kosmider B., Alveolar organoids in lung disease modeling. Biomolecules. 14(1)2024. PMID38254715. PMC10813493.

35.      Rodriguez A.L., Cappelletti L., Kurian S.M., Passio C., Rux S., Transitional care navigation. Semin Oncol Nurs: 151580, 2024. PMID38290928.

36.      Sahin Y., Wang Y.L., Pei J., Mansoor N., Styler M., Testa J.R., Nejati R., Multiple genomic alterations, including a novel aff4::Irf1 fusion gene, in a treatment-refractory blastic plasmacytoid dendritic-cell neoplasm: A case report and literature review. Int J Mol Sci. 25(1)2023. PMID38203475. PMC10778852.

37.      Schmults C.D., Blitzblau R., Aasi S.Z., Alam M., Amini A., Bibee K., Bolotin D., Bordeaux J., Chen P.L., Contreras C.M., DiMaio D., Donigan J.M., Farma J.M., Ghosh K., Harms K., Ho A.L., Lukens J.N., Manber S., Mark L., Medina T., Nehal K.S., Nghiem P., Olino K., Park S., Patel T., Puzanov I., Rich J., Sekulic A., Shaha A.R., Srivastava D., Thomas V., Tomblinson C., Venkat P., Xu Y.G., Yu S., Yusuf M., McCullough B., Espinosa S.  NCCN guidelines® insights: Merkel cell carcinoma, version 1.2024. J Natl Compr Canc Netw. 22(1d): e240002, 2024. PMID38244274.

38.      Shah S.M., Demidova E.V., Ringenbach S., Faezov B., Andrake M., Gandhi A., Mur P., Viana-Errasti J., Xiu J., Swensen J., Valle L., Dunbrack R.L., Jr., Hall M.J., Arora S. Exploring co-occurring pole exonuclease and non-exonuclease domain mutations and their impact on tumor mutagenicity. Cancer Res Commun. 4(1): 213-25, 2024. PMID38207205.PMC10812383.

39.      Siminoff L.A., Alolod G.P., McGregor H., Hasz R.D., Mulvania P.A., Barker L.K., Gardiner H.M., Developing online communication training to request donation for vascularized composite allotransplantation (vca): Improving performance to match new us organ donation targets. BMC Med Educ. 24(1): 77, 2024. PMID38254115.PMC10802059.

40.      Sterling J., Simhan J., Flynn B.J., Rusilko P., Franca W.A., Ramirez E.A., Angulo J.C., Martins F.E., Patel H.V., Higgins M., Swerdloff D., Nikolavsky D., Multi-institutional outcomes of dorsal onlay buccal mucosal graft urethroplasty in patients with postprostatectomy, postradiation anastomotic stenosis. J Urol: 101097ju0000000000003848, 2024. PMID38275201.

41.      Tawfik Z.A., Farid M.E., Shahat K.M.E., Hussein A.A., Eldib A.A., Al Etreby M., A dosimetric study comparing cyberknife and linac-based stereotactic radiotherapy or radiosurgery treatments. Journal of Radiation Research and Applied Sciences. 17(1)2024. WOS:001135169000001.

42.      Toma M.M., Karami A., Nieborowska-Skorska M., Chirtala K.N., Pepek M., Hadzijusufovic E., Stoklosa T., Valent P., Skorski T. Clonal medicine targeting DNA damage response eradicates leukemia. Leukemia, 2024. PMID38228681.

43.      Ubba V., Joseph S., Awe O., Jones D., Dsilva M.K., Feng M., Wang J., Fu X., Akbar R.J., Bodnar B.H., Hu W., Wang H., Yang X., Yang L., Yang P., Taib B., Ahima R., Divall S.,Wu S., Reproductive profile of neuronal androgen receptor knockout female mice with a low dose of dht. Endocrinology. 165(3)2024. PMID38156784. PMC10794876.

44.      Whitehead R.A., Patel E.A., Liu J.C., Bhayani M.K.  Racial disparities in head and neck cancer: It’s not just about access. Otolaryngol Head Neck Surg, 2024. PMID38258967.

45.      Widstrom N.E., Andrianov G.V., Heier J.L., Heier C., Karanicolas J., Parker L.L.  Novel substrate prediction for the tam family of rtks using phosphoproteomics and structure-based modeling. ACS Chem Biol. 19(1): 117-128, 2024. PMID38159292.

46.      Williams A.D., Weiss A., Recent advances in the upfront surgical management of the axilla in patients with breast cancer. Clin Breast Cancer, 2023. PMID38220539.

47.      Yang J., Liu C., Deng W., Wu D., Weng C., Zhou Y., Wang K., Enhancing phenotype recognition in clinical notes using large language models: Phenobcbert and phenogpt. Patterns (N Y). 5(1): 100887, 2024. PMID38264716. PMC10801236.

48.      Zanti M., O’Mahony D.G., Parsons M.T., Li H.Y., Dennis J., Aittomäkkiki K., Andrulis I.L., Anton-Culver H., Aronson K.J., Augustinsson A., Becher H., Bojesen S.E., Bolla M.K., Brenner H., Brown M.A., Buys S.S., Canzian F., Caputo S.M., Castelao J.E., Chang-Claude J., Czene K., Daly M.B., De Nicolo A., Devilee P., Dörk T., Dunning A.M., Dwek M., Eccles D.M., Engel C., Evans D.G., Fasching P.A., Gago-Dominguez M., García-Closas M., García-Sáenz J.A., Gentry-Maharaj A., Geurts-Giele W.R.R., Giles G.G., Glendon G., Goldberg M.S., Garcia E.B.G., Güendert M., Guénel P., Hahnen E., Haiman C.A., Hall P., Hamann U., Harkness E.F., Hogervorst F.B.L., Hollestelle A., Hoppe R., Hopper J.L., Houdayer C., Houlston R.S., Howell A., Investigators A., Jakimovska M., Jakubowska A., Jernström H., John E.M., Kaaks R., Kitahara C.M., Koutros S., Kraft P., Kristensen V.N., Lacey J., Lambrechts D., Léoné M., Lindblom A., Lush M., Mannermaa A., Manoochehri M., Manoukian S., Margolin S., Martinez M.E., Menon U., Milne R.L., Monteiro A.N., Murphy R.A., Neuhausen S.L., Nevanlinna H., Newman W.G., Offit K., Park S.K., James P., Peterlongo P., Peto J., Plaseska-Karanfilska D., Punie K., Radice P., Rashid M.U., Rennert G., Romero A., Rosenberg E.H., Saloustros E., Sandler D.P., Schmidt M.K., Schmutzler R.K., Shu X.O., Simard J., Southey M.C., Stone J., Stoppa-Lyonnet D., Tamimi R.M., Tapper W.J., Taylor J.A., Teo S.H., Teras L.R., Terry M.B., Thomassen M., Troester M.A., Vachon C.M., Vega A., Vreeswijk M.P.G., Wang Q., Wappenschmidt B., Weinberg C.R., Wolk A., Zheng W., Feng B.J., Couch F.J., Spurdle A.B., Easton D.F., Goldgar D.E., Michailidou K.,Collaborators G.-H.S., A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: Application to brca1 and brca2. Human Mutation. 2023: 1-17, 2023. WOS:001091490300001.

Learn More

• Talbot Library Staff Publications Guide
• Staff Publications Database

Staff Publications Received in December, 2023

1.         Abu-Rustum N.R., Yashar C.M., Arend R., Barber E., Bradley K., Brooks R., Campos S.M., Chino J., Chon H.S., Crispens M.A., Damast S., Fisher C.M., Frederick P., Gaffney D.K., Gaillard S., Giuntoli R., Glaser S., Holmes J., Howitt B.E., Lea J., Mantia-Smaldone G., Mariani A., Mutch D., Nagel C., Nekhlyudov L., Podoll M., Rodabaugh K., Salani R., Schorge J., Siedel J., Sisodia R., Soliman P., Ueda S., Urban R., Wyse E., McMillian N.R., Aggarwal S.,Espinosa S., NCCN Guidelines® Insights: Cervical cancer, version 1.2024. J Natl Compr Canc Netw. 21(12): 1224-1233, 2023. PMID38081139.

2.         Behrens S., Lillemoe H.A., Dineen S.P., Russell M.C., Visser B., Berman R.S., Farma J.M., Grubbs E.,Davis J.L., Perceptions of readiness for practice after complex general surgical oncology fellowship: A survey study. Ann Surg Oncol. 31(1): 31-41, 2024. PMID37936022.PMC10695882.

3.         Benton D.,Chernoff J., Rhoa drivers take alternate routes in gastric cancer. Sci Signal. 16(816): eadk9171, 2023. PMID38113334.

4.         Berman E., Shah N.P., Deninger M., Altman J.K., Amaya M., Begna K., Bhatia R., Chan O., Collins R., Curtin P., DeAngelo D.J., Drazer M., Maness L., Metheny L., Mohan S., Moore J., Oehler V., Pratz K., Pusic I., Rose M., Shomali W., Smith B.D., Styler M., Sweet K., Talpaz M., Tanaka T., Tantravahi S., Tsai S., Vaughn J., Welborn J., Yang D., Mauro M., Cortes J., Radich J.,Druker B., Cml and the who: Why? J Clin Oncol: Jco2301689, 2023. PMID38086008.

5.         Budde L.E., Olszewski A.J., Assouline S., Lossos I.S., Diefenbach C., Kamdar M., Ghosh N., Modi D., Sabry W., Naik S., Mehta A., Nakhoda S.K., Smith S.D., Dorritie K., Jia T., Pham S., Huw L.Y., Jing J., Wu H., Ead W.S., To I., Batlevi C.L., Wei M.C.,Chavez J.C., Mosunetuzumab with polatuzumab vedotin in relapsed or refractory aggressive large b cell lymphoma: A phase 1b/2 trial. Nat Med, 2023. PMID38072960.

6.         Calbert M.L., Chandramouly G., Adams C.M., Saez-Ayala M., Kent T., Tyagi M., Ayyadevara V., Wang Y., Krais J.J., Gordon J., Atkins J., Toma M.M., Betzi S., Boghossian A.S., Rees M.G., Ronan M.M., Roth J.A., Goldman A.R., Gorman N., Mitra R., Childers W.E., Graña X., Skorski T., Johnson N., Hurtz C., Morelli X., Eischen C.M.,Pomerantz R.T., 4′-ethynyl-2′-deoxycytidine (edc) preferentially targets lymphoma and leukemia subtypes by inducing replicative stress. Mol Cancer Ther, 2023. PMID38064712.

7.         Chen Z., Cheng Z., Ding C., Cao T., Chen L., Wang H., Li J.,Huang X., Ros-activated trpm2 channel: Calcium homeostasis in cardiovascular/renal system and speculation in cardiorenal syndrome. Cardiovasc Drugs Ther, 2023. PMID38108918.

8.         Chen J., Bearz A., Kim D.W., Mamdani H., Bauman J., Chiari R., Ou S.I., Solomon B.J., Soo R.A., Felip E., Shaw A.T., Thurm H., Clancy J.S., Lee K., O’Gorman M., Tanski C.,Pithavala Y.K., Evaluation of the effect of lorlatinib on cyp2b6, cyp2c9, ugt, and p-glycoprotein substrates in patients with advanced non-small cell lung cancer. Clin Pharmacokinet, 2023. PMID38079095.

9.         Chiba M., Shimono J., Suto K., Ishio T., Endo T., Goto H., Hasegawa H., Maeda M., Teshima T., Yang Y.,Nakagawa M., Whole genome crispr screening identifies molecular mechanisms of pd-l1 expression in adult t-cell leukemia/lymphoma. Blood, 2023. PMID38142436.

10.       Chwistek M., Sherry D., Kinczewski L., Silveira M.J.,Davis M., Should buprenorphine be considered a first-line opioid for the treatment of moderate to severe cancer pain. Journal of Pain and Symptom Management. 66(5): e638-e643, 2023. WOS:001103584900001.

11.       Craig J.M., Gerhard G.S., Sharma S., Yankovskiy A., Miura S.,Kumar S., Methods for estimating personal disease risk and phylogenetic diversity of hematopoietic stem cells. Mol Biol Evol, 2023. PMID38124397.

12.       Dineen S.P., Behrens S., Grubbs E.G., Davis J.L.,Farma J.M., ASO author reflections: Surgical oncology fellowship training: Is training hitting the mark? Ann Surg Oncol, 2023. PMID38062295.

13.       Erkmen C.P., Chin K., Agarwal S., Adnan S., Cooke D.T.,Merrill W., The cost of being a woman in academic cardiothoracic surgery: Joint collaboration of the society of thoracic surgeons workforces on diversity, equity, and inclusion and cardiothoracic surgery practice models. Ann Thorac Surg. 117(1): 59-67, 2024. PMID37543350.

14.       Frosch Z.A.K., Jacobs L.M., O’Brien C.S., Brecher A.C., McKeown C.J., Lynch S.M., Geynisman D.M., Hall M.J., Edelman M.J., Bleicher R.J., Fang C.Y. “Cancer’s a demon”: A qualitative study of fear and multilevel factors contributing to cancer treatment delays. Support Care Cancer. 32(1): 13, 2023. PMID38060063.

15.       Hadadi A., Krause H.B., Elliott A., Brown J.T., Nazha B., Harik L.R., Carthon B.C., Miron B., Nabhan C., Barata P.C., Saleh M., Yang Y., McKay R.R.,Bilen M.A., The genomic landscape of urothelial carcinoma with high and low erbb2 expression. Cancers (Basel). 15(24)2023. PMID38136267.PMC10742086.

16.       Hasan A., Khamjan N., Lohani M.,Mir S.S., Targeted inhibition of hsp90 in combination with metformin modulates programmed cell death pathways in a549 lung cancer cells. Appl Biochem Biotechnol. 195(12): 7338-7378, 2023. PMID37000353.

17.       Hayek H., Rehbini O., Kosmider B., Brandt T., Chatila W., Marchetti N., Criner G.J., Bolla S., Kishore R., Bowler R.P., Bahmed K. The regulation of fasn by exosomal mir-143-5p and mir-342-5p in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol, 2023. PMID38117249.

18.       Hu B., Moiseev D., Schena I., Faezov B., Dunbrack R., Jonathan C. [Chernoff, J], Li J. Pak2 is necessary for myelination in the peripheral nervous system. Brain, 2023. PMID38079473.

19.       Kumar S.K., Callander N.S., Adekola K., Anderson L.D., Baljevic M., Baz R., Campagnaro E., Castillo J.J., Costello C., D’Angelo C., Devarakonda S., Elsedawy N., Garfall A., Godby K., Hillengass J., Holmberg L., Htut M., Huff C.A., Hultcrantz M., Kang Y., Larson S., Lee H.C., Liedtke M., Martin T., Omel J., Robinson T., Rosenberg A., Sborov D., Schroeder M.A., Sherbenou D., Suvannasankha A., Valent J., Varshavsky-Yanovsky A.N., Kumar R.,Snedeker J., Multiple myeloma, version 2.2024, NCCN Clinical Practice Guidelines in oncology. J Natl Compr Canc Netw. 21(12): 1281-1301, 2023. PMID38081133.

20.       Loghavi S., Kanagal-Shamanna R., Khoury J.D., Medeiros L.J., Naresh K.N., Nejati R.,Patnaik M.M., Fifth edition of the world health classification of tumors of the hematopoietic and lymphoid tissue: Myeloid neoplasms. Mod Pathol. 37(2): 100397, 2023. PMID38043791.

21.       Lukez A., Handorf E., Mendenhall N.P., Henderson R.H., Stish B.J., Davis B.J., Hallman M., Horwitz E.M., Vapiwala N.,Wong J.K., A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancer. Prostate, 2023. PMID38108113.

22.       Meric-Bernstam F., Rothe M., Mangat P.K., Garrett-Mayer E., Gutierrez R., Ahn E.R., Cannon T.L., Powell S., Krauss J.C., Reynolds C.M., von Mehren M., Behl D., Calfa C.J., Duvivier H.L., Kaplan H.G., Livingston M.B., Sharma M.R., Urba W.J., Grantham G.N., Hinshaw D.C., Gregory A., Halabi S.,Schilsky R.L., Cobimetinib plus vemurafenib in patients with solid tumors with braf mutations: Results from the targeted agent and profiling utilization registry study. JCO Precis Oncol. 7: e2300385, 2023. PMID38096472.PMC10735080.

23.       O’Brien J.,Bodor J.N., Perioperative immunotherapy in non-small cell lung cancer. Curr Treat Options Oncol, 2023. PMID38091187.

24.       Omil-Lima D.,Kutikov A., Editorial comment. Urol Pract. 11(1): 47-48, 2024. PMID38051207.

25.       Parham L.R., Williams P.A., Katada K., Nettleford S.K., Chatterji P., Acheampong K.K., Danan C.H., Ma X., Simon L.A., Naughton K.E., Karakasheva T., McMillan E.A., Whelan K.A., Brady D.C., Shaffer S.M.,Hamilton K.E., Igf2bp1/imp1 deletion enhances a facultative stem cell state via regulation of map1lc3b. Cell Mol Gastroenterol Hepatol, 2023. PMID38081361.

26.       Plimack E.R., Powles T., Stus V., Gafanov R., Nosov D., Waddell T., Alekseev B., Pouliot F., Melichar B., Soulières D., Borchiellini D., McDermott R.S., Vynnychenko I., Chang Y.H., Tamada S., Atkins M.B., Li C., Perini R., Molife L.R., Bedke J.,Rini B.I., Corrigendum to “pembrolizumab plus axitinib versus sunitinib as first-line treatment of advanced renal cell carcinoma: 43-month follow-up of the phase 3 keynote-426 study” [eur urol 84(5) (2023) 449-454]. Eur Urol, 2023. PMID38071169.

27.       Price A.D., Foote D.C., Woeste M.R., Winer L.K., Montgomery K.B., Al Yafi M., Nahmias J.T., Postlewait L.M., Sutton J.M., Quillin R.C., Cortez A.R., Consortium U.R., Defining the disparity: A multi-institutional analysis of factors associated with decreased resident operative experience. Journal of Surgical Research. 293: 647-655, 2024. WOS:001103579100001.

28.       Raddi R.M.,Voelz V.A., Markov state model of solvent features reveals water dynamics in protein-peptide binding. J Phys Chem B. 127(50): 10682-10690, 2023. PMID38078851.

29.       Rencsok E.M., Slopen N., McManus H.D., Autio K.A., Morgans A.K., McSwain L., Barata P., Cheng H.H., Dreicer R., Gerke T., Green R., Heath E.I., Howard L.E., McKay R.R., Nowak J., Pileggi S., Pomerantz M.M., Rathkopf D.E., Tagawa S.T., Whang Y.E., Ragin C., Odedina F.T., Kantoff P.W., Vinson J., Villanti P., Haneuse S., Mucci L.A.,George D.J., Pain and its association with survival for Black and White individuals with advanced prostate cancer in the US. Cancer Res Commun, 2023. PMID38108490.

30.       Rohatgi N., Rothe M., Mangat P.K., Garrett-Mayer E., Meric-Bernstam F., Pisick E., Alese O.B., Reynolds C.M., Thota R., Vaccaro G.M., von Mehren M., Arend R.C., Chiu V.K., Duvivier H.L., Gold P.J., Hack K., Marr A.S., Winer A., Grantham G.N., Hinshaw D.C., Gregory A., Halabi S.,Schilsky R.L., Nivolumab plus ipilimumab in patients with solid tumors with atm mutations: Results from the targeted agent and profiling utilization registry (tapur) study. JCO Precis Oncol. 7: e2300279, 2023. PMID38039429.

31.       Sommer S.B., Barroso J.V., Bass S.B., Congema M.R., Schoemann A.M.,Caiola C.E., Peer advice for women living with hiv in the southern USA. Cult Health Sex: 1-16, 2023. PMID38047389.

32.       Thomas P.G., Shubina M.,Balachandran S., Zbp1/dai-dependent cell death pathways in influenza a virus immunity and pathogenesis. Curr Top Microbiol Immunol. 442: 41-63, 2023. PMID31970498.

33.       Vose J.M., Fu K., Wang L., Mansoor A., Stewart D., Cheng H., Smith L., Yuan J., Qureishi H.N., Link B.K., Cessna M.H., Barr P.M., Kahl B.S., McKinney M.S., Khan N., Advani R.H., Martin P., Goy A.H., Phillips T.J., Mehta A., Kamdar M., Crump M., Pro B., Flowers C.R., Jacobson C.A., Smith S.M., Stephens D.M., Bachanova V., Jin Z., Wu S., Hernandez-Ilizaliturri F., Torka P., Anampa-Guzmán A., Kashef F., Li X., Sharma S., Greiner T.C., Armitage J.O., Lunning M., Weisenburger D.D., Bociek R.G., Iqbal J., Yu G.,Bi C., Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: A report from the North American mantle cell lymphoma consortium. J Hematol Oncol. 16(1): 122, 2023. PMID38104096.PMC10725579.

34.       Wang R., Uzzo N., Chelluri R., Mackrides N., Ehya H., Pei J., Baldwin D.A., Wasik M.A., Wei S.,Uzzo R., Genomic evolution of oligometastatic clear cell renal cell carcinoma presenting two decades following radical nephrectomy. Urology, 2023. PMID38128834.

35.       Wei S., Krause H.B., Geynisman D.M., Elliott A., Kutikov A., Uzzo R.G., Pei J., Barata P., Carneiro B., Heath E., Ryan C., Farrell A., Nabhan C., Ali-Fehmi R., Naqash A.R., Argani P.,McKay R.R., Molecular characterization of tfe3-rearranged renal cell carcinoma, a comparative study with papillary and clear cell renal cell carcinomas. Mod Pathol: 100404, 2023. PMID38104891.

36.       Zhang Z., Zhang Y., Liu C., Shao J., Chen Y., Zhu Y., Zhang L., Qin B., Kong Z., Wang X., Wang Y., Huang D., Liu L., Zhou Y., Tao R., Yang Z., Liu M.,Zhao W., A real-world study of immune checkpoint inhibitors in advanced triple-negative breast cancer. Cancer Innov. 2(3): 172-180, 2023. PMID38089401.PMC10686160.

Learn More

• Talbot Library Staff Publications Guide
• Staff Publications Database

Staff Publications Received in November, 2023

1.         Achimba F., Faezov B., Cohen B., Dunbrack R., Holford M. Targeting dysregulated ion channels in liver tumors with venom peptides. Mol Cancer Ther, 2023. PMID38015557.

2.         Akumuo R.C., Villano A.M., Reddy S.P., Devarajan K., Barrak D., Reddy S.S., Type of neoadjuvant treatment strategy is associated with differential pathologic responses in pancreatic ductal adenocarcinoma. Am J Surg, 2023. PMID37977978.

3.         Araya S., Hackley M., Amadio G.M., Deng M., Moss C., Reinhardt E., Walchak A., Tecce M.G., Patel S.A.  Survey of surgeon-reported postoperative protocols for deep inferior epigastric perforator flap in breast reconstruction. Plast Reconstr Surg Glob Open. 11(11): e5402, 2023. PMID38025610. PMC10653572.

4.         Baqai U., Kurimchak A.M., Trachtenberg I.V., Purwin T.J., Haj J.I., Han A., Luo K., Pachon N.F., Jeon A., Chua V., Davies M.A., Gutkind J.S., Benovic J.L., Duncan J.S., Aplin A.E., Kinome profiling identifies mark3 and stk10 as potential therapeutic targets in uveal melanoma. J Biol Chem. 299(12): 105418, 2023. PMID37923138.

5.         Behrens S., Lillemoe H.A., Dineen S.P., Russell M.C., Visser B., Berman R.S., Farma J.M., Grubbs E.,Davis J.L., Perceptions of readiness for practice after complex general surgical oncology fellowship: A survey study. Ann Surg Oncol, 2023. PMID37936022.

6.         Behrens S., Lillemoe H.A., Dineen S.P., Russell M.C., Visser B., Berman R.S., Farma J.M., Grubbs E.,Davis J.L., ASO visual abstract: Perceptions of readiness for practice after complex general surgical oncology fellowship: A survey study. Ann Surg Oncol, 2023. PMID38036928.

7.         Berg D., de Lima P.N., Knudsen A.B., Rutter C.M., Weinberg D., Lansdorp-vogelaar I.  NordICC trial results in line with expected colorectal cancer mortality reduction after colonoscopy: A modeling study. Gastroenterology. 165(4): 1077-1079 e2, 2023. PMIDWOS:001084550500001.

8.         Borghaei H., O’Byrne K.J., Paz-Ares L., Ciuleanu T.E., Yu X., Pluzanski A., Nagrial A., Havel L., Kowalyszyn R.D., Valette C.A., Brahmer J.R., Reck M., Ramalingam S.S., Zhang L., Ntambwe I., Rabindran S.K., Nathan F.E., Balli D.,Wu Y.L., Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: Results of the phase III checkmate 227 part 2 trial. ESMO Open. 8(6): 102065, 2023. PMID37988950.

9.         Broman K.K., Hughes T.M., Bredbeck B.C., Sun J., Kirichenko D., Carr M.J., Sharma A., Bartlett E.K., Nijhuis A.A.G., Thompson J.F., Hieken T.J., Kottschade L., Downs J., Gyorki D.E., Stahlie E., van Akkooi A., Ollila D.W., O’Shea K., Song Y., Karakousis G., Moncrieff M., Nobes J., Vetto J., Han D., Hotz M., Farma J.M., Deneve J.L., Fleming M.D., Perez M., Baecher K., Lowe M., Bagge R.O., Mattsson J., Lee A.Y., Berman R.S., Chai H., Kroon H.M., Teras J., Teras R.M., Farrow N.E., Beasley G.M., Hui J.Y.C., Been L., Kruijff S., Sinco B., Sarnaik A.A., Sondak V.K., Zager J.S.,Dossett L.A., International center-level variation in utilization of completion lymph node dissection and adjuvant systemic therapy for sentinel lymph node-positive melanoma at major referral centers. Ann Surg. 277(5): e1106-e1115, 2023. PMID35129464. PMC10097464.

10.       Camargo A.C., Constantino F.B., Santos S.A., Colombelli K.T., Portela L.M., Fioretto M.N., Barata L.A., Valente G.T., Moreno C.S., Justulin L.A., Deregulation of abcg1 early in life contributes to prostate carcinogenesis in maternally malnourished offspring rats. Mol Cell Endocrinol. 580: 112102, 2023. PMID37972683.

11.       Canepa E., Parodi-Rullan R., Vazquez-Torres R., Gamallo-Lana B., Guzman-Hernandez R., Lemon N.L., Angiulli F., Debure L., Ilies M.A., Østergaard L., Wisniewski T., Gutiérrez-Jiménez E., Mar A.C., Fossati S., FDA-approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness. Alzheimers Dement. 19(11): 5048-5073, 2023. PMID37186121. PMC10600328.

12.       Chanda A.K., Egleston B.L., Bai T., Vucetic S., Acm. Medcv: An interactive visualization system for patient cohort identification from medical claim data. in 31st ACM International Conference on Information and Knowledge Management (CIKM). 2022. Atlanta, GA.

13.       Daly M.B., Pal T., Maxwell K.N., Churpek J., Kohlmann W., Alhilli Z., Arun B., Buys S.S., Cheng H., Domchek S.M., Friedman S., Giri V., Goggins M., Hagemann A., Hendrix A., Hutton M.L., Karlan B.Y., Kassem N., Khan S., Khoury K., Kurian A.W., Laronga C., Mak J.S., Mansour J., McDonnell K., Menendez C.S., Merajver S.D., Norquist B.S., Offit K., Rash D., Reiser G., Senter-Jamieson L., Shannon K.M., Visvanathan K., Welborn J., Wick M.J., Wood M., Yurgelun M.B., Dwyer M.A., Darlow S.D., Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic, version 2.2024 featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network. 21(10): 1000-1010, 2023. WOS:001097901600007.

14.       Demetriadou C., Kantner D.S., Snyder N.W., Dietary branched-chain amino acids get to the heart of h3k23pr. J Clin Invest. 133(22)2023. PMID37966112.PMC10645384.

15.       Dudgeon C., Casabianca A., Harris C., Ogier C., Bellina M., Fiore S., Bernet A., Ducarouge B., Goldschneider D., Su X., Pitarresi J., Hezel A., De S., Narrow W., Soliman F., Shields C., Vendramini-Costa D.B., Prela O., Wang L., Astsaturov I., Mehlen P., Carpizo D.R., Netrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retinoid, and elf3 signaling. Cell Rep. 42(11): 113369, 2023. PMID37922311.

16.       Enofe N., Garcia Russo M., Kadakia E.R., Axelrod P.I., Friedberg J., Su S., Kumar R., Mediastinal mass, cancer, or infection, atypical paraesophageal actinomycosis infection, clinical and surgical approach. Am Surg: 31348231211039, 2023. PMID38009532.

17.       Fernandez S.V., Tan Y.F., Rao S., Fittipaldi P., Sheriff F., Borghaei H., Dotan E., Winn J.S., Edelman M.J., Treat J., Judd J., Alpaugh R.K., Wang Y.L., Yu J.Q., Wasik M., Baldwin D.A., Validation of a molecular diagnostic test for circulating tumor DNA by next-gen sequencing. Int J Mol Sci. 24(21)2023. PMID37958763.PMC10648112.

18.       Flashner S., Shimonosono M., Tomita Y., Matsuura N., Ohashi S., Muto M., Klein-Szanto A.J., Diehl J.A., Chen C.H., Mochly-Rosen D., Weinberg K.I.,Nakagawa H., Aldh2 dysfunction and alcohol cooperate in cancer stem cell enrichment. Carcinogenesis, 2023. PMID37978873.

19.       Gomaa S., Lopez A., Slamon R., Smith R., Lapitan E., Nightingale G., Miller S.M.,Wen K.Y., The lived experience of patients with breast cancer on adjuvant endocrine therapy: Side effects and coping strategies during the first year of medication initiation. Support Care Cancer. 31(12): 719, 2023. PMID38008817.

20.       Harmange G., Hueros R.A.R., Schaff D.L., Emert B., Saint-Antoine M., Kim L.C., Niu Z., Nellore S., Fane M.E., Alicea G.M., Weeraratna A.T., Simon M.C., Singh A.,Shaffer S.M., Disrupting cellular memory to overcome drug resistance. Nat Commun. 14(1): 7130, 2023. PMID37932277.PMC10628298.

21.       Hu J., Hameed M.R., Agaram N.P., Whiting K.A., Qin L.X., Villano A.M., O’Connor R.B., Rozenberg J.M., Cohen S., Prendergast K., Kryeziu S., White R.L., Posner M.C., Socci N.D., Gounder M.M., Singer S., Crago A.M.  Pdgfrβ signaling cooperates with β-catenin to modulate c-abl and biologic behavior of desmoid-type fibromatosis. Clin Cancer Res, 2023. PMID37943631.

22.       Hurley M.F.D., Raddi R.M., Pattis J.G.,Voelz V.A., Expanded ensemble predictions of absolute binding free energies in the sampl9 host-guest challenge. Phys Chem Chem Phys, 2023. PMID38009066.

23.       Ji J., Bae M., Sun C.L., Wildes T.M., Freedman R.A., Magnuson A., O’Connor T., Moy B., Klepin H.D., Chapman A.E., Tew W.P., Dotan E., Fenton M.A., Kim H., Katheria V., Gross C.P., Cohen H.J., Muss H.B., Sedrak M.S., Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter hope trial. Cancer, 2023. PMID37962093.

24.       Jonasch E., Bauer T.M., Papadopoulos K.P., Plimack E.R., Merchan J.R., McDermott D.F., Dror Michaelson M., Appleman L.J., Roy A., Perini R.F., Liu Y., Choueiri T.K., Phase i litespark-001 study of belzutifan for advanced solid tumors: Extended 41-month follow-up in the clear cell renal cell carcinoma cohort. Eur J Cancer. 196: 113434, 2023. PMID38008031.

25.       Kantner D.S., Megill E., Bostwick A., Yang V., Bekeova C., Van Scoyk A., Seifert E., Deininger M.W., Snyder N.W., Comparison of colorimetric, fluorometric, and liquid chromatography-mass spectrometry assays for acetyl-coenzyme a. Anal Biochem. 685: 115405, 2023. PMID38016493.

26.       Khalil S., Olds A., Chin K., Erkmen C.P., Implementation of well-being for cardiothoracic surgeons. Thorac Surg Clin. 34(1): 63-76, 2024. PMID37953054.

27.       Krais J.J., Glass D.J., Chudoba I., Wang Y., Feng W., Simpson D., Patel P., Liu Z., Neumann-Domer R., Betsch R.G., Bernhardy A.J., Bradbury A.M., Conger J., Yueh W.T., Nacson J., Pomerantz R.T., Gupta G.P., Testa J.R., Johnson N., Genetic separation of brca1 functions reveal mutation-dependent polθ vulnerabilities. Nat Commun. 14(1): 7714, 2023. PMID38001070. PMC10673838.

28.       Liu Z.S., Sinha S., Bannister M., Song A., Arriaga-Gomez E., McKeeken A.J., Bonner E.A., Hanson B.K., Sarchi M., Takashima K., Zong D., Corral V.M., Nguyen E., Yoo J., Chiraphapphaiboon W., Leibson C., McMahon M.C., Rai S., Swisher E.M., Sachs Z., Chatla S., Stirewalt D.L., Deeg H.J., Skorski T., Papapetrou E.P., Walter M.J., Graubert T.A., Doulatov S., Lee S.C.,Nguyen H.D., R-loop accumulation in spliceosome mutant leukemias confers sensitivity to parp1 inhibition by triggering transcription-replication conflicts. Cancer Res, 2023. PMID37967363.

29.       Longacre M.L., Chwistek M., Keleher C., Siemon M., Egleston B.L., Collins M., Fang C.Y., Patient-caregiver portal system in palliative oncology: Assessment of usability and perceived benefit. JMIR Hum Factors. 10: e47624, 2023. PMID37917129.PMC10654898.

30.       Miller C., Bleicher R.J., Williams A.D., Breast cancer diagnosis, treatment, and outcomes of patients from sex and gender minority groups. Transl Cancer Res. 12(10): 2458-2460, 2023. PMID37969366.PMC10643937.

31.       Molli V.L.P., Kissa J., Baraniya D., Gharibi A., Chen T., Al-Hebshi N.N., Albandar J.M., Bacteriome analysis of aggregatibacter actinomycetemcomitans-jp2 genotype-associated grade c periodontitis in Moroccan adolescents. Front Oral Health. 4: 1288499, 2023. PMID38033462.PMC10682098.

32.       Movva S., Matloob S., Handorf E.A., Choy E., Merriam P., Flieder D.B., Cai K.Q., Zhou Y., Tetzlaff E.D., Pagan C., Barker E., Veggeberg R., Zumpano D., Rink L., von Mehren M.,George S., Sar-096: Phase II clinical trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (ddl), and leiomyosarcoma (lms). Clin Cancer Res, 2023. PMID37967116.

33.       Mulki R., Qayed E., Yang D., Chua T.Y., Singh A., Yu J.X., Bartel M.J., Tadros M.S., Villa E.C., Lightdale J.R., The 2022 top 10 list of endoscopy topics in medical publishing: An annual review by the American Society for Gastrointestinal Endoscopy editorial board. Gastrointest Endosc. 98(6): 1009-1016, 2023. PMID37977661.

34.       Oleinikov P.D., Fedulova A.S., Armeev G.A., Motorin N.A., Singh-Palchevskaia L., Sivkina A.L., Feskin P.G., Glukhov G.S., Afonin D.A., Komarova G.A., Kirpichnikov M.P., Studitsky V.M., Feofanov A.V.,Shaytan A.K., Interactions of nucleosomes with acidic patch-binding peptides: A combined structural bioinformatics, molecular modeling, fluorescence polarization, and single-molecule fret study. International Journal of Molecular Sciences. 24(20)2023. WOS:001089430400001. PMC10606924.

35.       Pang Y., Andargie T.E., Jang M.K., Kong H., Park W., Hill T., Redekar N., Fu Y.P., Parth D.A., Holtzman N.G., Pavletic S.Z., Agbor-Enoh S., Chronic graft-versus-host disease is characterized by high levels and distinctive tissue-of-origin patterns of cell-free DNA. iScience. 26(11): 108160, 2023. PMID38026221.PMC10651673.

36.       Papin C., Ibrahim A., Sabir J.S.M., Le Gras S., Stoll I., Albiheyri R.S., Zari A.T., Bahieldin A., Bellacosa A., Bronner C., Hamiche A., Mbd4 loss results in global reactivation of promoters and retroelements with low methylated cpg density. J Exp Clin Cancer Res. 42(1): 301, 2023. PMID37957685.PMC10644448.

37.       Paskett E.D., Battaglia T., Calhoun E.A., Chappell M.C., Dwyer A., Fleisher L.G., Greenwald J.,Wells K.J., Isn’t there enough evidence on the benefits of patient navigation? CA Cancer J Clin. 73(6): 562-564, 2023. PMID37358050.

38.       Portela L.M.F., Constantino F.B., Camargo A.C.L., Santos S.A.A., Colombelli K.T., Fioretto M.N., Barata L.A., Silva E.J.R., Scarano W.R., Felisbino S.L., Moreno C.S., Justulin L.A., Early-life origin of prostate cancer through deregulation of mir-206 networks in maternally malnourished offspring rats. Sci Rep. 13(1): 18685, 2023. PMID37907720.PMC10618455.

39.       Quinn C., Rico M.C., Merali C., Barrero C.A., Perez-Leal O., Mischley V., Karanicolas J., Friedman S.L.,Merali S., Secreted folate receptor γ drives fibrogenesis in metabolic dysfunction-associated steatohepatitis by amplifying tgfβ signaling in hepatic stellate cells. Science Translational Medicine. 15(715): eade2966, 2023. PMIDWOS:001082818900005.

40.       Robbins J., Halegoua-DeMarzio D., Basu Mallick A., Vijayvergia N., Ganetzky R., Lavu H., Giri V.N., Miller J., Maley W., Shah A.P., DiMeglio M., Ambelil M., Yu R., Sato T., Lefler D.S., Liver transplantation in a woman with mahvash disease. N Engl J Med. 389(21): 1972-1978, 2023. PMID37991855.

41.       Schaeffer E.M., Srinivas S., Adra N., An Y., Barocas D., Bitting R., Bryce A., Chapin B., Cheng H.H., D’Amico A.V., Desai N., Dorff T., Eastham J.A., Farrington T.A., Gao X., Gupta S., Guzzo T., Ippolito J.E., Kuettel M.R., Lang J.M., Lotan T., McKay R.R., Morgan T., Netto G., Pow-Sang J.M., Reiter R., Roach M., III, Robin T., Rosenfeld S., Shabsigh A., Spratt D., Teply B.A., Tward J., Valicenti R., Wong J.K., Shead D.A., Snedeker J.,Freedman-Cass D.A., Prostate cancer, version 4.2023. Journal of the National Comprehensive Cancer Network. 21(10): 1067-1096, 2023. PMIDWOS:001097901600014.

42.       Schmults C.D., Blitzblau R., Aasi S.Z., Alam M., Amini A., Bibee K., Bordeaux J., Chen P.L., Contreras C.M., DiMaio D., Donigan J.M., Farma J.M., Ghosh K., Harms K., Ho A.L., Lukens J.N., Mark L., Medina T., Nehal K.S., Nghiem P., Olino K., Park S., Patel T., Puzanov I., Rich J., Sekulic A., Shaha A.R., Srivastava D., Thomas V., Tomblinson C., Venkat P., Xu Y.G., Yu S., Yusuf M., McCullough B.,Espinosa S., Basal cell skin cancer, version 2.2024, NCCN Clinical Practice Guidelines in oncology. J Natl Compr Canc Netw. 21(11): 1181-1203, 2023. PMID37935106.

43.       Schober J.P., Wang R.,Kutikov A., Re: Giuseppe Basile, Giuseppe Fallara, Paolo Verri, et al. The role of (99m)tc-sestamibi single-photon emission computed tomography/computed tomography in the diagnostic pathway for renal masses: A systematic review and meta-analysis. Eur urol. In press. Https://doi.Org/10.1016/j.Eururo.2023.07.013. Eur Urol, 2023. PMID37977960. Letter.

44.       Serebriiskii I.G., Pavlov V.A., Andrianov G.V., Litwin S., Basickes S., Newberg J.Y., Frampton G.M., Meyer J.E., Golemis E.A.  Source, co-occurrence, and prognostic value of pten mutations or loss in colorectal cancer. NPJ Genom Med. 8(1): 40, 2023. PMID38001126.PMC10674024.

45.       Siminoff L.A., Wilson-Genderson M., West S.M., Hasz R.D., Suplee L., Clarke J., Barker K.L., Mulvania P.A.  Messaging White and Black next of kin in advance to promote authorization for tissue donation. Prog Transplant: 15269248231212922, 2023. PMID37946530.

46.       Sinko L., Ghazal L.V., Fauer A., Wheldon C.W.  It takes more than rainbows: Supporting sexual and gender minority patients with trauma-informed cancer care. Cancer, 2023. PMID38009962.

47.       Smit R.D., Ghosh B., Campion T.J., 3rd, Stingel R., Lavell E., Hooper R., Fan X., Soboloff J., Smith G.M., Stat3 protects dopaminergic neurons against degeneration in animal model of Parkinson’s disease. Brain Res. 1824: 148691, 2023. PMID38030102.

48.       Song Z., Wu W., Wei W., Xiao W., Lei M., Cai K.Q., Huang D.W., Jeong S., Zhang J.P., Wang H., Kadin M.E., Waldmann T.A., Staudt L.M., Nakagawa M.,Yang Y., Analysis and therapeutic targeting of the il-1r pathway in anaplastic large cell lymphoma. Blood. 142(15): 1297-1311, 2023. PMID37339580.PMC10613726.

49.       Sorscher S., LoPiccolo J., Heald B., Chen E., Bristow S.L., Michalski S.T., Nielsen S.M., Lacoste A., Keyder E., Lee H., Nussbaum R.L., Martins R., Esplin E.D., Rate of pathogenic germline variants in patients with lung cancer. JCO Precis Oncol. 7: e2300190, 2023. PMID37992258. PMC10681406.

50.       Swiecki-Sikora A.L., Lauder A., Harris A., Tagai E.K., Deng M., Jeronis S.L., Houck K.L., Miller S.M., Hernandez E., Attitudes about the human papillomavirus vaccine among patients with and without cervical dysplasia. J Low Genit Tract Dis, 2023. PMID37922471.

51.       Tangudu N.K., Huang Z., Fang R., Buj R., Uboveja A., Cole A.R., Happe C., Sun M., Gelhaus S.L., MacDonald M.L., Hempel N., Snyder N.W., Aird K.M., ATR promotes MTORC1 activation via de novo cholesterol synthesis in p16-low cancer cells. bioRxiv, 2023. PMID37961201. PMC10634888; PrePrint.

52.       Thomas K.K., Francescatti A.B., Vreeland T.J., Teshome M.K., Morris A.M., Hunt K.K., Katz M.H.G., Villano A.M., ASO visual abstract: Standardization of colon resection for cancer-an overview of the American College of Surgeons commission on cancer standard 5.6. Ann Surg Oncol, 2023. PMID37914924.

53.       Villamar-Cruz O., Loza-Mejía M.A., Vivar-Sierra A., Saldivar-Cerón H.I., Patiño-López G., Olguín J.E., Terrazas L.I., Armas-López L., Ávila-Moreno F., Saha S., Chernoff J., Camacho-Arroyo I.,Arias-Romero L.E., A ptp1b-cdk3 signaling axis promotes cell cycle progression of human glioblastoma cells through an rb-e2f dependent pathway. Mol Cell Biol: 1-19, 2023. PMID38014992.

54.       Wang Y., Zhu W., Jang Y., Sommers J.A., Yi G., Puligilla C., Croteau D.L., Yang Y., Kai M.,Liu Y., The RNA-binding motif protein 14 regulates telomere integrity at the interface of terra and telomeric r-loops. Nucleic Acids Res, 2023. PMID37930826.

55.       Wen K.Y., Dayaratna S., Slamon R., Granda-Cameron C., Tagai E.K., Kohler R.E., Hudson S.V., Miller S.M.  Chatbot-interfaced and cognitive-affective barrier-driven messages to improve colposcopy adherence after abnormal pap test results in underserved urban women: A feasibility pilot study. Transl Behav Med, 2023. PMID38014626.

56.       Wiese W., Barczuk J., Racinska O., Siwecka N., Rozpedek-Kaminska W., Slupianek A., Sierpinski R., Majsterek I.  Pi3k/AKT/MTOR signaling pathway in blood malignancies-new therapeutic possibilities. Cancers (Basel). 15(21)2023. PMID37958470.PMC10648005.

57.       Williams A.D., Ruth K., Shaikh S.S., Vasigh M., Pronovost M.T., Aggon A.A., Porpiglia A.S., Bleicher R.J.  Should patients with hormone receptor-positive, her2-negative breast cancer and one or two positive sentinel nodes undergo axillary dissection to determine candidacy for adjuvant abemaciclib? Cancer, 2023. PMID38018862.

58.       Xu K., Saaoud F., Shao Y., Lu Y., Jiang X., Wu S., Sun J., Fernades Conti F., Martinez L., Vazquez-Padron R., Wang H.,Yang X., Editorial: Debates in cardiovascular pharmacology and drug discovery: 2022. Front Cardiovasc Med. 10: 1304680, 2023. PMID37920177.PMC10619719.

59.       Yin J., Zenezan D., Doan K.D., Nobee A., Wei S., Mollaee M.,Proca D.M., Radiologic and clinicopathologic features of eosinophilic solid and cystic renal cell carcinoma: Report of two cases and review of literature. Int J Clin Exp Pathol. 16(10): 303-308, 2023. PMID37970333.PMC10641369.

60.       Yueh W.T., Glass D.J., Johnson N., Brca1 mouse models: Functional insights and therapeutic opportunities. J Mol Biol: 168372, 2023. PMID37979908.

61.       Zelenetz A.D., Gordon L.I., Abramson J.S., Advani R.H., Andreadis B., Bartlett N.L., Budde L.E., Caimi P.F., Chang J.E., Christian B., DeVos S., Dholaria B., Fayad L.E., Habermann T.M., Hamid M.S., Hernandez-Ilizaliturri F., Hu B., Kaminski M.S., Karimi Y., Kelsey C.R., King R., Krivacic S., LaCasce A.S., Lim M., Messmer M., Narkhede M., Rabinovitch R., Ramakrishnan P., Reid E., Roberts K.B., Saeed H., Smith S.D., Svoboda J., Swinnen L.J., Tuscano J., Vose J.M., Dwyer M.A.,Sundar H., Nccn guidelines® insights: B-cell lymphomas, version 6.2023. J Natl Compr Canc Netw. 21(11): 1118-1131, 2023. PMID37935098.

62.       Zhang X., Ali M., Pantuck M.A., Yang X., Lin C.R., Bahmed K., Kosmider B.,Tian Y., Cd8 t cell response and its released cytokine ifn-γ are necessary for lung alveolar epithelial repair during bacterial pneumonia. Front Immunol. 14: 1268078, 2023. PMID37954603.PMC10639165.

63.       Zhou Y., Börcsök J., Adib E., Kamran S.C., Neil A.J., Stawiski K., Freeman D., Stormoen D.R., Sztupinszki Z., Samant A., Nassar A., Bekele R.T., Hanlon T., Valentine H., Epstein I., Sharma B., Felt K., Abbosh P., Wu C.L., Efstathiou J.A., Miyamoto D.T., Anderson W., Szallasi Z.,Mouw K.W., Atm deficiency confers specific therapeutic vulnerabilities in bladder cancer. Sci Adv. 9(47): eadg2263, 2023. PMID37992168.PMC10664985.

Learn More

Fox Chase Cancer Center Staff Publication Database

Staff Publications Received in October, 2023

1.         Ahn M.J., Cho B.C., Felip E., Korantzis I., Ohashi K., Majem M., Juan-Vidal O., Handzhiev S., Izumi H., Lee J.S., Dziadziuszko R., Wolf J., Blackhall F., Reck M., Bustamante Alvarez J., Hummel H.D., Dingemans A.C., Sands J., Akamatsu H., Owonikoko T.K., Ramalingam S.S., Borghaei H., Johnson M.L., Huang S., Mukherjee S., Minocha M., Jiang T., Martinez P., Anderson E.S.,Paz-Ares L., Tarlatamab for patients with previously treated small-cell lung cancer. N Engl J Med, 2023. PMID37861218.

2.         Bandini L., Schatz A., Hood V., Clark N., Hall M.J., Carlson R.W., NCCN policy summit: Reducing the cancer burden through prevention and detection. Journal of the National Comprehensive Cancer Network. 21(9): 910-+, 2023. WOS:001079774300004.

3.         Bergerot C.D., Malhotra J., Bergerot P., Philip E.J., Castro D.V., Hsu J., Mota A., de Azeredo A.C., Neto J.N.D., Hutson T., Grünwald V., Bex A., Psutka S.P., Rini B., Plimack E.R., Master V., Albiges L., Choueiri T.K., Pal S., Powles T. Patients’ perceptions regarding the relevance of items contained in the functional assessment of cancer therapy kidney symptom index-19. Oncologist. 28(6): 494-500, 2023. WOS:001048007900022.

4.         Bevers T.B., Niell B.L., Baker J.L., Bennett D.L., Bonaccio E., Camp M.S., Chikarmane S., Conant E.F., Eghtedari M., Flanagan M.R., Hawley J., Helvie M., Hodgkiss L., Hoyt T.L., Ivanovich J., Jochelson M.S., Kulkarni S., Lancaster R.B., Mauer C., Maxwell J., Patel B.K., Pearlman M., Philpotts L., Plecha D., Plichta J.K., Shakeri S., Smith M.L., Streibert C.L., Strigel R.M., Tumyan L., Winkler N.S., Wolverton D.E., Bergman M.A., Kumar R., Stehman K., NCCN guidelines® Insights CE breast cancer screening and diagnosis, version 1.2023. Journal of the National Comprehensive Cancer Network. 21(9): 900-909, 2023. WOS:001079774300003.

5.         Borghaei H., de Marinis F., Dumoulin D., Reynolds C., Theelen W., Percent I., Calderon V.G., Johnson M.L., Madroszyk-Flandin A., Garon E.B., He K., Planchard D., Reck M., Popat S., Herbst R.S., Leal T.A., Shazer R.L., Yan X., Harrigan R., Peters S., Sapphire: Phase III study of sitravatinib plus nivolumab versus docetaxel in advanced non-squamous non-small cell lung cancer. Ann Oncol, 2023. PMID37866811.

6.         Choueiri T.K., Powles T., Voss M.H., Plimack E.R., Gurney H., Song Y., Perini R.F., Rodriguez-Lopez K., Rini B.I. Litespark-012: Pembrolizumab plus lenvatinib with or without belzutifan or quavonlimab for advanced renal cell carcinoma. Future Oncol, 2023. PMID37882432.

7.         Diefenbach M.A., Marziliano A., Tagai E.K., Pfister H., Lapitan E., Hall S.J., Vira M., Ibrahim S., Aibel K., Kutikov A., Horwitz E.M., Miyamoto C., Reese A.C., Miller S.M., Preference elicitation and treatment decision-making among men diagnosed with prostate cancer: Randomized controlled trial results of healium. J Med Internet Res. 25: e46552, 2023. PMID37862103.

8.         Dougherty T.P., Meyer J.E. Comparing lifestyle modifications and the magnitude of their associated benefit on cancer mortality. Nutrients. 15(9): 2038, 2023. doi:10.3390/nu15092038.

9.         Douglawi A., Ghoreifi A., Carbonara U., Yip W., Uzzo R.G., Margulis V., Ferro M., Cobelli O., Wu Z., Simone G., Mastroianni R., Rha K.H., Eun D.D., Reese A.C., Porter J.R., Derweesh I., Mehrazin R., Rosiello G., Tellini R., Jamil M., Kenigsberg A., Farrow J.M., Schrock W.P., Cacciamani G., Srivastava A., Bhattu A.S., Mottrie A., Gonzalgo M.L., Sundaram C.P., Abdollah F., Minervini A., Autorino R.,Djaladat H. Impact of variant histology on oncological outcomes in upper tract urothelial carcinoma: Results from the ROBUUST collaborative group. Clin Genitourin Cancer. 21(5): 563-568, 2023. PMID37301663.

10.       El Naggar A., Robins D., Baca Y., Arguello D., Ulm M., Arend R., Mantia-Smaldone G., Chu C., Winer I., Holloway R., Krivak T., Jones N., Galvan-Turner V., Herzog T.J., Brown J. Genomic profiling in low grade serous ovarian cancer: Identification of novel markers for disease diagnosis and therapy. Gynecol Oncol. 167(2): 306-313, 2022. PMID36229265.

11.       Epstein M., Helstrom E., Correa A., Balancing patient safety and early postoperative discharge: An American College of Surgeons national surgical quality improvement program analysis of postoperative complications after minimally invasive urologic surgery. J Urol: 101097ju0000000000003724, 2023. PMID37788014.

12.       Epstein M., Syed K., Danella J., Ginzburg S., Belkoff L., Tomaszewski J., Trabulsi E., Singer E.A., Jacobs B.L., Raman J.D., Guzzo T.J., Uzzo R., Reese A.C. Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: A cohort analysis of over 3000 men. Prostate Cancer Prostatic Dis, 2023. PMID37821578.

13.       Fiev D.N., Sirota E.S., Kozlov V.V., Proskura A.V., Shpot E.V., Chernenkiy M.M., Chernenkiy I.M., Puzakov K.B., Azil’gareeva K.R., Ismailov K.M., Butnaru D.V., Kutikov A., Vinarov A.Z., Correlation between 3d morphometric characteristics of kidney tumors and their histological structure. Onkourologiya. 19(2): 17-28, 2023. WOS:001054312300001.

14.       Fuller A.D., Whelan K.A., The underappreciated role of eosinophils in esophageal cancer. Cell Mol Gastroenterol Hepatol, 2023. PMID37839465.

15.       Gerson J.N., Handorf E., Villa D., Gerrie A.S., Chapani P., Li S., Medeiros L.J., Wang M.L., Cohen J., Churnetski M.C., Hill B.T., Sawalha Y., Hernandez-Ilizaliturri F.J., Kothari S.K., Vose J.M., Bast M.A., Fenske T.S., Narayana Rao Gari S., Maddocks K.J., Bond D.A., Bachanova V., Kolla B., Chavez J.C., Shah B.D., Lansigan F., Burns T.F., Donovan A., Wagner-Johnston N.D., Messmer M.R., Mehta A., Anderson J., Reddy N., Kovach A., Landsburg D.J., Glenn M.J., Inwards D.J., Ristow K., Karmali R., Kaplan J., Caimi P.F., Rajguru S.A., Evens A.M., Klein A.K., Umyarova E., Pulluri B., Amengual J.E., Lue J.K., Diefenbach C., Fisher R.I., Barta S.K., Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma. Blood Adv, 2023. PMID37874912.

16.       Gray Z.H., Chakraborty D., Duttweiler R.R., Alekbaeva G.D., Murphy S.E., Chetal K., Ji F., Ferman B.I., Honer M.A., Wang Z., Myers C., Sun R., Kaniskan H., Toma M.M., Bondarenko E.A., Santoro J.N., Miranda C., Dillingham M.E., Tang R., Gozani O., Jin J., Skorski T., Duy C., Lee H., Sadreyev R.I., Whetstine J.R., Epigenetic balance ensures mechanistic control of MLL amplification and rearrangement. Cell. 186(21): 4528-4545.e18, 2023. PMID37788669. PMC10591855.

17.       Grunvald E., Wei J., Lin T., Yang K., Tu X.M., Lunde O., Ross E., Cheng J., DeConde J., Farber N., Exploring the effect of adding an interactive lecture to a standardized patient curriculum on the attitudes of third-year medical students about patients with obesity: A quasi-experimental study. J Med Educ Curric Dev. 10: 23821205231207683, 2023. PMID37854280. PMC10580723.

18.       Habib M.H., Schlögl M., Raza S., Chwistek M., Gulati A.  Interventional pain management in cancer patients-a scoping review. Ann Palliat Med, 2023. PMID37872129.

19.       Handorf E.A., Beck J.R., Correa A., Ramamurthy C., Geynisman D.M., Cost-effectiveness analysis for therapy sequence in advanced cancer: A microsimulation approach with application to metastatic prostate cancer. Med Decis Making: 272989×231201621, 2023. PMID37811793.

20.       Heinrich M.C., Corless C.L., Demetri G.D., Blanke C.D., von Mehren M., Joensuu H., McGreevey L.S., Chen C.J., Van den Abbeele A.D., Druker B.J., Kiese B., Eisenberg B., Roberts P.J., Singer S., Fletcher C.D.M., Silberman S., Dimitrijevic S., Fletcher J.A., Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol. 41(31): 4829-4836, 2023. PMID37890277.

21.       Im E.O., Chee W., Paul S., Choi M.Y., Kim S.Y., Deatrick J.A., Inouye J., Ma G., Meghani S., Nguyen G.T., Schapira M.M., Ulrich C.M., Yeo S., Bao T., Shin D.,Mao J.J., A randomized controlled trial testing a virtual program for Asian American women breast cancer survivors. Nat Commun. 14(1): 6475, 2023. PMID37838727.PMC10576740.

22.       Ioffe D., Dotan E., Evidence-based care of older adults with metastatic colorectal cancer: Insights from landmark clinical trials. J Clin Oncol: Jco2301337, 2023. PMID37856768.

23.       Leader A.E., Brandt H.M., Briant K.J., Curry G., Ellis K., Gonzalez E.T., Guerra C.E., Harding G., Hull P.C., Israel A., Melillo R., Mesia R.J., Schiffelbein J.E., Song Y., Surani Z., Tiro J.A., Vadaparampil S.T., Vanderpool R.C., Paskett E.D., Community outreach and engagement at U.S. Cancer centers: Notes from the 3rd cancer center community impact forum. Cancer Epidemiol Biomarkers Prev, 2023. PMID37791915.

24.       Lightle H.E., Kafley P., Lewis T.R., Wang R.E., Site-specific protein conjugates incorporating para-azido-l-phenylalanine for cellular and in vivo imaging. Methods. 219: 95-101, 2023. PMID37804961.

25.       Lundgren P., Sharma P.V., Dohnalová L., Coleman K., Uhr G.T., Kircher S., Litichevskiy L., Bahnsen K., Descamps H.C., Demetriadou C., Chan J., Chellappa K., Cox T.O., Heyman Y., Pather S.R., Shoffler C., Petucci C., Shalem O., Raj A., Baur J.A., Snyder N.W., Wellen K.E., Levy M., Seale P., Li M., Thaiss C.A., A subpopulation of lipogenic brown adipocytes drives thermogenic memory. Nat Metab. 5(10): 1691-1705, 2023. PMID37783943.

26.       Marziliano A., Miller S.M., Fleisher L.G., Ropka M.E., Stanton A.L., Wen K.Y., Cornelius T., Lapitan E., Diefenbach M.A., Examining the impact of a multimedia intervention on decisional conflict and psychological distress among early-stage breast cancer patients: Results from a nationwide rct. Transl Behav Med. 13(10): 727-735, 2023. PMID37379519.PMC10538468.

27.       Neelapu S.S., Chavez J.C., Sehgal A., Epperla N., Ulrickson M.L., Bachy E., Munshi P., Casulo C., Maloney D.G., de Vos S., Reshef R., Leslie L.A., Oluwole O.O.D., Yakoubagha I., Khanal R., Rosenblatt J.D., Korn R., Peng W., Lui C., Wullf J., Shen R.R., Poddar S., Jung A.S., Miao H., Beygi S., Jacobson C.A., Three-year follow-up analysis of axicabtagene ciloleucel in relapsed/refractory indolent non-hodgkin lymphoma (zuma-5). Blood, 2023. PMID37879047.

28.       Nigam A., Hurley M.F.D., Li F., Konkoĭová E., Klíma M., Trylčová J., Pollice R., Çinaroǧlu S.S., Levin-Konigsberg R., Handjaya J., Schapira M., Chau I., Perveen S., Ng H.L., Ümit Kaniskan H., Han Y., Singh S., Gorgulla C., Kundaje A., Jin J., Voelz V.A., Weber J., Nencka R., Boura E., Vedadi M., Aspuru-Guzik A., Drug discovery in low data regimes: Leveraging a computational pipeline for the discovery of novel sars-cov-2 nsp14-mtase inhibitors. bioRxiv, 2023. PMID37873443. PMC10592886. (Preprint)

29.       Oleinikov P.D., Fedulova A.S., Armeev G.A., Motorin N.A., Singh-Palchevskaia L., Sivkina A.L., Feskin P.G., Glukhov G.S., Afonin D.A., Komarova G.A., Kirpichnikov M.P., Studitsky V.M., Feofanov A.V., Shaytan A.K., Interactions of nucleosomes with acidic patch-binding peptides: A combined structural bioinformatics, molecular modeling, fluorescence polarization, and single-molecule fret study. Int J Mol Sci. 24(20)2023. PMID37894874. PMC10606924.

30.       Peyton S.R., Platt M.O., Cukierman E., Challenges and opportunities modeling the dynamic tumor matrisome. BME Front. 4: 0006, 2023. PMID37849664.PMC10521682.

31.       Pivirotto A.M., Platt A., Patel R., Kumar S., Hey J., Analyses of allele age and fitness impact reveal human beneficial alleles to be older than neutral controls. bioRxiv, 2023. PMID37873438. PMC10592680.

32.       Pook D., Geynisman D.M., Carles J., de Braud F., Joshua A.M., Pérez-Gracia J.L., Llácer Pérez C., Shin S.J., Fang B., Barve M., Maruzzo M., Bracarda S., Kim M., Kerloeguen Y., Gallo J.D., Maund S.L., Harris A., Huang K.C., Poon V., Sutaria D.S., Gurney H., A phase Ib, open-label study evaluating the safety and efficacy of ipatasertib plus rucaparib in patients with metastatic castration-resistant prostate cancer. Clin Cancer Res. 29(17): 3292-3300, 2023. PMID37339186.

33.       Price A.D., Foote D.C., Woeste M.R., Winer L.K., Montgomery K.B., Al Yafi M., Nahmias J.T., Postlewait L.M., Sutton J.M., Quillin R.C., Cortez A.R., Defining the disparity: A multi-institutional analysis of factors associated with decreased resident operative experience. J Surg Res. 293: 647-655, 2023. PMID37837821.

34.       Pruthi D.K., Miller G., Ankerst D.P., Neumair M., Capitanio U., Correa A.F., Lane B.R., Roussel E., McGregor T.B., Derweesh I.H., Cordeiro M., Pierorazio P.M., Calvo C., Bi H., Noyes S.L., Meagher M., Kutikov A., Uzzo R.G., Van Poppel H., Larcher A., Montorsi F., Kattan M.W., Kaushik D., Liss M.A., Reply by authors. J Urol. 210(5): 761-762, 2023. PMID37811759.

35.       Rodgers-Fouche L., Arora S., Ricker C., Li D., Farooqi M., Balaguer F., Dominguez-Valentin M., Guillem J.G., Kanth P., Liska D., Melson J., Mraz K.A., Shirts B.H., Vilar E., Katona B.W., Hodan R., Exploring stakeholders’ perspectives on implementing universal germline testing for colorectal cancer: Findings from a clinical practice survey. JCO Precis Oncol. 7: e2300440, 2023. PMID37897815.

36.       Sanft T., Day A., Ansbaugh S., Armenian S., Baker K.S., Ballinger T., Demark-Wahnefried W., Dickinson K., Fairman N.P., Felciano J., Flores T.F., Friedman D.L., Gabel N.M., Goldman M., Henry N.L., Hill-Kayser C., Hudson M., Koura D., Lee K., McDonough A.L., Melisko M., Mooney K., Moore H.C.F., Moryl N., Neuman H., O’Connor T., Overholser L., Paskett E.D., Patel C., Peterson L., Pirl W., Porpiglia A., Rodriguez M.A., Schapira L., Schwartz A.L., Smith S., Tevaarwerk A., Yang E.R., Zee P., McMillian N.R.,F reedman-Cass D.A., Survivorship, version 1.2023 featured updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network. 21(8): 792-803, 2023. WOS:001063796600005.

37.       Schwartzberg L., Navari R.M., Ruddy K.J., LeBlanc T.W., Clark-Snow R., Wickham R., Kloth D., Binder G., Bailey W.L., Turini M., Potluri R., Liu X., Papademetriou E.,Roeland E.J., Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxis. Support Care Cancer. 31(12): 654, 2023. PMID37878086.PMC10600031.

38.       Seeger C., A crispr-based system to investigate HBV cccDNA biology. J Virol. 97(10): e0118523, 2023. PMID37819132.PMC10617570.

39.       Singla K., Vempuluru V.S., Ehya H., Shields C.L., Iridociliary metastasis from cryptic cutaneous melanoma simulating primary uveal melanoma. Can J Ophthalmol, 2023. PMID37863108.

40.       Sit Y.T., Takasaki K., An H.H., Xiao Y., Hurtz C., Gearhart P., Zhang Z., Gadue P., French D., Chou S.T., Synergistic roles of dyrk1a and gata1 in trisomy 21 megakaryopoiesis. JCI Insight, 2023. PMID37906251.

41.       Snyder R.A., Burtness B., Cho M., Del Rivero J., Doroshow D.B., Hitchcock K.E., Kalyan A., Kim C.A., Lukovic J., Parikh A.R., Sanford N.N., Singh B., Shen C., Shroff R.T., Vijayvergia N., Goodman K.A., Kunz P.L., The room where it happens: Addressing diversity, equity, and inclusion in national clinical trials network clinical trial leadership. J Natl Cancer Inst. 115(10): 1132-1138, 2023. PMID37364007.

42.       Thomas K.K., Francescatti A.B., Vreeland T.J., Teshome M.K., Morris A.M., Hunt K.K., Katz M.H.G., Villano A.M., Standardization of colon resection for cancer: An overview of the American College of Surgeons commission on cancer standard 5.6. Ann Surg Oncol, 2023. PMID37880516.

43.       Topchu I., Bychkov I., Gursel D., Makhov P., Boumber Y., Nsd1 supports cell growth and regulates autophagy in hpv-negative head and neck squamous cell carcinoma. bioRxiv, 2023. PMID37786686.PMC10541623. (Preprint)

44.       Uzzo R., Bex A., Pal S.K., Authors’ reply. Lancet. 402(10397): 181-181, 2023. WOS:001081489900001.

45.       Uzzo R., Bex A., Pal S.K., The value of immotion010 for rare kidney cancer histologies reply. Lancet. 402(10397): 181-182, 2023.  WOS:001081489900002.

46.       Uzzo N., Loecher M., Uzzo R.G. ,Eun D.D., A sheep in wolf’s clothing; a case of renal leiomyoma masquerading as hereditary leiomyomatosis and renal cell carcinoma. Urol Case Rep. 51: 102567, 2023. PMID37818410. PMC10561035.

47.       van den Berg D.M.N., Nascimento de Lima P., Knudsen A.B., Rutter C.M., Weinberg D., Lansdorp-Vogelaar I., NordICC trial results in line with expected colorectal cancer mortality reduction after colonoscopy: A modeling study. Gastroenterology. 165(4): 1077-1079.e2, 2023. PMID37454978.

48.       Van Houtven C.H., Miller K.E.M., James H.J., Blunt R., Zhang W., Mariani A.C., Rose S., Alolod G.P., Wilson-Genderson M., Smith V.A., Thomson M.D., Siminoff L.A., Economic costs of family caregiving for persons with advanced stage cancer: A longitudinal cohort study. J Cancer Surviv, 2023. PMID37823982.

49.       Walmer R.W., Ritter V.S., Sridharan A., Kasoji S.K., Altun E., Lee E., Olinger K., Wagner S., Radhakrishna R., Johnson K.A., Rathmell W.K., Qaqish B., Dayton P.A.,Chang E.H., The performance of flash replenishment contrast-enhanced ultrasound for the qualitative assessment of kidney lesions in patients with chronic kidney disease. J Clin Med. 12(20)2023. PMID37892632.PMC10607866.

50.       Wang X., Liu L., Jiang X., Saredy J., Xi H., Cueto R., Sigler D., Khan M., Wu S., Ji Y., Snyder N.W., Hu W., Yang X., Wang H., Identification of methylation-regulated genes modulating microglial phagocytosis in hyperhomocysteinemia-exacerbated Alzheimer’s disease. Alzheimers Res Ther. 15(1): 164, 2023. PMID37789414. PMC10546779.

51.       Wang Y., He S., Calendo G., Bui T., Tian Y., Lee C.Y., Zhou Y., Zhao X., Abraham C., Mo W., Chen M., Sanders-Braggs R., Madzo J., Issa J.J., Hexner E.O., Wiest D.L., Reshef R., Xue H.H., Zhang Y., Tissue-infiltrating alloreactive t cells require id3 to deflect PD-1-mediated immune suppression during gvhd. Blood, 2023. PMID37871574.

52.       Waraksa-Deutsch T.L., Leading medical laboratory professionals toward change readiness: A correlational study. Lab Med, 2023. PMID37788447.

53.       Yang Y., Johnson J., Troupes C.D., Feldsott E.A., Kraus L., Megill E., Bian Z., Asangwe N., Kino T., Eaton D.M., Wang T., Wagner M., Ma L., Bryan C., Wallner M., Kubo H., Berretta R.M., Khan M., Wang H., Kishore R., Houser S.R., Mohsin S. Mir-182/183-rasa1 axis induced macrophage polarization and redox regulation promotes repair after ischemic cardiac injury. Redox Biol. 67: 102909, 2023. PMID37801856.PMC10570148.

54.       Zhu L., Dodd S.J., Chen Y., Kaminsky E.R., Liu Z.E., Ma G.X., Ogunwobi O.O., Fang C.Y., Educating the next generation of cancer researchers: Evaluation of a cancer research partnership training program. PLoS One. 18(10): e0286279, 2023. PMID37792689.PMC10550190.

Learn More

Fox Chase Cancer Center Staff Publication Database

Publications Received in September, 2023

1.         Andreeva T.V., Maluchenko N.V., Efremenko A.V., Lyubitelev A.V., Korovina A.N., Afonin D.A., Kirpichnikov M.P., Studitsky V.M., Feofanov A.V., Epigallocatechin gallate affects the structure of chromatosomes, nucleosomes and their complexes with parp1. Int J Mol Sci. 24(18)2023. PMID37762491.PMC10532227.

2.         Aquino A.M., Alonso-Costa L.G., Santos S.A.A., Rocha V.A., Barbisan L.F., Bedrat A., Justulin L.A., Flaws J.A., Lemos B., Scarano W.R., Integrated transcriptome and proteome analysis indicates potential biomarkers of prostate cancer in offspring of pregnant rats exposed to a phthalate mixture during gestation and lactation. Chemosphere. 341: 140020, 2023. PMID37690569.

3.         Bandini L., Schatz A., Hood V., Clark N., Hall M.J., Carlson R.W., NCCN policy summit: Reducing the cancer burden through prevention and early detection. J Natl Compr Canc Netw. 21(9): 910-914.e1, 2023. PMID37673113.

4.         Barham D.W., Simhan J., Yafi F.A., Gross M.S., An approach to the thoughtful selection of antimicrobial prophylaxis for inflatable penile prosthesis surgery. J Sex Med. 20(9): 1140-1142, 2023. PMID37655674.

5.         Barta J.A., Erkmen C.P., Shusted C.S., Myers R.E., Saia C., Cohen S., Wainwright J., Zeigler-Johnson C., Dako F., Wender R., Kane G.C., Vachani A., Rendle K.A., The Philadelphia lung cancer learning community: A multi-health-system, citywide approach to lung cancer screening. JNCI Cancer Spectr, 2023. PMID37713466.

6.         Bevers T.B., Niell B.L., Baker J.L., Bennett D.L., Bonaccio E., Camp M.S., Chikarmane S., Conant E.F., Eghtedari M., Flanagan M.R., Hawley J., Helvie M., Hodgkiss L., Hoyt T.L., Ivanovich J., Jochelson M.S., Kulkarni S., Lancaster R.B., Mauer C., Maxwell J., Patel B.K., Pearlman M., Philpotts L., Plecha D., Plichta J.K., Shakeri S., Smith M.L., Streibert C.L., Strigel R.M., Tumyan L., Winkler N.S., Wolverton D.E., Bergman M.A., Kumar R., Stehman K., NCCN Guidelines® Insights: Breast cancer screening and diagnosis, version 1.2023. J Natl Compr Canc Netw. 21(9): 900-909, 2023. PMID37673117.

7.         Cheng N.H., Li Y., Cheng G., Metastatic pulmonary calcification on bone scintigraphy of a patient with lupus nephritis and end-stage renal disease. Radiol Case Rep. 18(11): 3993-3996, 2023. PMID37691761. PMC10491819.

8.         Clevenger M.H., Karami A.L., Carlson D.A., Kahrilas P.J., Gonsalves N., Pandolfino J.E., Winter D.R., Whelan K.A., Tétreault M.P., Suprabasal cells retain progenitor cell identity programs in eosinophilic esophagitis-driven basal cell hyperplasia. JCI Insight. 8(19)2023. PMID37672481.

9.         Daniel O., Ashrafi A., Muthoni M.A., Njoki N., Eric H., Marilynn O., Faith A.B., Beth W.G., Nyakio M., Odero-Marah V., Ragin C. , Llanos A.A.M., Delayed breast cancer presentation, diagnosis, and treatment in Kenya. Breast Cancer Res Treat, 2023. PMID37668821.

10.       Del Rivero J., Perez K., Kennedy E.B., Mittra E.S., Vijayvergia N., Arshad J., Basu S., Chauhan A., Dasari A.N., Bellizzi A.M., Gangi A., Grady E., Howe J.R., Ivanidze J., Lewis M., Mailman J., Raj N., Soares H.P., Soulen M.C., White S.B., Chan J.A., Kunz P.L., Singh S., Halfdanarson T.R., Strosberg J.R., Bergsland E.K. Systemic therapy for tumor control in metastatic well-differentiated gastroenteropancreatic neuroendocrine tumors: ASCO guideline. J Clin Oncol: Jco2301529, 2023. PMID37774329.

11.       Drzewiecka M., Jaśniak D., Barszczewska-Pietraszek G., Czarny P., Kobrzycka A., Wieczorek M., Radek M., Szemraj J., Skorski T., Śliwiński T., Class I hdac inhibition leads to a downregulation of fancd2 and rad51, and the eradication of glioblastoma cells. J Pers Med. 13(9)2023. PMID37763083.PMC10532614.

12.       Efe G., Dunbar K.J., Sugiura K., Cunningham K., Carcamo S., Karaiskos S., Tang Q., Cruz-Acuna R., Resnick-Silverman L., Peura J., Lu C., Hasson D., Klein-Szanto A.J., Taylor A.M., Manfredi J.J., Prives C., Rustgi A.K., P53 gain-of-function mutation induces metastasis via brd4-dependent csf-1 expression. Cancer Discov, 2023. PMID37676642.

13.       Ettinger D.S., Wood D.E., Stevenson J., Aisner D.L., Akerley W., Bauman J.R., Bharat A., Bruno D.S., Chang J.Y., Chirieac L.R., DeCamp M., Dilling T.J., Dowell J., Durm G.A., Gettinger S., Grotz T.E., Gubens M.A., Hegde A., Lackner R.P., Lanuti M., Lin J., Loo B.W., Lovly C.M., Maldonado F., Massarelli E., Morgensztern D., Mullikin T.C., Ng T., Otterson G.A., Patel S.P., Patil T., Polanco P.M., Riely G.J., Riess J., Shapiro T.A., Singh A.P., Tam A., Tanvetyanon T., Yanagawa J., Yang S.C., Yau E., Gregory K.M., Hughes M.  Mesothelioma: Peritoneal, version 2.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 21(9): 961-979, 2023. PMID37673108.

14.       Filchner K., Zoucha R., Lockhart J.S., Denlinger C.S., Empowering lung cancer survivors in post-treatment survivorship care using participatory action research. Oncol Nurs Forum. 50(5): 563-575, 2023. PMID37677759.

15.       Fleisher L., Kenny C., Rusten C., Koren D., Landau Z. Correction to: Right information, right patient, right time: Utilizing the mycarecompass platform to deliver patient education in the oncology setting. J Cancer Educ, 2023. PMID37707651.

16.       Ghatalia P., Plimack E.R. Harnessing potent therapies with care: Enfortumab vedotin plus pembrolizumab for advanced-stage urothelial carcinoma. Nat Rev Clin Oncol, 2023. PMID37667009.

17.       Golan T., Casolino R., Biankin A.V., Hammel P., Whitaker K.D., Hall M.J., Riegert-Johnson D.L., Germline brca testing in pancreatic cancer: Improving awareness, timing, turnaround, and uptake. Ther Adv Med Oncol. 15: 17588359231189127, 2023. PMID37720496.PMC10504836.

18.       Gross S., Womer L., Kappes D.J., Soboloff J.  Multifaceted control of t cell differentiation by stim1. Trends Biochem Sci, 2023. PMID37696713.

19.       Hernandez N.E., Jankowski W., Frick R., Kelow S.P., Lubin J.H., Simhadri V., Adolf-Bryfogle J., Khare S.D., Dunbrack R.L., Jr., Gray J.J.,Sauna Z.E., Corrigendum to “computational design of nanomolar-binding antibodies specific to multiple sars-cov-2 variants by engineering a specificity switch of antibody 80r using rosettaantibodydesign (rabd) results in potential generalizable therapeutic antibodies for novel sars-cov-2 virus” [heliyon 9(4) (april 2023) e15032]. Heliyon. 9(8): e17901, 2023. PMID37701412.PMC10493423.

20.       Hsu R., Chen D., Xia B., Feldman R., Cozen W., Raez L.E., Borghaei H., Kim C., Nagasaka M., Mamdani H., Vanderwalde A.M., Lopes G., Socinski M.A., Wozniak A.J., Spira A.I., Liu S.V., Nieva J.J., Impact of gender and mutational differences in hormone receptor expressing non-small cell lung cancer. Front Oncol. 13: 1215524, 2023. PMID37700839.PMC10494442.

21.       Jan R., Huang M. ,Lewis-Wambi J. Retraction note: Loss of pigment epithelium-derived factor: A novel mechanism for the development of endocrine resistance in breast cancer. Breast Cancer Res. 25(1): 107, 2023. PMID37726770.PMC10508022.

22.       Kaplan J., Lee Z.H., Grome L., Yao C.M.K.L., Mericli A.F., Roubaud M.S., Largo R.D., Garvey P.B., Sensory outcomes for inferior alveolar nerve reconstruction with allograft following free fibula mandible reconstruction. Plast Reconstr Surg. 152(3): 499e-506e, 2023. PMID36780351.

23.       Kaur J., Vijayvergia N. Narrative review of immunotherapy in gastroentero-pancreatic neuroendocrine neoplasms. Curr Oncol. 30(9): 8653-8664, 2023. PMID37754542.PMC10527684.

24.       Kim P.M., Nejati R., Lu P., Thakkar D., Mackrides N., Dupoux V., Nakhoda S., Baldwin D.A., Pei J., Dave S.S., Wang Y.L., Wasik M. Leukemic presentation and progressive genomic alterations of mcd/c5 diffuse large b-cell lymphoma (dlbcl). Cold Spring Harb Mol Case Stud, 2023. PMID37730436.

25.       Klaus C.A., Henry K.A., Il’yasova D.  Capturing emergency dispatch address points as geocoding candidates to quantify delimited confidence in residential geolocation. Int J Health Geogr. 22(1): 25, 2023. PMID37752482.PMC10523746.

26.       Lee R.A., Kutikov A.  Pathological and clinical outcomes in a large surveillance and intervention cohort of radiographically cystic renal masses. Reply. Journal of Urology. 210(3): 408-410, 2023.  

27.       Lu Y., Sun Y., Saaoud F., Shao Y., Xu K., Jiang X., Wu S., Yu J., Snyder N.W., Yang L., Shi X.M., Zhao H., Wang H., Yang X.  Er stress mediates angiotensin ii-augmented innate immunity memory and facilitates distinct susceptibilities of thoracic from abdominal aorta to aneurysm development. Front Immunol. 14: 1268916, 2023. PMID37731512.PMC10507336.

28.       Maluchenko N.V., Korovina A.N., Saulina A.A., Studitsky V.M., Feofanov A.V.  [the role of the wgr domain in the functions of parp1 and parp2]. Mol Biol (Mosk). 57(5): 782-791, 2023. PMID37752643.

29.       Mann-Barnes T., Bhimla A., Coronado M., Lin T., Duro-Aina A., Park H., Ma G.X.  Factors that predict HPV vaccination behavior among young men-who-have-sex-with-men in the greater Philadelphia region. J Racial Ethn Health Disparities. 10(5): 2167-2174, 2023. PMID36036840.PMC9422934.

30.       Midya A., Hiremath A., Huber J., Sankar Viswanathan V., Omil-Lima D., Mahran A., Bittencourt L.K., Harsha Tirumani S., Ponsky L., Shiradkar R., Madabhushi A., Delta radiomic patterns on serial bi-parametric MRI are associated with pathologic upgrading in prostate cancer patients on active surveillance: Preliminary findings. Front Oncol. 13: 1166047, 2023. PMID37731630.PMC10508842.

31.       Mohsin S., Wang H., Khan M., Inflammation attenuating lncrnas in diabetic cardiomyopathy. Mol Ther Nucleic Acids. 34: 102029, 2023. PMID37766794.PMC10520423.

32.       Nejati R., Neumann-Domer R., Liu Z., Koslosky L., Neumann-Domer E., Pei J., Wang Y.L., Testa J.R.  Isochromosome 7p, i(7)(p10): A rare aml, myelodysplasia-related entity. Leuk Res Rep. 20: 100387, 2023. PMID37701905.PMC10493252.

33.       Okyere A.D., Nayak T.K., Patwa V., Teplitsky D., McEachern E., Carter R.L., Xu H., Gao E., Zhou Y., Tilley D.G.  Myeloid cell-specific deletion of epidermal growth factor receptor aggravates acute cardiac injury. Clin Sci (Lond). 137(19): 1513-1531, 2023. PMID37728308. NEEDS PMCID.

34.       Plimack E.R., Powles T., Stus V., Gafanov R., Nosov D., Waddell T., Alekseev B., Pouliot F., Melichar B., Soulières D., Borchiellini D., McDermott R.S., Vynnychenko I., Chang Y.H., Tamada S., Atkins M.B., Li C., Perini R., Rhoda Molife L., Bedke J., Rini B.I.  Corrigendum to “pembrolizumab plus axitinib versus sunitinib as first-line treatment of advanced renal cell carcinoma: 43-month follow-up of the phase 3 keynote-426 study” [eur. Urol. (2023)]. Eur Urol. 84(5): e123-e124, 2023. PMID37666734.

35.       Quinn C., Rico M.C., Merali C., Barrero C.A., Perez-Leal O., Mischley V., Karanicolas J., Friedman S.L., Merali S.  Secreted folate receptor γ drives fibrogenesis in metabolic dysfunction-associated steatohepatitis by amplifying tgfβ signaling in hepatic stellate cells. Sci Transl Med. 15(715): eade2966, 2023. PMID37756380.

36.       Roldan L., Montoya C., Solanki V., Cai K.Q., Yang M., Correa S., Orrego S., A novel injectable piezoelectric hydrogel for periodontal disease treatment. ACS Appl Mater Interfaces. 15(37): 43441-43454, 2023. PMID37672788.

37.       Rosser B.R.S., Weideman B.C.D., Rider G.N., Jatoi A., Ecklund A.M., Wheldon C.W., Talley K.M.C., Kulasingam S., Smith M.K., Jacobs D.R., Mitteldorf D., West W., Alley R., Ross M.W.  Sexual and gender minority invisibility in cancer studies: A call for effective recruitment methods to address cancer disparities. J Clin Oncol: Jco2300655, 2023. PMID37725780.

38.       Schober J.P., Ginsburg K.B., Kutikov A., Cho E.Y., Loecher M., Strauss D., Castro Bigalli A.A., Handorf E., Deng M., Anaokar J., Chen D.Y.T., Greenberg R.E., Smaldone M.C., Viterbo R., Correa A.F., Uzzo R.G., Strother M.  Real-time estimation of nephron activity with a linear measurement system (renal-ms) predicts postoperative estimated glomerular filtration rate. BJU Int, 2023. PMID37667554.

39.       Schweke H., Xu Q., Tauriello G., Pantolini L., Schwede T., Cazals F., Lhéritier A., Fernandez-Recio J., Rodríguez-Lumbreras L.A., Schueler-Furman O., Varga J.K., Jiménez-García B., Réau M.F., Bonvin A., Savojardo C., Martelli P.L., Casadio R., Tubiana J., Wolfson H.J., Oliva R., Barradas-Bautista D., Ricciardelli T., Cavallo L., Venclovas Č., Olechnovič K., Guerois R., Andreani J., Martin J., Wang X., Terashi G., Sarkar D., Christoffer C., Aderinwale T., Verburgt J., Kihara D., Marchand A., Correia B.E., Duan R., Qiu L., Xu X., Zhang S., Zou X., Dey S., Dunbrack R.L., Levy E.D., Wodak S.J.  Discriminating physiological from non-physiological interfaces in structures of protein complexes: A community-wide study. Proteomics. 23(17): e2200323, 2023. PMID37365936.

40.       Ubba V., Joseph S., Awe O., Jones D., Dsilva M.K., Feng M., Wang J., Fu X., Akbar R.J., Bodnar B.H., Hu W., Wang H., Yang X., Yang L., Yang P., Ahima R., Divall S.,Wu S., Neuronal ar regulates glucose homeostasis and energy expenditure in lean female mice with androgen excess. Endocrinology. 164(11)2023. PMID37738624.

41.       Vaidya R., Unger J.M., Qian L., Minichiello K., Herbst R.S., Gandara D.R., Neal J.W., Leal T.A., Patel J.D., Dragnev K.H., Waqar S.N., Edelman M.J., Sigal E.V., Adam S.J., Malik S., Blanke C.D., LeBlanc M.L., Kelly K., Gray J.E., Redman M.W.  Representativeness of patients enrolled in the lung cancer master protocol (lung-map). JCO Precis Oncol. 7: e2300218, 2023. PMID37677122.

42.       Wang Y., Risteski P., Yang Y., Chen H., Droby G., Walens A., Jayaprakash D., Troester M., Herring L., Chernoff J., Tolić I.M., Bowser J., Vaziri C.  The trim69-mst2 signaling axis regulates centrosome dynamics and chromosome segregation. Nucleic Acids Res, 2023. PMID37739411.

43.       Watson R.J., Caba A.E., Lawrence S.E., Renley B.M., McCauley P.S., Wheldon C.W., Eaton L.A., Russell S.T., Eisenberg M.E.  Examining mental health and bullying concerns at the intersection of sexuality, gender, race, and ethnicity among a national sample of sexual and gender diverse youth. LGBT Health, 2023. PMID37668602.

44.       Wilt J.K., Siminoff L.A., Thomson M.D.  Pre-diagnosis symptoms, attributed causes, and healthcare seeking assets of younger colorectal cancer survivors. J Cancer Educ, 2023. PMID37715897.

45.       Wong S.J., Torres-Saavedra P.A., Saba N.F., Shenouda G., Bumpous J.M., Wallace R.E., Chung C.H., El-Naggar A.K., Gwede C.K., Burtness B., Tennant P.A., Dunlap N.E., Redman R., Stokes W.A., Rudra S., Mell L.K., Sacco A.G., Spencer S.A., Nabell L., Yao M., Cury F.L., Mitchell D.L., Jones C.U., Firat S., Contessa J.N., Galloway T., Currey A., Harris J., Curran W.J., Jr., Le Q.T. Radiotherapy plus cisplatin with or without lapatinib for non-human papillomavirus head and neck carcinoma: A phase 2 randomized clinical trial. JAMA Oncol, 2023. PMID37768670.PMC10540060. 46.       Zhang Q., Basappa J., Wang H.Y., Nunez-Cruz S., Lobello C., Wang S., Liu X., Chekol S., Guo L., Ziober A., Nejati R., Shestov A., Feldman M., Glickson J.D., Turner S.D., Blair I.A., Van Dang C., Wasik M.A.  Chimeric kinase alk induces expression of nampt and selectively depends on this metabolic enzyme to sustain its own

Staff Publications Received in August, 2023

1.         Arring N., Barton D.L., Reese J.B., Clinical practice strategies to address sexual health in female cancer survivors. J Clin Oncol: Jco2300523, 2023. PMID37535889.

2.         Auchincloss A.H., Mucciaccio F., Fang C.Y., Ruggiero D.A., Hirsch J.A., Zhong J., Li M., Egleston B.L.,Tseng M., Neighborhood gentrification, wealth, and co-ethnic density associations with acculturation stressors among Chinese immigrants. SSM Popul Health. 23: 101476, 2023. PMID37583620.PMC10424118.

3.         Badr D., Fouad M.A., Hussein M., Salem S., Zekri A., Shouman S., Rebound increase in microrna levels at the end of 5-fu-based therapy in colorectal cancer patients. Sci Rep. 13(1): 14237, 2023. PMID37648713. PMC10469181.

4.         Barba-Montoya J., Sharma S., Kumar S., Molecular timetrees using relaxed clocks and uncertain phylogenies. Front Bioinform. 3: 1225807, 2023. PMID37600967.PMC10435864.

5.         Belani N., Liang K., Fradley M., Judd J., Borghaei H., How to treat egfr-mutated non-small cell lung cancer. JACC CardioOncol. 5(4): 542-545, 2023. PMID37614580.PMC10443111.

6.         Bhatia S., Pappo A.S., Acquazzino M., Allen-Rhoades W.A., Barnett M., Borinstein S.C., Casey R., Choo S., Chugh R., Dinner S., Ermoian R., Fair D., Federman N., Folbrecht J., Gandhi S., Germann J., Goldsby R., Hayashi R., Huang A.Y., Huang M.S., Jacobs L.A., Lee-Miller C., Link M.P., Livingston J.A., Lustberg M., Malogolowkin M., Oeffinger K.C., Pratilas C.A., Reed D., Skiles J., von Mehren M., Yeager N., Montgomery S.,Hang L., Adolescent and young adult (aya) oncology, version 2.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 21(8): 851-880, 2023. PMID37549914.

7.         Blay J.Y., von Mehren M., Jones R.L., Martin-Broto J., Stacchiotti S., Bauer S., Gelderblom H., Orbach D., Hindi N., Dei Tos A., Nathenson M., Synovial sarcoma: Characteristics, challenges, and evolving therapeutic strategies. ESMO Open. 8(5): 101618, 2023. PMID37625194.

8.         Blum K.A., Silagy A.W., Knezevic A., Weng S., Wang A., Mano R., Marcon J., DiNatale R.G., Sanchez A., Tickoo S., Gupta S., Motzer R., Haas N.B., Kim S.E., Uzzo R.G., Coleman J.A., Hakimi A.A.,Russo P., Localized non-metastatic sarcomatoid renal cell carcinoma: A 31 year externally verified study. BJU Int, 2023. PMID37589200.

9.         Bowers J.T., Anna J.L., Bair S.M., Annunzio K., Epperla N., Joy Pullukkara J., Gaballa S., Spinner M.A., Li S., Messmer M.R., Nguyen J.D.K., Ayers E.C., Wagner C., Hu B., Di M., Huntington S.F., Furqan F., Shah N.N., Chen C., Ballard H.J., Hughes M.E., Chong E.A., Nasta S.D., Barta S.K., Landsburg D.J.,Svoboda J., Brentuximab vedotin plus avd for hodgkin lymphoma: Incidence and management of peripheral neuropathy in a multisite cohort. Blood Adv, 2023. PMID37595053.

10.       Cerrato C., Meagher M.F., Autorino R., Simone G., Yang B., Uzzo R.G., Kutikov A., Porpiglia F., Capitanio U., Montorsi F., Porter J., Beksac A.T., Puri D., Nguyen M., Wang L., Hakimi K., Dhanji S., Liu F., Cerruto M.A., Pandolfo S.D., Minervini A., Lau C., Monish A., Eun D., Mottrie A., Mir C., Sundaram C., Antonelli A., Kaouk J.,Derweesh I.H., Partial versus radical nephrectomy for complex renal mass: Multicenter comparative analysis of functional outcomes (rosula collaborative group). Minerva Urol Nephrol. 75(4): 425-433, 2023. PMID37530659.

11.       Chang C., Barham D.W., Dalimov Z., Swerdloff D., Sadeghi-Nejad H., Andrianne R., Sempels M., Hsieh T.C., Hatzichristodoulou G., Hammad M., Miller J., Osmonov D., Lentz A., Perito P., Suarez-Sarmiento A., Hotaling J., Gross K., Jones J.M., van Renterghem K., Park S.H., Nicholas Warner J., Ziegelmann M., Modgil V., Jones A., Pearce I., Gross M.S., Yafi F.A., Simhan J., Single dilation in primary inflatable penile prosthesis placement is associated with fewer corporal complications than sequential dilation. Urology, 2023. PMID37574145.

12.       Cooke D.T., Bonner S., Bostock I.C., Bush E.L., Godoy L.A., Kotova S., Lagisetty K.H., Medlock A., Pereira S.J., Erkmen C.P., Surgical perspective on the American Thoracic Society statement on race correction of pulmonary function testing. Ann Thorac Surg, 2023. PMID37558152.

13.       Cornwell A.C., Tisdale A.A., Venkat S., Maraszek K.E., Alahmari A.A., George A., Attwood K., George M., Rempinski D., Franco-Barraza J., Seshadri M., Parker M.D., Cortes Gomez E., Fountzilas C., Cukierman E., Steele N.G., Feigin M.E., Lorazepam stimulates il6 production and is associated with poor survival outcomes in pancreatic cancer. Clin Cancer Res: Of1-of20, 2023. PMID37587561.

14.       Dougherty T.P., The most difficult lesson from cancer just might be its most valuable. JAMA Oncol, 2023. PMID37535376.

15.       Erkmen C.P., Chin K., Agarwal S., Adnan S., Cooke D.T.,Merrill W., The cost of being a woman in academic cardiothoracic surgery: Joint collaboration of the STS workforces on diversity, equity and inclusion and cardiothoracic surgery practice models. Ann Thorac Surg, 2023. PMID37543350.

16.       Fleisher L., Kenny C., Rusten C., Koren D.,Landau Z., Right information, right patient, right time: Utilizing the mycarecompass platform to deliver patient education in the oncology setting. J Cancer Educ, 2023. PMID37540339.

17.       Frosch Z.A.K., Hasler J., Handorf E., DuBois T., Bleicher R.J., Edelman M.J., Geynisman D.M., Hall M.J., Fang C.Y., Lynch S.M., Development of a multilevel model to identify patients at risk for delay in starting cancer treatment. JAMA Netw Open. 6(8): e2328712, 2023. PMID37578796. PMC10425824.

18.       Gao T., Cho E.A., Zhang P.,Wu J., Inhibition of talin-induced integrin activation by a double-hit stapled peptide. Structure. 31(8): 948-957.e3, 2023. PMID37369205.

19.       Gelderblom H., Jones R.L., Blay J.Y., George S., von Mehren M., Zalcberg J.R., Kang Y.K., Razak A.A., Trent J., Attia S., Le Cesne A., Siontis B.L., Goldstein D., Boye K., Sanchez C., Steeghs N., Rutkowski P., Druta M., Serrano C., Somaiah N., Chi P., Harrow B., Becker C., Reichmann W., Sherman M.L., Ruiz-Soto R., Heinrich M.C.,Bauer S., Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in intrigue, a phase 3, open-label study. Eur J Cancer. 192: 113245, 2023. PMID37598656.

20.       Gomaa S., Kelly W.K., Mitchell E., Storozynsky E., Zeigler-Johnson C., Juon H.S.,Wen K.Y., Racial disparities in new-onset diabetes mellitus in prostate cancer patients on androgen deprivation therapy: A retrospective analysis of trinetx data. World J Urol. 41(9): 2351-2357, 2023. PMID37555986.

21.       Han D.S., Ingram J.W., Gorroochurn P., Badalato G.M., Anderson C.B., Joice G.A., Simhan J., The state of urotrauma education among residency programs in the united states: A systematic review and meta-analysis. Curr Urol Rep, 2023. PMID37572174.

22.       Hernandez L.M., Montersino A., Niu J., Guo S., Faezov B., Sanders S.S., Dunbrack R.L.,Thomas G.M., Palmitoylation-dependent control of jak1 kinase signaling governs responses to neuropoietic cytokines and survival in drg neurons. J Biol Chem. 299(8): 104965, 2023. PMID37356718. PMC10413081.

23.       Hussen A.S., Kravitz H.L., Freudenthal B.D., Whitaker A.M., Oxidative DNA damage on the vegf g-quadruplex forming promoter is repaired via long-patch ber. Environ Mol Mutagen, 2023. PMID37606505.

24.       Kappes D., Wiest D.L., Doubling down to make killer t cells. Nat Immunol. 24(9): 1407-1408, 2023. PMID37620604.

25.       Kaur J., Patil G., Geynisman D.M., Ghatalia P., Role of perioperative immunotherapy in localized renal cell carcinoma. Ther Adv Med Oncol. 15: 17588359231181497, 2023. PMID37529159.PMC10387776.

26.       Kennecke H.F., Auer R., Cho M., Dasari N.A., Davies-Venn C., Eng C., Dorth J., Garcia-Aguilar J., George M., Goodman K.A., Kreppel L., Meyer J.E., Monzon J., Saltz L., Schrag D., Smith J.J., Zell J.A.,Das P., NCI rectal-anal task force consensus recommendations for design of clinical trials in rectal cancer. J Natl Cancer Inst, 2023. PMID37535679.

27.       Kilbride M., Egleston B.L., Chung W.K., Olopade O., Maxwell K.N., Shah P., Churpek J.E., Fleisher L., Terry M.B., Fetzer D., Gaieski J.B., Bulafka J., Espinal A., Karpink K., Walser S., Singleton D., Palese M., Siljander I., Brandt A., Clark D., Koval C., Wynn J., Long J.M., McKenna D., Powers J., Nielsen S., Domchek S.M., Nathanson K.L.,Bradbury A.R., Uptake of genetic research results and patient-reported outcomes with return of results incorporating web-based predisclosure education. J Clin Oncol: Jco2200516, 2023. PMID37611220.

28.       Kramer T., Wijmans L., van Heumen S., Bansal S., Jeannerat D., Manley C., de Bruin M., Bonta P.I., Annema J.T., Needle-based confocal laser endomicroscopy for real-time granuloma detection. Respirology, 2023. PMID37562791.

29.       Lee R.A., Kutikov A., Pathological and clinical outcomes in a large surveillance and intervention cohort of radiographically cystic renal masses. Reply. J Urol. 210(3): 409-410, 2023. PMID37378562.

30.       Lee R.A., Masic S., Bland J., Handorf E., Kutikov A., Esnaola N., Farma J., Su S., Ridge J.A., Chu C., Patel S., Curcillo P., Helstrom J.L., Uzzo R.G., Transition to value-based healthcare: Development, implementation, and results of an optimal surgical care framework at a National Cancer Institute-designated comprehensive cancer center. Eur Urol Focus, 2023. PMID37648597.

31.       Litsas D.C., Mulvania P.A., Roth S., Siminoff L.A., A rapid scoping review of the dual advocacy model for donation conversations. Prog Transplant. 33(3): 247-255, 2023. PMID37545474.

32.       Lubas M.J., Santos P.M.G., Yerramilli D.,Simone C.B., 2nd, Proton therapy in the palliative setting. Ann Palliat Med, 2023. PMID37574582.

33.       Magee D.E., Bukavina L.,Correa A., Taking a stand – no conferences in anti-abortion states. J Urol: 101097ju0000000000003686, 2023. PMID37643454.

34.       Manley C., Kail N.,Su S., Novel bronchoscopic management of bronchopleural fistula following pneumonectomy. Surg Technol Int. 422023. PMID37548541.

35.       Mehta S., Mehran R., Hassan S., Kaur J., Sule A., Arsene C., Krishnamoorthy G.,Szklo M., Prevalence and outcomes of patients with acute ischemic stroke and concomitant non-st-elevation myocardial infarction (results from the national inpatient sample 2016 to 2019). Am J Cardiol. 205: 346-353, 2023. PMID37639760.

36.       Miura S., Dolker T., Sanderford M.,Kumar S., Improving cellular phylogenies through the integrated use of mutation order and optimality principles. Comput Struct Biotechnol J. 21: 3894-3903, 2023. PMID37602230.PMC10432911.

37.       Nikonova A.S., Deneka A.Y., Silva F.N., Pirestani S., Tricarico R., Kiseleva A.A., Zhou Y., Nicolas E., Flieder D.B., Grivennikov S.I., Golemis E.A., Loss of pkd1 limits susceptibility to colitis and colorectal cancer. Oncogenesis. 12(1): 40, 2023. PMID37542051.PMC10403611.

38.       O’Donnell P.H., Milowsky M.I., Petrylak D.P., Hoimes C.J., Flaig T.W., Mar N., Moon H.H., Friedlander T.W., McKay R.R., Bilen M.A., Srinivas S., Burgess E.F., Ramamurthy C., George S., Geynisman D.M., Bracarda S., Borchiellini D., Geoffrois L., Maroto Rey J.P., Ferrario C., Carret A.S., Yu Y., Guseva M., Homet Moreno B.,Rosenberg J.E., Enfortumab vedotin with or without pembrolizumab in cisplatin-ineligible patients with previously untreated locally advanced or metastatic urothelial cancer. J Clin Oncol. 41(25): 4107-4117, 2023. PMID37369081.

39.       Ozols R.F., Bundy B.N., Greer B.E., Fowler J.M., Clarke-Pearson D., Burger R.A., Mannel R.S., DeGeest K., Hartenbach E.M., Baergen R., Phase iii trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage iii ovarian cancer: A gynecologic oncology group study. J Clin Oncol. 41(25): 4077-4083, 2023. PMID37643542. Corrected and Republished Article

40.       Panichella J.C., Araya S., Nannapaneni S., Robinson S.G., You S., Gubara S.M., Gebreyesus M.T., Webster T., Patel S.A., Hamidian Jahromi A., Cancer screening and management in the transgender population: Review of literature and special considerations for gender affirmation surgery. World J Clin Oncol. 14(7): 265-284, 2023. PMID37583948. PMC10424092.

41.       Papazian M.R., Chow M., Weed D., Liu J.C., Bewley A.F., Moore M.G., Givi B., Virtual tumor boards for remote learning in head and neck surgical oncology. JAMA Otolaryngol Head Neck Surg, 2023. PMID37615974.PMC10450583.

42.       Pruthi D.K., Miller G., Ankerst D.P., Neumair M., Capitanio U., Correa A.F., Lane B.R., Roussel E., McGregor T.B., Derweesh I.H., Cordeiro M., Pierorazio P.M., Calvo C., Bi H., Noyes S.L., Meagher M., Kutikov A., Uzzo R.G., Van Poppel H., Larcher A., Montorsi F., Kattan M.W., Kaushik D., Liss M.A., Diabetes, obesity, and pathological upstaging in renal cell carcinoma: Results from a large multi-institutional consortium. J Urol: 101097ju0000000000003650, 2023. PMID37579345.

43.       Restifo D., McDermott J.R., Cvetkovic D., Dos Santos T., Ogier C., Surumbayeva A., Handorf E.A., Schimke C., Ma C., Cai K.Q., Olszanski A.J., Kathad U., Bhatia K., Sharma P., Kulkarni A., Astsaturov I., Conditional dependency of lp-184 on prostaglandin reductase 1 is synthetic lethal in pancreatic cancers with DNA damage repair deficiencies. Mol Cancer Ther, 2023. PMID37552607.

44.       Sanft T., Day A., Ansbaugh S., Armenian S., Baker K.S., Ballinger T., Demark-Wahnefried W., Dickinson K., Fairman N.P., Felciano J., Flores T.F., Friedman D.L., Gabel N.M., Goldman M., Henry N.L., Hill-Kayser C., Hudson M., Koura D., Lee K., McDonough A.L., Melisko M., Mooney K., Moore H.C.F., Moryl N., Neuman H., O’Connor T., Overholser L., Paskett E.D., Patel C., Peterson L., Pirl W., Porpiglia A., Rodriguez M.A., Schapira L., Schwartz A.L., Smith S., Tevaarwerk A., Yang E., Zee P., McMillian N.R.,Freedman-Cass D.A., NCCN guidelines® insights: Survivorship, version 1.2023. J Natl Compr Canc Netw. 21(8): 792-803, 2023. PMID37549906.

45.       Schober J.P., Braun A., Ginsburg K.B., Bell S., Castro Bigalli A.A., Chen M., Wang R., Magee D., Bukavina L., Handorf E., Yu J.Q., Chen D.Y.T., Greenberg R.E., Smaldone M.C., Viterbo R., Correa A.F., Uzzo R.G., Kutikov A., Clinical performance of technetium-99m-sestamibi spect/ct imaging in differentiating oncocytic tumors from renal cell carcinoma in routine clinical practice. J Urol. 210(3): 438-445, 2023. PMID37378576.

46.       Shusted C.S., Barta J.A., Nguyen A., Wen K.Y., Juon H.S., Zeigler-Johnson C., Characterizing lung cancer burden among Asian-American communities in Philadelphia. J Racial Ethn Health Disparities, 2023. PMID37540304.

47.       Sommer S.B., Barroso J.V., Bass S.B., Congema M.R., Schoemann A.M.,Caiola C.E., Barriers and facilitators to engagement in care and medication adherence for women living with hiv in the southern united states. AIDS Care: 1-9, 2023. PMID37535630.

48.       Stefanova M.E., Volokh O.I., Chertkov O.V., Armeev G.A., Shaytan A.K., Feofanov A.V., Kirpichnikov M.P., Sokolova O.S.,Studitsky V.M., Structure and dynamics of compact dinucleosomes: Analysis by electron microscopy and spfret. Int J Mol Sci. 24(15)2023. PMID37569503. PMC10419094.

49.       Su M.C., Nethi S.K., Dhanyamraju P.K.,Prabha S., Nanomedicine strategies for targeting tumor stroma. Cancers (Basel). 15(16)2023. PMID37627173. PMC10452920.

50.       Tagai E.K., Mantia-Smaldone G.M., Belfiglio A., Chu C.S., Lapitan E., Santos H., Hernandez E., Sarwer D.B., Miller S.M., Perceived importance of weight loss and exercise among endometrial cancer survivors with overweight or obesity: Implications for lifestyle modification interventions. Obesity Science & Practice, 2023. PMIDWOS:001037636100001.

51.       Teoh J.Y.C., Bhatt N.R., Cucchiara V., Rojo E.G., Pradere B., Borgmann H., Loeb S., Kutikov A., Ribal M.J., Giannarini G., Urology Guidelines O., The power of hashtags in social media: Lessons learnt from the urology tag ontology project. European Urology Focus. 8(6): 1565-1567, 2022. PMIDWOS:001043325700001.

52.       Wheldon C.W., Psychometric validation of the patient anal cancer knowledge scale (packs) in a cohort of Black and Hispanic/Latino sexual and gender diverse young adults. J Cancer Educ, 2023. PMID37648950.

53.       Wiese D., DuBois T.D., Sorice K.A., Fang C.Y., Ragin C., Daly M.B., Reese A.C., Henry K.A.,Lynch S.M., Defining aggressive prostate cancer: A geospatial perspective. BMC Cancer. 23(1): 754, 2023. PMID37580675.PMC10424402.

54.       Yong V., Reddy R., Erkmen C.P., Discussion to: Gender differences in cardiothoracic surgery letters of recommendation. J Thorac Cardiovasc Surg, 2023. PMID37530692.

Staff Publications Received in July, 2022

1.        Ambrose N., Sadacharam K., Burke B., Figueroa T.E., Lang R.S., Kjelstrom S.,Hagerty J., Spinal versus general anesthesia: Comparing outcomes in pediatric patients undergoing urologic procedures. J Pediatr Urol, 2023. PMID37487883.

2.        Amirshaghaghi A., Chang W.C., Chhay B., Bartolomeu A.R., Clapper M.L., Cheng Z.,Tsourkas A., Phthalocyanine-blue nanoparticles for the direct visualization of tumors with white light illumination. ACS Appl Mater Interfaces. 15(28): 33373-33381, 2023. PMID37395349.

3.        Aragon-Ching J.B., Uzzo R., Multidisciplinary treatment (mdt) perspectives in renal cell carcinoma. Therapeutic Advances in Urology. 15: 17562872231182216, 2023. WOS:001015229600001. PMC10286529.

4.        Araya S., Webster T.K., Egleston B., Amadio G.M., Panichella J.C., Elmer N.A., Patel S.A., Significant reduction in length of stay in deep inferior epigastric perforator flap breast reconstruction with implementation of multimodal eras protocol. Ann Plast Surg. 91(1): 90-95, 2023. PMID37450866.

5.        Barham D.W., Chang C., Hammad M., Pyrgidis N., Swerdloff D., Gross K., Hatzichristodoulou G., Hsieh T.C., Hotaling J.M., Jenkins L.C., Jones J.M., Modgil V., Osmonov D., Pearce I., Perito P., Sadeghi-Nejad H., Suarez-Sarmiento A., Jr., Sempels M., Service C.A., Simhan J., Yafi F.A.,Gross M.S., Delayed placement of an inflatable penile prosthesis is associated with a high complication rate in men with a history of ischemic priapism. J Sex Med. 20(7): 1052-1056, 2023. PMID37279440.

6.        Basch E., Dueck A.C., Mitchell S.A., Mamon H., Weiser M., Saltz L., Gollub M., Rogak L., Ginos B., Mazza G.L., Colgrove B., Chang G., Minasian L., Denicoff A., Thanarajasingam G., Musher B., George T., Venook A., Farma J., O’Reilly E., Meyerhardt J.A., Shi Q., Schrag D., Patient-reported outcomes during and after treatment for locally advanced rectal cancer in the prospect trial (alliance n1048). J Clin Oncol. 41(21): 3724-3734, 2023. PMID37270691.PMC10351948.

7.        Basu J., Olsson A., Ferchen K., Titerina E.K., Chetal K., Nicolas E., Czyzewicz P., Levchenko D., Ge L., Hua X., Grimes H.L., Salomonis N., Kappes D.J., Thpok is a critical multifaceted regulator of myeloid lineage development. Nat Immunol. 24(8): 1295-1307, 2023. PMID37474652.

8.        Bauman J.E., Saba N.F., Roe D., Bauman J.R., Kaczmar J., Bhatia A., Muzaffar J., Julian R., Wang S., Bearelly S., Baker A., Steuer C., Giri A., Burtness B., Centuori S., Caulin C., Klein R., Saboda K., Obara S.,Chung C.H., Randomized phase ii trial of ficlatuzumab with or without cetuximab in pan-refractory, recurrent/metastatic head and neck cancer. J Clin Oncol. 41(22): 3851-3862, 2023. PMID36977289.

9.        Benson A.B., D’Angelica M.I., Abrams T., Abbott D.E., Ahmed A., Anaya D.A., Anders R., Are C., Bachini M., Binder D., Borad M., Bowlus C., Brown D., Burgoyne A., Castellanos J., Chahal P., Cloyd J., Covey A.M., Glazer E.S., Hawkins W.G., Iyer R., Jacob R., Jennings L., Kelley R.K., Kim R., Levine M., Palta M., Park J.O., Raman S., Reddy S., Ronnekleiv-Kelly S., Sahai V., Singh G., Stein S., Turk A., Vauthey J.N., Venook A.P., Yopp A., McMillian N., Schonfeld R.,Hochstetler C., NCCN guidelines® insights: Biliary tract cancers, version 2.2023. J Natl Compr Canc Netw. 21(7): 694-704, 2023. PMID37433432.

10.      Benson A., Venook A.P., Al-Hawary M.M., Azad N., Chen Y.J., Ciombor K.K., Cohen S., Cooper H.S., Deming D., Garrido-Laguna I., Grem J.L., Hecht J.R., Hoffe S., Hubbard J., Hunt S., Hussan H., Jeck W., Johung K.L., Joseph N., Kirilcuk N., Krishnamurthi S., Maratt J., Messersmith W.A., Meyerhardt J., Miller E.D., Mulcahy M.F., Nurkin S., Overman M.J., Parikh A., Patel H., Pedersen K., Saltz L., Schneider C., Shibata D., Skibber J.M., Sofocleous C.T., Stotsky-Himelfarb E., Tavakkoli A., Willett C.G., Williams G., Algieri F., Gurski L.,Stehman K., Anal carcinoma, version 2.2023. Journal of the National Comprehensive Cancer Network. 21(6): 653-+, 2023. WOS:001020834100012.

11.      Benton D., Chernoff J., Trimming away colon cancer: Trim21-mediated ubiquitination as an activator of the hippo tumor suppressor pathway. Cell Chem Biol. 30(7): 699-701, 2023. PMID37478825.

12.      Bodor J.N., Patel J.D., Wakelee H.A., Levy B.P., Borghaei H., Pellini B., Costello M.R., Dowell J.E., Finley G., Huang C.H., Neal J.W., Nieva J.J., Puri S., Socinski M.A., Thomas C., Ross E.A., Litwin S., Clapper M.L.,Treat J., Phase ii randomized trial of carboplatin, pemetrexed, and bevacizumab with and without atezolizumab in stage iv nonsquamous non-small-cell lung cancer patients who harbor a sensitizing EGFR mutation or have never smoked. Clin Lung Cancer, 2023. PMID37451930.

13.      Carey M.E., Rando J., Melnyk S., James S.J., Snyder N., Salafia C., Croen L.A., Fallin M.D., Hertz-Picciotto I., Volk H., Newschaffer C.,Lyall K., Examining associations between prenatal biomarkers of oxidative stress and asd-related outcomes using quantile regression. J Autism Dev Disord. 53(8): 2975-2985, 2023. PMID35678944.PMC9732143.

14.      Carthon B.C., Kim S.E., McDermott D.F., Dutcher J.P., Puligandla M., Manola J., Pins M., Carducci M.A., Plimack E.R., Appleman L.J., MacVicar G.R., Kohli M., Kuzel T.M., DiPaola R.S.,Haas N.B., Results from a randomized phase ii trial of sunitinib and gemcitabine or sunitinib in advanced renal cell carcinoma with sarcomatoid features: Ecog-acrin e1808. Clin Genitourin Cancer, 2023. PMID37455214.

15.      Chandrasekar T., Denisenko A., Mico V., McPartland C., Shah Y., Mark J.R., Lallas C.D., Fonshell C., Danella J., Jacobs B., Lanchoney T., Raman J.D., Tomaszewski J., Reese A., Singer E.A., Ginzburg S., Smaldone M., Uzzo R., Guzzo T.J.,Trabulsi E.J., Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborative. Urol Oncol. 41(8): 355.e1-355.e8, 2023. PMID37357123.

16.      Chiorean E.G., Chiaro M.D., Tempero M.A., Malafa M.P., Benson A.B., Cardin D.B., Christensen J.A., Chung V., Czito B., Dillhoff M., Donahue T.R., Dotan E., Fountzilas C., Glazer E.S., Hardacre J., Hawkins W.G., Klute K., Ko A.H., Kunstman J.W., LoConte N., Lowy A.M., Masood A., Moravek C., Nakakura E.K., Narang A.K., Nardo L., Obando J., Polanco P.M., Reddy S., Reyngold M., Scaife C., Shen J., Truty M.J., Vollmer C., Wolff R.A., Wolpin B.M., Rn B.M., Lubin S.,Darlow S.D., Ampullary adenocarcinoma, version 1.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 21(7): 753-782, 2023. PMID37433437.

17.      Cichocki F., Zhang B., Wu C.Y., Chiu E., Day A., O’Connor R.S., Yackoubov D., Simantov R., McKenna D.H., Cao Q., Defor T.E., Janakiram M., Wangen R., Cayci Z., Snyder N., Kumar A., Grzywacz B., Hwang J., Geffen Y., Miller J.S., Maakaron J.,Bachanova V., Nicotinamide enhances natural killer cell function and yields remissions in patients with non-hodgkin lymphoma. Sci Transl Med. 15(705): eade3341, 2023. PMID37467318.

18.      DeAntoneo C., Herbert A.,Balachandran S., Z-form nucleic acid-binding protein 1 (zbp1) as a sensor of viral and cellular z-rnas: Walking the razor’s edge. Current Opinion in Immunology. 83: 102347, 2023. WOS:001014826400001.

19.      Demidova E.V., Serebriiskii I.G., Vlasenkova R., Kelow S., Andrake M.D., Hartman T.R., Kent T., Virtucio J., Rosen G.L., Pomerantz R.T., Dunbrack R.L., Jr., Golemis E.A., Hall M.J., Chen D.Y.T., Daly M.B.,Arora S., Correction: Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing. BMC Genomics. 24(1): 388, 2023. PMID37430226.PMC10331989.

20.      Diefenbach M.A., Marziliano A., Siembida E.J., Mistretta T., Pfister H., Yacoub A., Aibel K., Patel P., Lapitan E., Tagai E.K., Smaldone M.,Miller S.M., Cancer resource and information support (cris) for bladder cancer survivors and their caregivers: Development and usability testing study. Jmir Formative Research. 7: e41876, 2023. WOS:001021681400002. PMC10337367.

21.      Friedman-DeLuca M., Patel P.P., Karadal-Ferrena B., Barth N.D., Duran C.L., Ye X., Papanicolaou M., Condeelis J.S., Oktay M.H., Borriello L.,Entenberg D., Tracking tumor cell dissemination from lung metastases using photoconversion. J Vis Exp, (197)2023. PMID37486129.

22.      Gamero A.M., Rosalind franklin society proudly announces the 2022 award recipient for journal of interferon and cytokine research. J Interferon Cytokine Res. 43(7): 281-282, 2023. PMID37463461.

23.      Gao Y., Wang Y., Chauss D., Villarino A.V., Link V.M., Nagashima H., Spinner C.A., Koparde V.N., Bouladoux N., Abers M.S., Break T.J., Chopp L.B., Park J.H., Zhu J., Wiest D.L., Leonard W.J., Lionakis M.S., O’Shea J.J., Afzali B., Belkaid Y.,Lazarevic V., Transcription factor egr2 controls homing and pathogenicity of t(h)17 cells in the central nervous system. Nat Immunol. 24(8): 1331-1344, 2023. PMID37443284.

24.      Gardiner H., Siminoff L., Gordon E.J., Alolod G., Richardson B., Schupler M., Benitez A., Hernandez I., Guinansaca N., Ramos L., Bergeron C.D., Pappaterra L., Norden R.,Daly T., Direct and indirect effects of a web-based educational and communication skills intervention “promotoras de donación” to increase donor designation in latinx communities: Evaluation study. J Med Internet Res. 25: e37140, 2023. PMID37428526. PMC10366967.

25.      George L.S., Saraiya B., Trevino K.M., Pflueger K., Voelbel S., Tagai E.K., Miller S.M., Epstein A.S., Duberstein P., Feasibility and acceptability of an online oncologist training to optimize oncologist-patient communication and value-concordant care in advanced cancer. J Palliat Med, 2023. PMID37459165.

26.      Ghatalia P., Kaur J., Sonpavde G., Muscle invasive bladder cancer: Where is the field headed? Expert Opin Biol Ther: 1-15, 2023. PMID37477127.

27.      Gironda D.J., Bergan R.C., Alpaugh R.K., Danila D.C., Chuang T.L., Hurtado B.Y., Ho T., Adams D.L., Cancer associated macrophage-like cells are prognostic for highly aggressive prostate cancer in both the non-metastatic and metastatic settings. Cancers (Basel). 15(14)2023. PMID37509385.PMC10378487.

28.      Gracia-Diaz C., Zhou Y., Yang Q., Maroofian R., Espana-Bonilla P., Lee C.H., Zhang S., Padilla N., Fueyo R., Waxman E.A., Lei S., Otrimski G., Li D., Sheppard S.E., Mark P., Harr M.H., Hakonarson H., Rodan L., Jackson A., Vasudevan P., Powel C., Mohammed S., Maddirevula S., Alzaidan H., Faqeih E.A., Efthymiou S., Turchetti V., Rahman F., Maqbool S., Salpietro V., Ibrahim S.H., di Rosa G., Houlden H., Alharbi M.N., Al-Sannaa N.A., Bauer P., Zifarelli G., Estaras C., Hurst A.C.E., Thompson M.L., Chassevent A., Smith-Hicks C.L., de la Cruz X., Holtz A.M., Elloumi H.Z., Hajianpour M.J., Rieubland C., Braun D., Banka S., French D.L., Heller E.A., Saade M., Song H., Ming G.L., Alkuraya F.S., Agrawal P.B., Reinberg D., Bhoj E.J., Martínez-Balbás M.A.,Akizu N., Gain and loss of function variants in ezh1 disrupt neurogenesis and cause dominant and recessive neurodevelopmental disorders. Nat Commun. 14(1): 4109, 2023. PMID37433783. PMC10336078.

29.      Gradishar W.J., Moran M.S., Abraham J., Abramson V., Aft R., Agnese D., Allison K.H., Anderson B., Burstein H.J., Chew H., Dang C., Elias A.D., Giordano S.H., Goetz M.P., Goldstein L.J., Hurvitz S.A., Jankowitz R.C., Javid S.H., Krishnamurthy J., Leitch A.M., Lyons J., Mortimer J., Patel S.A., Pierce L.J., Rosenberger L.H., Rugo H.S., Schneider B., Smith M.L., Soliman H., Stringer-Reasor E.M., Telli M.L., Wei M., Wisinski K.B., Young J.S., Yeung K.Y., Dwyer M.A.,Kumar R., Breast cancer, version 4.2023. Journal of the National Comprehensive Cancer Network. 21(6): 594-608, 2023. WOS:001020834100006.

30.      Guan A., Pruitt S.L., Henry K.A., Lin K., Meltzer D., Canchola A.J., Rathod A.B., Hughes A.E., Kroenke C.H., Gomez S.L., Hiatt R.A., Stroup A.M., Pinheiro P.S., Boscoe F.P., Zhu H.,Shariff-Marco S., Asian American enclaves and healthcare accessibility: An ecologic study across five states. Am J Prev Med, 2023. PMID37429388.

31.      Heaton E.S., Hu M., Liu T., Hui H., Tan Y., Ye K.,Jin S., Extracellular matrix-derived peptide stimulates the generation of endocrine progenitors and islet organoids from ipscs. J Tissue Eng. 14: 20417314231185858, 2023. PMID37435573.PMC10331343.

32.      Hemenway G., Lewis B., Ghatalia P., Anari F., Plimack E.R., Kokate R., Handorf E., Deng M., Geynisman D.M.,Zibelman M., Neoadjuvant chemotherapy with accelerated methotrexate, vinblastine, doxorubicin, and cisplatin in patients with muscle-invasive bladder cancer: A retrospective age-stratified analysis on safety and efficacy. Eur Urol Oncol. 6(4): 431-436, 2023. PMID35792045.

33.      Hermida-Prado F., Xie Y., Sherman S., Nagy Z., Russo D., Akhshi T., Chu Z., Feit A., Campisi M., Chen M., Nardone A., Guarducci C., Lim K., Font-Tello A., Lee I., García-Pedrero J., Canadas I., Agudo J., Huang Y., Sella T., Jin Q., Tayob N., Mittendorf E.A., Tolaney S.M., Qiu X., Long H., Symmans W.F., Lin J.R., Santagata S., Bedrosian I., Yardley D.A., Mayer I.A., Richardson E.T., Oliveira G., Wu C.J., Schuster E.F., Dowsett M., Welm A.L., Barbie D., Metzger O.,Jeselsohn R., Endocrine therapy synergizes with smac mimetics to potentiate antigen presentation and tumor regression in hormone receptor-positive breast cancer. Cancer Res, 2023. PMID37450351.

34.      Hu M., Bodnar B., Zhang Y., Xie F., Li F., Li S., Zhao J., Zhao R., Gedupoori N., Mo Y., Lin L., Li X., Meng W., Yang X., Wang H., Barbe M.F., Srinivasan S., Bethea J.R., Mo X., Xu H.,Hu W., Defective neurite elongation and branching in nibp/trappc9 deficient zebrafish and mice. Int J Biol Sci. 19(10): 3226-3248, 2023. PMID37416774.PMC10321293.

35.      Jensen L.E., Pellino proteins in viral immunity and pathogenesis. Viruses. 15(7)2023. PMID37515108.PMC10383966.

36.      Koch C.A., Obesity is a risk factor. Deutsches Arzteblatt International. 120(11): 188-188, 2023. WOS:001000824500011. PMC10213471.

37.      Kottschade L.A., Pond G.R., Olszanski A.J., Zakharia Y., Domingo-Musibay E., Hauke R.J., Curti B.D., Schober S., Milhem M.M., Block M.S., Hieken T.,McWilliams R.R., Salvo: Single-arm trial of ipilimumab and nivolumab as adjuvant therapy for resected mucosal melanoma. Clinical Cancer Research. 29(12): 2220-2225, 2023. WOS:001016302400001.

38.      Kumar S., Tao Q., Lamarca A.P.,Tamura K., Computational reproducibility of molecular phylogenies. Mol Biol Evol. 40(7)2023. PMID37467477.PMC10370456.

39.      Lal B., Kulkarni A., McDermott J., Rais R., Alt J., Wu Y., Lopez-Bertoni H., Sall S., Kathad U., Zhou J., Slusher B.S., Bhatia K.,Laterra J., Preclinical efficacy of lp-184, a tumor site activated synthetic lethal therapeutic, in glioblastoma. Clin Cancer Res, 2023. PMID37494541.

40.      Lee C.T., Koleoso O., Deng M., Veltchev I., Lin T., Hallman M.A., Horwitz E.M.,Wong J.K., A dosimetric analysis of rectal hydrogel spacer use in patients with recurrent prostate cancer undergoing salvage high-dose-rate brachytherapy. Brachytherapy, 2023. PMID37393186.

41.      Levi H., Carmi S., Rosset S., Yerushalmi R., Zick A., Yablonski-Peretz T., Wang Q., Bolla M.K., Dennis J., Michailidou K., Lush M., Ahearn T., Andrulis I.L., Anton-Culver H., Antoniou A.C., Arndt V., Augustinsson A., Auvinen P., Beane Freeman L., Beckmann M., Behrens S., Bermisheva M., Bodelon C., Bogdanova N.V., Bojesen S.E., Brenner H., Byers H., Camp N., Castelao J., Chang-Claude J., Chirlaque M.D., Chung W., Clarke C., Collee M.J., Colonna S., Couch F., Cox A., Cross S.S., Czene K., Daly M., Devilee P., Dork T., Dossus L., Eccles D.M., Eliassen A.H., Eriksson M., Evans G., Fasching P., Fletcher O., Flyger H., Fritschi L., Gabrielson M., Gago-Dominguez M., García-Closas M., Garcia-Saenz J.A., Genkinger J., Giles G.G., Goldberg M., Guénel P., Hall P., Hamann U., He W., Hillemanns P., Hollestelle A., Hoppe R., Hopper J., Jakovchevska S., Jakubowska A., Jernström H., John E., Johnson N., Jones M., Vijai J., Kaaks R., Khusnutdinova E., Kitahara C., Koutros S., Kristensen V., Kurian A.W., Lacey J., Lambrechts D., Le Marchand L., Lejbkowicz F., Lindblom A., Loibl S., Lori A., Lubinski J., Mannermaa A., Manoochehri M., Mavroudis D., Menon U., Mulligan A., Murphy R., Nevelsteen I., Newman W.G., Obi N., O’Brien K., Offit K., Olshan A., Plaseska-Karanfilska D., Olson J., Panico S., Park-Simon T.W., Patel A., Peterlongo P., Rack B., Radice P., Rennert G., Rhenius V., Romero A., Saloustros E., Sandler D., Schmidt M.K., Schwentner L., Shah M., Sharma P., Simard J., Southey M., Stone J., Tapper W.J., Taylor J., Teras L., Toland A.E., Troester M., Truong T., van der Kolk L.E., Weinberg C., Wendt C., Yang X.R., Zheng W., Ziogas A., Dunning A.M., Pharoah P., Easton D.F., Ben-Sachar S., Elefant N., Shamir R.,Elkon R., Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. J Med Genet, 2023. PMID37451831.

42.      Liacini A., Tripathi G., McCollick A., Gravante C., Abdelmessieh P., Shestovska Y., Mathew L.,Geier S., Chimerism testing by next generation sequencing for detection of engraftment and early disease relapse in allogeneic hematopoietic cell transplantation and an overview of ngs chimerism studies. Int J Mol Sci. 24(14)2023. PMID37511573.PMC10380370.

43.      Licata J.P., Schwab K.H., Har-El Y.E., Gerstenhaber J.A., Lelkes P.I., Bioreactor technologies for enhanced organoid culture. Int J Mol Sci. 24(14)2023. PMID37511186.PMC10380004.

44.      Lieberman W.K., Brown Z.A., Kantner D.S., Jing Y., Megill E., Evans N.D., Crawford M.C., Jhulki I., Grose C., Jones J.E., Snyder N.W.,Meier J.L., Chemoproteomics yields a selective molecular host for acetyl-coa. J Am Chem Soc, 2023. PMID37486078.

45.      Lilly A.C., Astsaturov I.,Golemis E.A., Intrapancreatic fat, pancreatitis, and pancreatic cancer. Cell Mol Life Sci. 80(8): 206, 2023. PMID37452870. PMC10349727.

46.      Liu L., Ross N.M., Handorf E.A., Meeker C.R., Chen G., Baldwin D.,  Vijayvergia N., Incidence of asymptomatic covid-19 positivity in cancer patients and effects on therapy. J Cancer Res Clin Oncol. 149(7): 3243-3247, 2023. PMID35904602.PMC9334983.

47.      Lyubitelev A.,Studitsky V., Inhibition of cancer development by natural plant polyphenols: Molecular mechanisms. Int J Mol Sci. 24(13)2023. PMID37445850.PMC10341686.

48.      Mishra K., Isali I., Sindhani M., Prunty M., Bell S., Mahran A., Damiani G., Ghannoum M., Retuerto M., Kutikov A., Ross J., Woo L.L., Abbosh P.H.,Bukavina L., Characterization of changes in penile microbiome following pediatric circumcision. Eur Urol Focus. 9(4): 669-680, 2023. PMID36566099.

49.      Morra A., Schreurs M.A.C., Andrulis I.L., Anton-Culver H., Augustinsson A., Beckmann M.W., Behrens S., Bojesen S.E., Bolla M.K., Brauch H., Broeks A., Buys S.S., Camp N.J., Castelao J.E., Cessna M.H., Chang-Claude J., Chung W.K., Colonna S.V., Couch F.J., Cox A., Cross S.S., Czene K., Daly M.B., Dennis J., Devilee P., Dörk T., Dunning A.M., Dwek M., Easton D.F., Eccles D.M., Eriksson M., Evans D.G., Fasching P.A., Fehm T.N., Figueroa J.D., Flyger H., Gabrielson M., Gago-Dominguez M., García-Closas M., García-Sáenz J.A., Genkinger J., Grassmann F., Gündert M., Hahnen E., Haiman C.A., Hamann U., Harrington P.A., Hartikainen J.M., Hoppe R., Hopper J.L., Houlston R.S., Howell A., Jakubowska A., Janni W., Jernström H., John E.M., Johnson N., Jones M.E., Kristensen V.N., Kurian A.W., Lambrechts D., Le Marchand L., Lindblom A., Lubiński J., Lux M.P., Mannermaa A., Mavroudis D., Mulligan A.M., Muranen T.A., Nevanlinna H., Nevelsteen I., Neven P., Newman W.G., Obi N., Offit K., Olshan A.F., Park-Simon T.W., Patel A.V., Peterlongo P., Phillips K.A., Plaseska-Karanfilska D., Polley E.C., Presneau N., Pylkäs K., Rack B., Radice P., Rashid M.U., Rhenius V., Robson M., Romero A., Saloustros E., Sawyer E.J., Schmutzler R.K., Schuetze S., Scott C., Shah M., Smichkoska S., Southey M.C., Tapper W.J., Teras L.R., Tollenaar R., Tomczyk K., Tomlinson I., Troester M.A., Vachon C.M., van Veen E.M., Wang Q., Wendt C., Wildiers H., Winqvist R., Ziogas A., Hall P., Pharoah P.D.P., Adank M.A., Hollestelle A., Schmidt M.K.,Hooning M.J., Association of the chek2 c.1100delc variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. Cancer Med, 2023. PMID37401034.

50.      Noh S., Nessim C., Keung E.Z., Roland C.L., Strauss D., Sivarajah G., Fiore M., Biasoni D., Cioffi S.P.B., Mehtsun W., Cananzi F.C.M., Sicoli F., Quagliuolo V., Chen J., Luo C., Gladdy R.A., Swallow C., Johnston W., Ford S.J., Evenden C., Tirotta F., Almond M., Nguyen L., Rutkowski P., Krotewicz M., Pennacchioli E., Cardona K., Gamboa A., Hompes D., Renard M., Kollár A., Ryser C.O., Vassos N., Raut C.P., Fairweather M., Krakorova D.A., Quildrian S., Perhavec A., Nizri E., Farma J.M., Greco S.H., Vincenzi B., Lopez J.A.G., Solerdecoll M.S., Iwata S., Fukushima S., Kim T., Tolomeo F., Snow H., Howlett-Jansen Y., Tzanis D., Nikulin M., Gronchi A.,Sicklick J.K., Retrospective analysis of retroperitoneal-abdominal-pelvic ganglioneuromas: An international study by the transatlantic australasian retroperitoneal sarcoma working group (tarpswg). Ann Surg. 278(2): 267-273, 2023. PMID35866666.PMC10191524.

51.      Orji P., Sun H., Isali I., Bell S., Zaorsky N., Mishra K., Gupta S., Correa A., Smaldone M., Calaway A., Viterbo R.,Bukavina L., Female sexual function evaluation and intraoperative vaginal reconstruction in bladder cancer. World J Urol. 41(7): 1751-1762, 2023. PMID37419972.

52.      Ostrowski D.A., Chelluri R.R., Herzig M., Xia L., Cortese B.D., Roberson D.S., Guzzo T.J., Lee D.J.,Malkowicz S.B., Diminished short-term efficacy of reduced-dose induction bcg in the treatment of non-muscle invasive bladder cancer. Cancers (Basel). 15(14)2023. PMID37509407.PMC10377836.

53.      Patel S.A., Gibson M.K., Deal A., Sheth S., Heiling H., Johnson S.M., Douglas K., Flores M., Blumberg J., Lumley C., Yarbrough W.G., Shen C., Chera B.S., Bauman J.R., Hackman T.,Weiss J., A phase 2 study of neoadjuvant chemotherapy plus durvalumab in resectable locally advanced head and neck squamous cell carcinoma. Cancer, 2023. PMID37395170.

54.      Plimack E.R., Powles T., Stus V., Gafanov R., Nosov D., Waddell T., Alekseev B., Pouliot F., Melichar B., Soulières D., Borchiellini D., McDermott R.S., Vynnychenko I., Chang Y.H., Tamada S., Atkins M.B., Li C., Perini R., Molife L.R., Bedke J.,Rini B.I., Pembrolizumab plus axitinib versus sunitinib as first-line treatment of advanced renal cell carcinoma: 43-month follow-up of the phase 3 keynote-426 study. Eur Urol, 2023. PMID37500340.

55.      Presley C.J., Baumgart M., Halmos B.,Dotan E., Cancer rarely travels alone: Addressing the accumulation of risk and early mortality for older adults with advanced lung cancer. J Geriatr Oncol: 101579, 2023. PMID37429784.

56.      Rencsok E.M., Slopen N., Autio K., Morgans A., McSwain L., Barata P., Cheng H.H., Dreicer R., Heath E., McKay R.R., Pomerantz M., Rathkopf D., Tagawa S., Whang Y.E., Ragin C., Odedina F.T., George D.J., Kantoff P.W., Vinson J., Villanti P., Haneuse S.,Mucci L.A., Quality of life in the year after new diagnosis with advanced prostate cancer for black and white individuals living in the us. Qual Life Res, 2023. PMID37410340.

57.      Ryan C.W., Tangen C.M., Heath E.I., Stein M.N., Meng M.V., Alva A.S., Pal S.K., Puzanov I., Clark J.I., Choueiri T.K., Agarwal N., Uzzo R.G., Haas N.B., Synold T.W., Plets M., Vaishampayan U.N., Shuch B.M., Thompson I.M., Jr.,Lara P.N., Jr., Adjuvant everolimus after surgery for renal cell carcinoma (everest): A double-blind, placebo-controlled, randomised, phase 3 trial. Lancet, 2023. PMID37524096.

58.      Salgado T.M., Radwan R.M., Hickey Zacholski E., Mackler E., Buffington T.M., Musselman K.T., Irvin W.J., Jr., Perkins J.M., Le T.N., Dixon D.L., Farris K.B., Sheppard V.B., Jones R.M., Oncologists’ responsibility, comfort, and knowledge managing hyperglycemia in patients with cancer undergoing chemotherapy: A cross sectional study. Support Care Cancer. 31(8): 450, 2023. PMID37421495.

59.      Schrag D., Shi Q., Weiser M.R., Gollub M.J., Saltz L.B., Musher B.L., Goldberg J., Al Baghdadi T., Goodman K.A., McWilliams R.R., Farma J.M., George T.J., Kennecke H.F., Shergill A., Montemurro M., Nelson G.D., Colgrove B., Gordon V., Venook A.P., O’Reilly E.M., Meyerhardt J.A., Dueck A.C., Basch E., Chang G.J.,Mamon H.J., Preoperative treatment of locally advanced rectal cancer. N Engl J Med. 389(4): 322-334, 2023. PMID37272534.

60.      Simons M., Sharaiha R., Updates in metabolic bariatric endoscopy. Dig Endosc, 2023. PMID37405807.

61.      Skvorak K., Mitchell V., Teadt L., Franklin K.A., Lee H.O., Kruse N., Huitt-Roehl C., Hang J., Du F., Galanie S., Guan S., Aijaz H., Zhang N., Rajkovic G., Kruger W.D., Ismaili M.H.A., Huisman G., McCluskie K.,Silverman A.P. An orally administered enzyme therapeutic for homocystinuria that suppresses homocysteine by metabolizing methionine in the gastrointestinal tract. Mol Genet Metab. 139(4): 107653, 2023. PMID37463544.

62.      Strauss A.L., Triggs J.R., Tewksbury C.M., Soriano I., Wernsing D.S., Dumon K.R., Williams N.N.,Shao J.M., Conversion to roux-en-y gastric bypass: A successful means of mitigating reflux after laparoscopic sleeve gastrectomy. Surg Endosc. 37(7): 5374-5379, 2023. PMID36997653.

63.      Syphers J.L., Xue L., Yi X., Wang R.E.,Haubrich B.A., Meeting proceedings from icbs 2022 – uncovering solutions for diseases. ACS Chem Biol. 18(7): 1447-1459, 2023. PMID37310212.

64.      Thomson M.D., Van Houtven C.H., Xu R., Siminoff L.A., The many “costs” of transportation: Examining what cancer caregivers experience as transportation obstacles. Cancer Med, 2023. PMID37485648.

65.      Unfer V., Koch C.A., Benvenga S., eung A.M., Editorial: Dietary supplements for preserving thyroid health: The scientific evidence-based view. Front Endocrinol (Lausanne). 14: 1213082, 2023. PMID37396174.PMC10311543.

66.      Uzzo R., Bex A.,Pal S.K., The value of immotion010 for rare kidney cancer histologies – authors’ reply. Lancet. 402(10397): 181-182, 2023. PMID37453745.Letter.

67.      van den Berg D.M.N., de Lima P.N., Knudsen A.B., Rutter C.M., Weinberg D.,Lansdorp-Vogelaar I., Nordicc trial results in line with expected colorectal cancer mortality reduction after colonoscopy: A modelling study. Gastroenterology, 2023. PMID37454978.

68.      Voelz V.A., Pande V.S.,Bowman G.R., Folding@home: Achievements from over 20 years of citizen science herald the exascale era. Biophys J. 122(14): 2852-2863, 2023. PMID36945779.

69.      Ward C.L., Kozian L., Bartolacci J., Krupp J.C., Karadsheh M.J., Weiss E.S.,Patel S.A., A novel approach to reducing splash exposure in pulsatile lavage. Plast Reconstr Surg Glob Open. 11(6): e5016, 2023. PMID37396839.PMC10313271.

70.      Wheldon C.W., Sykes K.J., Ramaswamy M., Bass S.B.,Collins B.N., Integrating HPV vaccination within prep care delivery for underserved populations: A mixed methods feasibility study. J Community Health. 48(4): 640-651, 2023. PMID36894796.

71.      Williams J.L., Freedman J.A., Ragin C., Odedina F.T.,Thompson P., Editorial: Racial health disparity in cancer: Assessments of need. Front Oncol. 13: 1226697, 2023. PMID37416527.PMC10322203.

72.      Yang D., Draganov P.V., Pohl H., Aihara H., Jeyalingam T., Khashab M., Liu N., Hasan M.K., Jawaid S., Othman M., Al-Haddad M., DeWitt J.M., Triggs J.R., Wang A.Y., Bechara R., Sethi A., Law R., Aadam A.A., Kumta N., Sharma N., Hayat M., Zhang Y., Yi F.,Elmunzer B.J., Development and initial validation of a video-based peroral endoscopic myotomy assessment tool. Gastrointest Endosc, 2023. PMID37500019.

73.      Zibelman M., MacFarlane A.W.t., Costello K., McGowan T., O’Neill J., Kokate R., Borghaei H., Denlinger C.S., Dotan E., Geynisman D.M., Jain A., Martin L., Obeid E., Devarajan K., Ruth K., Alpaugh R.K., Dulaimi E.A., Cukierman E., Einarson M., Campbell K.S., Plimack E.R., A phase 1 study of nivolumab in combination with interferon-gamma for patients with advanced solid tumors. Nat Commun. 14(1): 4513, 2023. PMID37500647.PMC10374608.

74.      Zimmer K., Kocher F., Untergasser G., Kircher B., Amann A., Baca Y., Xiu J., Korn W.M., Berger M.D., Lenz H.J., Puccini A., Fontana E., Shields A.F., Marshall J.L., Hall M., El-Deiry W.S., Hsiehchen D., Macarulla T., Tabernero J., Pichler R., Khushman M., Manne U., Lou E., Wolf D., Sokolova V., Schnaiter S., Zeimet A.G., Gulhati P., Widmann G., Seeber A., Pbrm1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system. NPJ Precis Oncol. 7(1): 64, 2023. PMID37400502.PMC10317977.

Staff Publications Received in June, 2023

1.         Bessho S., Grando K.C.M., Kyrylchuk K., Miller A., Klein-Szanto A.J., Zhu W., Gallucci S., Tam V., Tükel Ç. Systemic exposure to bacterial amyloid curli alters the gut mucosal immune response and the microbiome, exacerbating salmonella-induced arthritis. Gut Microbes. 15(1): 2221813, 2023. PMID37317012.PMC10269392.

2.         Broman K.K., Hughes T.M., Bredbeck B.C., Sun J.M., Kirichenko D., Carr M.J., Sharma A., Bartlett E.K., Nijhuis A.A.G., Thompson J.F., Hieken T.J., Kottschade L., Downs J., Gyorki D.E., Stahlie E., van Akkooi A., Ollila D., O’Shea K., Song Y., Karakousis G., Moncrieff M., Nobes J., Vetto J., Han D.L., Hotz M., Farma J.M., Deneve J.L., Fleming M.D., Perez M., Baecher K., Lowe M., Bagge R.O., Mattsson J., Lee A.Y., Berman R.S., Chai H., Kroon H.M., Teras J., Teras R.M., Farrow N.E., Beasley G.M., Hui J.Y.C., Been L., Kruijff S., Sinco B., Sarnaik A.A., Sondak V.K., Zager J.S., Dossett L.A.,Int High Risk Melanoma C.  International center-level variation in utilization of completion lymph node dissection and adjuvant systemic therapy for sentinel lymph node-positive melanoma at major referral centers. Annals of Surgery. 277(5): E1106-E1115, 2023. PMC10097464.

3.         Chang W.L., Ghosh J., Cooper H.S., Vanderveer L., Schultz B., Zhou Y., Harvey K.N., Kaunga E., Devarajan K., Li Y., Jelinek J., Fragoso M.F., Sapienza C., Clapper M.L. Folic acid supplementation promotes hypomethylation in both the inflamed colonic mucosa and colitis-associated dysplasia. Cancers (Basel). 15(11)2023. PMID37296911.PMC10252136.

4.         Collins B.N., Lepore S.J.,Egleston B.L., Eliminating children’s tobacco smoke exposure: A pathway to bioverified abstinence among low-income maternal smokers in the babies living safe and smokefree (bliss) trial. J Behav Med, 2023. PMID37285107.NEEDS PMC

5.         Dougherty T.P., Meyer J.E., Comparing lifestyle modifications and the magnitude of their associated benefit on cancer mortality. Nutrients. 15(9)2023. WOS:000987390900001.

6.         Drevik J., Simhan J., Welliver C.,Gross M., Gabapentinoids in urology: A review of their current role. Journal of Urology. 209(1): 12-13, 2023. WOS:000947769700005.

7.         Drzewiecka M., Gajos-Michniewicz A., Hoser G., Jaśniak D., Barszczewska-Pietraszek G., Sitarek P., Czarny P., Piekarski J., Radek M., Czyż M., Skorski T.,Śliwiński T. Histone deacetylases (hdac) inhibitor-valproic acid sensitizes human melanoma cells to dacarbazine and parp inhibitor. Genes (Basel). 14(6)2023. PMID37372475.PMC10298302.

8.         Franco-Rocha O.Y., Wheldon C.W., Trainum K., Kesler S.R.,Henneghan A.M., Clinical, psychosocial, and sociodemographic factors of sexual and gender minority groups with cancer: A systematic review. Eur J Oncol Nurs. 64: 102343, 2023. PMID37290162.

9.         Freedman L., Galloway T., Hu K., Mierzwa M., Variation in routine use of a 60 to 63 gy intermediate dose clinical target volume with primary radiation therapy for mucosal squamous cell carcinoma of the head and neck. Practical Radiation Oncology. 12(5): E393-E396, 2022. WOS:000992562500007. Editorial.

10.       Gomes V., Wiese D., Stroup A.,Henry K.A., Ethnic enclaves and colon cancer stage at diagnosis among New Jersey Hispanics. Soc Sci Med. 328: 115977, 2023. PMID37301107.

11.       Halasz L.M., Attia A., Bradfield L., Brat D.J., Kirkpatrick J.P., Laack N.N., Lalani N., Lebow E.S., Liu A.K., Niemeier H.M., Palmer J.D., Peters K.B., Sheehan J., Thomas R.P., Vora S.A., Wahl D.R., Weiss S.E., Yeboa D.N., Zhong J.,Shih H.A., Radiation therapy for idh-mutant grade 2 and grade 3 diffuse glioma: An ASTRO clinical practice guideline. Practical Radiation Oncology. 12(5): 370-386, 2022. WOS:000992566600002.

12.       Huang C., Zhang J., Huang J., Li H., Wen K., Bao J., Wu X., Sun R., Abudukeremu A., Wang Y., He Z., Chen Q., Huang X., Wang H.,Zhang Y., Proteomic and functional analysis of hdl subclasses in humans and rats: A proof-of-concept study. Lipids Health Dis. 22(1): 86, 2023. PMID37386457.PMC10308741.

13.       Huzar J., Shenoy M., Sanderford M.D., Kumar S.,Miura S., Bootstrap confidence for molecular evolutionary estimates from tumor bulk sequencing data. Front Bioinform. 3: 1090730, 2023. PMID37261293.PMC10228696.

14.       Jain V., Baraniya D., El-Hadedy D.E., Chen T., Slifker M., Alakwaa F., Cai K.Q., Chitrala K.N., Fundakowski C.,Al-Hebshi N.N., Integrative metatranscriptomic analysis reveals disease-specific microbiome-host interactions in oral squamous cell carcinoma. Cancer Res Commun. 3(5): 807-820, 2023. PMID37377901.PMC10166004.

15.       Jang H.J., Hostetter G., Macfarlane A.W., Madaj Z., Ross E.A., Hinoue T., Kulchycki J.R., Burgos R.S., Tafseer M., Alpaugh R.K., Schwebel C.L., Kokate R., Geynisman D.M., Zibelman M.R., Ghatalia P., Nichols P.W., Chung W.B., Madzo J., Hahn N.M., Quinn D.I., Issa J.P.J., Topper M.J., Baylin S.B., Shen H., Campbell K.S., Jones P.A., Plimack E.R. A phase ii trial of guadecitabine plus atezolizumab in metastatic urothelial carcinoma progressing after initial immune checkpoint inhibitor therapy. Clinical Cancer Research. 29(11): 2052-2065, 2023. WOS:001009913500001.PMC10233355.

16.       Kumar S.,Gojobori T., Obituary: Masatoshi Nei (1931–2023). Mol Biol Evol. 40(6)2023. PMID37379687.PMC10306398.

17.       Liu H., Chen C., Liao S., Sohaii D.K., Cruz C.R.Y., Burdo T.H., Cradick T.J., Mehta A., Barrero C., Florez M., Gordon J., Grauzam S., Dressman J., Amini S., Bollard C.M., Kaminski R.,Khalili K., Strategic self-limiting production of infectious HIV particles by CRISPR in permissive cells. Mol Ther Nucleic Acids. 32: 1010-1025, 2023. PMID37346975.PMC10280355.

18.       Mazurel D., Carda-Diéguez M., Langenburg T., Žiemytė M., Johnston W., Martínez C.P., Albalat F., Llena C., Al-Hebshi N., Culshaw S., Mira A.,Rosier B.T., Nitrate and a nitrate-reducing rothia aeria strain as potential prebiotic or synbiotic treatments for periodontitis. NPJ Biofilms Microbiomes. 9(1): 40, 2023. PMID37330520.PMC10276839.

19.       McGillivray E., Jain R., Ramamurthy C., Sheng J.Y., Granina E., Yu D.H., Lu X.N., Abbas A.E., Dotan E., Meyer J.E., Fang C.Y., Denlinger C.S., Understanding the challenges faced by esophageal and gastroesophageal junction cancer survivors. Journal of Patient Experience. 10: 23743735231179545, 2023. WOS:001005257600001. PMC10265376.

20.       Mraz K.A., Hodan R., Rodgers-Fouche L., Arora S., Balaguer F., Guillem J.G., Jeter J.M., Kanth P., Li D., Liska D., Melson J., Perez K., Ricker C., Shirts B.H., Vilar E., Katona B.W., Dominguez-Valentin M.,Collaborat Grp Amer Inherited G., Current chemoprevention approaches in Lynch syndrome and familial adenomatous polyposis: A global clinical practice survey. Frontiers in Oncology. 13: 1141810, 2023. WOS:001002750100001. PMC10247284.

21.       Nethi S.K., Li X., Bhatnagar S., Prabha S., Enhancing anticancer efficacy of chemotherapeutics using targeting ligand-functionalized synthetic antigen receptor-mesenchymal stem cells. Pharmaceutics. 15(6)2023. PMID37376189.PMC10304812.

22.       Paulus K., Kelly P.J.A., Brajuha J., D’Avanzo P., Dauria E.F., Trainor A., Alrez A.,Bass S.B., The relationship of prep beliefs to perceived personal, interpersonal and structural benefits and barriers to prep use in women who inject drugs. BMC Womens Health. 23(1): 303, 2023. PMID37291563.PMC10251529.

23.       Saaoud F., Martinez L., Lu Y., Xu K., Shao Y., Zhuo J.L., Gillespie A., Wang H., Tabbara M., Salama A., Yang X.,Vazquez-Padron R.I., Chronic kidney disease transdifferentiates veins into a specialized immune-endocrine organ with increased mycn-ap1 signaling. Cells. 12(11)2023. PMID37296603.PMC10252601.

24.       Sullivan-Reed K., Toma M.M., Drzewiecka M., Nieborowska-Skorska M., Nejati R., Karami A., Wasik M.A., Sliwinski T.,Skorski T., Simultaneous targeting of DNA polymerase theta and parp1 or rad52 triggers dual synthetic lethality in homologous recombination-deficient leukemia cells. Mol Cancer Res, 2023. PMID37358557.

25.       Syphers J.L., Xue L., Yi X., Wang R.E.,Haubrich B.A., Meeting proceedings from icbs 2022 – uncovering solutions for diseases. ACS Chem Biol, 2023. PMID37310212.

26.       Vandeloo M.J., Kellen E., Fang C.Y., Neven K.Y., Nawrot T.S.,Van Ongeval C., Age at first full-term pregnancy and mammographic breast density in postmenopausal women: A systematic review. European Journal of Gynaecological Oncology. 44(2): 1-13, 2023. WOS:000983229000001.

27.       Weiss J.M., Palmieri E.M., Gonzalez-Cotto M., Bettencourt I.A., Megill E.L., Snyder N.W.,McVicar D.W., Itaconic acid underpins hepatocyte lipid metabolism in non-alcoholic fatty liver disease in male mice. Nat Metab. 5(6): 981-995, 2023. PMID37308721.PMC10290955.

28.       Wiese D., Stroup A.M., Islami F., Mattes M., Baylor E., Boscoe F.P.,Henry K.A., Geographic diffusion of digital mammography in the united states. Cancer. 129(14): 2144-2151, 2023. PMID36988982.

29.       Xu K., Saaoud F., Shao Y., Lu Y., Wu S., Zhao H., Chen K., Vazquez-Padron R., Jiang X., Wang H.,Yang X., Early hyperlipidemia triggers metabolomic reprogramming with increased sah, increased acetyl-coa-cholesterol synthesis, and decreased glycolysis. Redox Biol. 64: 102771, 2023. PMID37364513.PMC10310484.

30.       Yeh M.C., Lau W., Keady C.A., Horlyck-Romanovsky M., Tung H.J., Hu L., Ma G.X.,Wylie-Rosett J., Evaluation of feasibility and acceptability of a web-based diabetes prevention program (dpp) for diabetes risk reduction in Chinese Americans in New York City. Front Public Health. 11: 1199746, 2023. PMID37333528.PMC10272575.

31.       Zainol Abidin Q.H., Ida T., Morita M., Matsunaga T., Nishimura A., Jung M., Hassan N., Takata T., Ishii I., Kruger W., Wang R., Motohashi H., Tsutsui M.,Akaike T., Synthesis of sulfides and persulfides is not impeded by disruption of three canonical enzymes in sulfur metabolism. Antioxidants. 12(4)2023. PMID37107243.PMC10135671.

32.       Zarrabi K.K., Narayan V., Mille P.J., Zibelman M.R., Miron B., Bashir B.,Kelly W.K., Bispecific psma antibodies and car-t in metastatic castration-resistant prostate cancer. Therapeutic Advances in Urology. 15: 17562872231182219, 2023. WOS:001006706700001. PMC10285603.

33.       Zhang J.,Kumar S., Masatoshi Nei (1931-2023). Nat Ecol Evol, 2023. PMID37380699.

34.       Zhu X., Wang Y., Soaita I., Lee H.W., Bae H., Boutagy N., Bostwick A., Zhang R.M., Bowman C., Xu Y., Trefely S., Chen Y., Qin L., Sessa W., Tellides G., Jang C., Snyder N.W., Yu L., Arany Z.,Simons M., Acetate controls endothelial-to-mesenchymal transition. Cell Metab, 2023. PMID37327791.

Publications Received in May, 2023

1.         Albert M.J., Collins M.E., Bauman J.R., Hematology/oncology fellows’ training in palliative care: A narrative review. J Palliat Med, 2023. PMID37130299.

2.         Alolod G.P., Gardiner H.M., Blunt R., Yucel R.M.,Siminoff L.A., Organ donation willingness among Asian Americans: Results from a national study. J Racial Ethn Health Disparities. 10(3): 1478-1491, 2023. PMID35595917.PMC9675880.

3.         Amador C., Cook J.R., Czader M., Duffield A., Goodlad J., Nejati R., Ott G., Xiao W., Dave S., Wasik M.A.,Dogan A., Transdifferentiation, phenotypic infidelity, progression, and transformation in t/nk-cell neoplasms: Report from the 2021 sh/eahp workshop. Am J Clin Pathol, 2023. PMID37167533.

4.         Atkins M.B., Jegede O.A., Haas N.B., McDermott D.F., Bilen M.A., Stein M., Sosman J.A., Alter R., Plimack E.R., Ornstein M.C., Hurwitz M., Peace D.J., Signoretti S., Denize T., Cimadamore A., Wu C.J., Braun D., Einstein D., Catalano P.J.,Hammers H., Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naive patients with advanced non-clear cell renal cell carcinoma (hcrn gu16-260-cohort b). Journal for Immunotherapy of Cancer. 11(3)2023. PMIDWOS:000968091600008.PMC10040058.

5.         Baishya M., Zisman-Ilani Y., Hoadley A., Litsas D., Roth S.,Collins B.N., Urban neighbourhood elements that influence psychoactive substance use among populations with adverse childhood experiences: A scoping review protocol. BMJ Open. 13(5): e066796, 2023. PMID37197818.PMC10193084.

6.         Braun A.E., Swerdloff D., Sudhakar A., Patel R.D., Gross M.S., Simhan J., Defining the incidence and management of postoperative scrotal hematoma after primary and complex three-piece inflatable penile prosthesis surgery. Int J Impot Res: 1-5, 2023. PMID37156930.PMC10166027.

7.         Brown J.C., Sturgeon K., Sarwer D.B., Troxel A.B., DeMichele A.M., Denlinger C.S.,Schmitz K.H., The effects of exercise and diet on oxidative stress and telomere length in breast cancer survivors. Breast Cancer Res Treat. 199(1): 109-117, 2023. PMID36933050.PMC10148914.

8.         Bukavina L., Luckenbaugh A.N., Hofman M.S., Hope T., Kamran S.C., Murphy D.G., Yamoah K.,Ost P., Incorporating prostate-specific membrane antigen positron emission tomography in management decisions for men with newly diagnosed or biochemically recurrent prostate cancer. Eur Urol. 83(6): 521-533, 2023. PMID36404204.

9.         Bukavina L., Bell S., Packiam V.T., Smaldone M., Abbosh P., Uzzo R., Kutikov A., Correa A.F.,Magee D.E., Sequential intravesical gemcitabine-docetaxel vs. Bacillus calmette-guerin (bcg) in the treatment of non-muscle invasive bladder cancer: A preliminary cost-effectiveness analysis. Urol Oncol, 2023. PMID37127478.

10.       Bukavina L., Dubin J., Isali I., Calaway A., Mortach S., Loeb S., Kutikov A., Mishra K., Sindhani M., Adan F.,Ponsky L., Twitter footprint and the match in the covid-19 era: Understanding the relationship between applicant online activity and residency match success. Urol Pract. 9(4): 331-339, 2022. PMID37145779.

11.       Bychkov I., Topchu I., Makhov P., Kudinov A., Patel J.D.,Boumber Y., Regulation of vegfr2 and AKT signaling by musashi-2 in lung cancer. Cancers (Basel). 15(9)2023. PMID37173995.PMC10177017.

12.       Canepa E., Parodi-Rullan R., Vazquez-Torres R., Gamallo-Lana B., Guzman-Hernandez R., Lemon N.L., Angiulli F., Debure L., Ilies M.A., Østergaard L., Wisniewski T., Gutiérrez-Jiménez E., Mar A.C.,Fossati S., Fda-approved carbonic anhydrase inhibitors reduce amyloid β pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness. Alzheimers Dement, 2023. PMID37186121.

13.       Carlisle B.G., Coffman D.L., Egleston B.L.,Salholz-Hillel M., Training artificial intelligence on a gender-biased virtual world can result in biased conclusions. Ann Surg Oncol, 2023. PMID37140747.

14.       Chen X., Cvetkovic D., Chen L.,Ma C.M., An in-vivo study of the combined therapeutic effects of pulsed non-thermal focused ultrasound and radiation for prostate cancer. Int J Radiat Biol: 1-8, 2023. PMID37191462.

15.       Chen Y., Li H., Janowczyk A., Toro P., Corredor G., Whitney J., Lu C., Koyuncu C.F., Mokhtari M., Buzzy C., Ganesan S., Feldman M.D., Fu P., Corbin H., Harbhajanka A., Gilmore H., Goldstein L.J., Davidson N.E., Desai S., Parmar V.,Madabhushi A., Computational pathology improves risk stratification of a multi-gene assay for early stage ER+ breast cancer. NPJ Breast Cancer. 9(1): 40, 2023. PMID37198173.PMC10192429.

16.       Chew L., Chang C.,Simhan J., Climacturia: What treatment options do we offer to those with and without concomitant erectile dysfunction? Int J Impot Res, 2023. PMID37161059.

17.       Chun S.G., Rimner A., Amini A., Chang J.Y., Donington J., Edelman M.J., Geng Y., Gubens M.A., Higgins K.A., Iyengar P., Movsas B., Ning M.S., Park H.S., Rodrigues G., Wolf A.,Simone C.B., 2nd, American radium society appropriate use criteria for radiation therapy in the multidisciplinary management of thymic carcinoma. JAMA Oncol, 2023. PMID37186595.

18.       Cook J.R., Amador C., Czader M., Duffield A., Goodlad J., Ott G., Xiao W., Dave S., Thakkar D., Thacker E., Dogan A., Wasik M., Nejati R., Transformations of marginal zone lymphomas and lymphoplasmacytic lymphomas: Report from the 2021 sh/eahp workshop. Am J Clin Pathol, 2023. PMID37186259.

19.       Duffield A.S., Dogan A., Amador C., Cook J.R., Czader M., Goodlad J.R., Nejati R., Xiao W., Happ L., Parker C., Thacker E., Thakkar D., Dave S.S., Wasik M.A.,Ott G., Progression of follicular lymphoma and related entities: Report from the 2021 sh/eahp workshop. Am J Clin Pathol, 2023. PMID37167543.

20.       Dutta Banik D., Martin L.J., Tang T., Soboloff J., Tourtellotte W.G.,Pierchala B.A., Egr4 is critical for cell-fate determination and phenotypic maintenance of geniculate ganglion neurons underlying sweet and umami taste. Proc Natl Acad Sci U S A. 120(22): e2217595120, 2023. PMID37216536.

21.       Eads J.R., Halfdanarson T.R., Asmis T., Bellizzi A.M., Bergsland E.K., Dasari A., El-Haddad G., Frumovittz M., Meyer J., Mittra E., Myrehaug S., Nakakura E., Raj N., Soares H.P., Untch B., Vijayvergia N., Chan J.A., Consensus recommendations for management of high grade neuroendocrine tumors. Endocr Relat Cancer, 2023. PMID37184955.

22.       Egleston B.L., Bleicher R.J., Fang C.Y., Galloway T.J.,Vucetic S., Benefits versus drawbacks of delaying surgery due to additional consultations in older patients with breast cancer. Cancer Rep (Hoboken). 6(5): e1805, 2023. PMID36943210.PMC10172180.

23.       Guo Q., Xin M., Lu Q., Feng D., Yang V., Peng L.F., Whelan K.A., Hu W., Wu S., Yang X., Wang H., Rothberg B.S., Gamero A.M., Gerhard G.S., Gao B.,Yang L., A novel nedd4l-txnip-chop axis in the pathogenesis of nonalcoholic steatohepatitis. Theranostics. 13(7): 2210-2225, 2023. PMID37153733.PMC10157740.

24.       Hall M.E., Padgett W.J., Klaassen Z., Magee D.E., Luckenbaugh A.N., Laviana A.A., Satkunasivam R., Schaffer K.,Wallis C.J.D., Association between rct methodology and disease indication with mineralocorticoid-related toxicity for patients receiving abiraterone acetate for advanced prostate cancer: A meta-analysis of rcts. Clin Genitourin Cancer, 2023. PMID37236862.

25.       Haslam D.E., John E.M., Knight J.A., Li Z., Buys S.S., Andrulis I.L., Daly M.B., Genkinger J.M., Terry M.B.,Zhang F.F., Diet quality and all-cause mortality in women with breast cancer from the breast cancer family registry. Cancer Epidemiol Biomarkers Prev. 32(5): 678-686, 2023. PMID36857773.PMC10066732.

26.       He H., Sugiyama A., Snyder N.W., Teneche M.G., Liu X., Maner-Smith K.M., Goessling W., Hagen S.J., Ortlund E.A., Najafi-Shoushtari S.H., Acuña M.,Cohen D.E., Acyl-coa thioesterase 12 suppresses yap-mediated hepatocarcinogenesis by limiting glycerolipid biosynthesis. Cancer Lett. 565: 216210, 2023. PMID37150501.

27.       Higa J., Canakis A.,Irani S.S., Management of a malignant esophagopleural fistula after stent failure with a suturing pexy: Time to seal the leak. VideoGIE. 8(5): 189-192, 2023. PMID37197160.PMC10183483.

28.       Hohl S.D., Matulewicz R.S., Salloum R.G., Ostroff J.S., Baker T.B., Schnoll R., Warren G., Bernstein S.L., Minion M., Lenhoff K., Dahl N., Juon H.S., Tsosie U., Fleisher L., D’Angelo H., Ramsey A.T., Ashing K.T., Rolland B., Nolan M.B., Bird J.E., Nguyen C.V.T., Pauk D., Adsit R.T., Tindle H.A., Shoenbill K., Yeung S., Presant C.A., Wiseman K.P., Wen K.Y., Chichester L.A.,Chen L.S., Integrating tobacco treatment into oncology care: Reach and effectiveness of evidence-based tobacco treatment across national cancer institute-designated cancer centers. J Clin Oncol. 41(15): 2756-2766, 2023. PMID36473135.

29.       Hu J., Zhu A., Vickers A., Allaf M.E., Ehdaie B., Schaeffer A., Pavlovich C., Ross A.E., Green D.A., Wang G., Ginzburg S., Montgomery J.S., George A., Graham J.N., Ristau B.T., Correa A., Shoag J.E., Kowalczyk K.J., Zhang T.R.,Schaeffer E.M., Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectious complications. BMJ Open. 13(5): e071191, 2023. PMID37208135.PMC10201229.

30.       Huda A., Arakawa H., Mazzucco G., Galli M., Petrocelli V., Casola S., Chen L.,Doksani Y., The telomerase reverse transcriptase elongates reversed replication forks at telomeric repeats. Science Advances. 9(12): eadf2011, 2023. PMIDWOS:000967266700004.PMC10032592.

31.       Indeglia A., Leung J.C., Miller S.A., Leu J.I., Dougherty J.F., Clarke N.L., Kirven N.A., Shao C., Ke L., Lovell S., Barnoud T., Lu D.Y., Lin C., Kannan T., Battaile K.P., Yang T.H.L., Batista Oliva I., Claiborne D.T., Vogel P., Liu L., Liu Q., Nefedova Y., Cassel J., Auslander N., Kossenkov A.V., Karanicolas J.,Murphy M.E., An African-specific variant of tp53 reveals padi4 as a regulator of p53-mediated tumor suppression. Cancer Discov, 2023. PMID37140445.

32.       Izzo L.T., Trefely S., Demetriadou C., Drummond J.M., Mizukami T., Kuprasertkul N., Farria A.T., Nguyen P.T.T., Murali N., Reich L., Kantner D.S., Shaffer J., Affronti H., Carrer A., Andrews A., Capell B.C., Snyder N.W.,Wellen K.E., Acetylcarnitine shuttling links mitochondrial metabolism to histone acetylation and lipogenesis. Sci Adv. 9(18): eadf0115, 2023. PMID37134161.PMC10156126.

33.       Jordan R.M., Rivera-Sanchez L., Kelley K., O’Brien M.A., Ruth K., Porpiglia A.S., Aggon A.A., Ross E., Sigurdson E.R.,Bleicher R.J., ASO visual abstract: The impact of an electromagnetic seed localization device versus wire localization on breast conserving surgery-a matched pair analysis. Ann Surg Oncol, 2023. PMID37154972.

34.       Jubber I., Ong S., Bukavina L., Black P.C., Compérat E., Kamat A.M., Kiemeney L., Lawrentschuk N., Lerner S.P., Meeks J.J., Moch H., Necchi A., Panebianco V., Sridhar S.S., Znaor A., Catto J.W.F.,Cumberbatch M.G., Epidemiology of bladder cancer in 2023: A systematic review of risk factors. Eur Urol, 2023. PMID37198015.

35.       Kang Y.J., Farma J.,Raut C.P., Special clinical scenarios in rps: Involvement of great vessels and pancreas and penetration across natural foramina. Eur J Surg Oncol. 49(6): 1091-1101, 2023. PMID36372616.

36.       Kashani-Sabet M., Leachman S.A., Stein J.A., Arbiser J.L., Berry E.G., Celebi J.T., Curiel-Lewandrowski C., Ferris L.K., Grant-Kels J.M., Grossman D., Kulkarni R.P., Marchetti M.A., Nelson K.C., Polsky D., Seiverling E.V., Swetter S.M., Tsao H., Verdieck-Devlaeminck A., Wei M.L., Bar A., Bartlett E.K., Bolognia J.L., Bowles T.L., Cha K.B., Chu E.Y., Hartman R.I., Hawryluk E.B., Jampel R.M., Karapetyan L., Kheterpal M., Lawson D.H., Leming P.D., Liebman T.N., Ming M.E., Sahni D., Savory S.A., Shaikh S.S., Sober A.J., Sondak V.K., Spaccarelli N., Usatine R.P., Venna S.,Kirkwood J.M., Early detection and prognostic assessment of cutaneous melanoma: Consensus on optimal practice and the role of gene expression profile testing. JAMA Dermatol. 159(5): 545-553, 2023. PMID36920356.

37.       Kellier D.J., de Prado B.M., Haagen D., Grabner P., Raj N., Lechtenberg L., Velasquez G., Hsu J.Y., Farrar J.T., Hershey A.D.,Szperka C.L., Validity of self-reported migraine in adolescents and children. Headache. 63(5): 634-641, 2023. PMID37140013.

38.       Klein K.A., Kocher M., Lourenco A.P., Niell B.L., Bennett D.L., Chetlen A., Freer P., Ivansco L.K., Jochelson M.S., Kremer M.E., Malak S.F., McCrary M., Mehta T.S., Neal C.H., Porpiglia A., Ulaner G.A.,Moy L., ACR appropriateness criteria® palpable breast masses: 2022 update. J Am Coll Radiol. 20(5s): S146-s163, 2023. PMID37236740.

39.       Kohler R.E., Hemler J., Wagner R.B., Sullivan B., Macenat M., Tagai E.K., Miller S.M., Wen K.Y., Ayers C., Einstein M.H.,Hudson S.V., Confusion and anxiety in between abnormal cervical cancer screening results and colposcopy: “The land of the unknown”. Patient Educ Couns. 114: 107810, 2023. PMID37244133.

40.       Kumar A., Taghi Khani A., Duault C., Aramburo S., Sanchez Ortiz A., Lee S.J., Chan A., McDonald T., Huang M., Lacayo N.J., Sakamoto K.M., Yu J., Hurtz C., Carroll M., Tasian S.K., Ghoda L., Marcucci G., Gu Z., Rosen S.T., Armenian S., Izraeli S., Chen C.W., Caligiuri M.A., Forman S.J., Maecker H.T.,Swaminathan S., Intrinsic suppression of type i interferon production underlies the therapeutic efficacy of il-15-producing natural killer cells in b-cell acute lymphoblastic leukemia. J Immunother Cancer. 11(5)2023. PMID37217248.PMC10231005.

41.       Laderman L., Sreekrishnanilayam K., Pandey R.K., Handorf E., Blumenreich A., Sorice K.A., Lynch S.M., Cheema K., Nagappan L., Sosa I.R., Dotan E.,Vijayvergia N., Venous thromboembolism in metastatic pancreatic cancer. Eur J Haematol. 110(6): 706-714, 2023. PMID36941225.

42.       Loggers E.T., Case A.A., Chwistek M., Dale W., Guay M.O.D., Edge S.B., Grossman S.R., Gustin J., Nelson J., Rajasekhara S., Reddy A., Tulsky J.A., Zachariah F.,Landrum K.M., Adcc’s improving goal concordant care initiative: Implementing primary palliative care principles. J Pain Symptom Manage, 2023. PMID37257523.

43.       Luo S., Kong C., Zhao S., Tang X., Wang Y., Zhou X., Li R., Liu X., Tang X., Sun S., Xie W., Zhang Z.R., Jing Q., Gu A., Chen F., Wang D., Wang H., Han Y., Xie L.,Ji Y., Endothelial hdac1-zeb2-nurd complex drives aortic aneurysm and dissection through regulation of protein s-sulfhydration. Circulation. 147(18): 1382-1403, 2023. PMID36951067.

44.       Madan R.A., Bilusic M., Stein M.N., Donahue R.N., Arlen P.M., Karzai F., Plimack E., Wong Y.N., Geynisman D.M., Zibelman M., Mayer T., Strauss J., Chen G., Rauckhorst M., McMahon S., Couvillon A., Steinberg S., Figg W.D., Dahut W.L., Schlom J.,Gulley J.L., Flutamide with or without prostvac in non-metastatic castration resistant (m0) prostate cancer. Oncologist, 2023. PMID37134294.

45.       McGee-Avila J.K., Richmond J., Henry K.A., Stroup A.M.,Tsui J., Disparities in geospatial patterns of cancer care within urban counties and structural inequities in access to oncology care. Health Serv Res, 2023. PMID37208901.

46.       Mori Y., Mizukami T., Segawa S., Roder H.,Maki K., Folding of staphylococcal nuclease induced by binding of chemically modified substrate analogues sheds light on mechanisms of coupled folding/binding reactions. Biochemistry, 2023. PMID37227385.

47.       Nakhoda S.,Hamad E., Bridging the knowledge gap for older patients with CLL on ibrutinib. JACC CardioOncol. 5(2): 244-245, 2023. PMID37144103.PMC10152201.

48.       Nasr C.E., Andrioli M., Endo M., Harrell R.M., Livhits M.J., Osakwe I., Polavarapu P., Siperstein A., Wei S., Zheng X., Jiang R., Hao Y., Huang J.I.N., Klopper J.P., Kloos R.T., Kennedy G.,Angell T.E., Real-world performance of the afirma genomic sequencing classifier (gsc)-a meta-analysis. J Clin Endocrinol Metab. 108(6): 1526-1532, 2023. PMID36470585.PMC10188305.

49.       Peluzzo A.M., Bkhache M., Do L.N.H., Autieri M.V.,Liu X., Differential regulation of lymphatic junctional morphology and the potential effects on cardiovascular diseases. Front Physiol. 14: 1198052, 2023. PMID37187962.PMC10175597.

50.       Pluta K., Hohl S.D., D’Angelo H., Ostroff J.S., Shelley D., Asvat Y., Chen L.S., Cummings K.M., Dahl N., Day A.T., Fleisher L., Goldstein A.O., Hayes R., Hitsman B., Buckles D.H., King A.C., Lam C.Y., Lenhoff K., Levinson A.H., Minion M., Presant C., Prochaska J.J., Shoenbill K., Simmons V., Taylor K., Tindle H., Tong E., White J.S., Wiseman K.P., Warren G.W., Baker T.B., Rolland B., Fiore M.C.,Salloum R.G., Data envelopment analysis to evaluate the efficiency of tobacco treatment programs in the NCI moonshot cancer center cessation initiative. Implement Sci Commun. 4(1): 50, 2023. PMID37170381.PMC10173908.

51.       Pollyea D.A., Altman J.K., Assi R., Bixby D., Fathi A.T., Foran J.M., Gojo I., Hall A.C., Jonas B.A., Kishtagari A., Lancet J., Maness L., Mangan J., Mannis G., Marcucci G., Mims A., Moriarty K., Mustafa Ali M., Neff J., Nejati R., Olin R., Percival M.E., Perl A., Przespolewski A., Rao D., Ravandi F., Shallis R., Shami P.J., Stein E., Stone R.M., Sweet K., Thota S., Uy G., Vachhani P., Cassara C.J., Freedman-Cass D.A.,Stehman K., Acute myeloid leukemia, version 3.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 21(5): 503-513, 2023. PMID37156478.

52.       Prado N.A., Armstrong E.E., Brown J.L., Goldenberg S.Z., Leimgruber P., Pearson V.R., Maldonado J.E.,Campana M.G., Genomic resources for Asian (elephas maximus) and African savannah elephant (loxodonta africana) conservation and health research. J Hered, 2023. PMID37246890.

53.       Rasco D.W., Medina T., Corrie P., Pavlick A.C., Middleton M.R., Lorigan P., Hebert C., Plummer R., Larkin J., Agarwala S.S., Daud A.I., Qiu J., Bozon V., Kneissl M., Barry E.,Olszanski A.J., Phase 1 study of the pan-raf inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma. Cancer Chemother Pharmacol, 2023. PMID37219686.

54.       Reck M., Ciuleanu T.E., Lee J.S., Schenker M., Zurawski B., Kim S.W., Mahave M., Alexandru A., Peters S., Pluzanski A., Caro R.B., Linardou H., Burgers J.A., Nishio M., Martinez-Marti A., Azuma K., Axelrod R., Paz-Ares L.G., Ramalingam S.S., Borghaei H., O’Byrne K.J., Li L., Bushong J., Gupta R.G., Grootendorst D.J., Eccles L.J.,Brahmer J.R., Systemic and intracranial outcomes with first-line nivolumab plus ipilimumab in patients with metastatic non-small cell lung cancer and baseline brain metastases from checkmate 227 part 1. J Thorac Oncol, 2023. PMID37146754.

55.       Rencsok E.M., Stopsack K.H., Slopen N., Odedina F.T., Ragin C., Nowak J., McSwain L., Manarite J., Heath E., George D.J., Kantoff P.W., Vinson J., Villanti P., Haneuse S.,Mucci L.A., Experience with the us health care system for black and white patients with advanced prostate cancer. Cancer, 2023. PMID37246339.

56.       Riba M.B., Donovan K.A., Ahmed K., Andersen B., Braun I., Breitbart W.S., Brewer B.W., Corbett C., Fann J., Fleishman S., Garcia S., Greenberg D.B., Handzo G.F., Hoofring L.H., Huang C.H., Hutchinson S., Johns S., Keller J., Kumar P., Lahijani S., Martin S., Niazi S.K., Pailler M., Parnes F., Rao V., Salman J., Scher E., Schuster J., Teply M., Usher A., Valentine A.D., Vanderlan J., Lyons M.S., McMillian N.R.,Darlow S.D., NCCN guidelines® insights: Distress management, version 2.2023. J Natl Compr Canc Netw. 21(5): 450-457, 2023. PMID37156476.

57.       Richardson V., Engel N.,Kulathinal R.J., Comparative developmental genomics of sex-biased gene expression in early embryogenesis across mammals. Biol Sex Differ. 14(1): 30, 2023. PMID37208698.PMC10199522.

58.       Riggs M.A., Madni S.A., Cornelius J., Zhang A., Czarnik M., Zullig K., Bensley R.J., Gibson-Young L., Gardner M., Waggett C.E., Grabeel V., Pettyjohn S.J., Fisher C., Jones R.M., Maniccia D.M., Doyle J., Treuth M., Neatherlin J., Thomas E.,Barrios L., Knowledge, attitudes, and behaviors with mask use and vaccines for covid-19 prevention at 13 colleges and universities, April 2021. J Am Coll Health: 1-11, 2023. PMID37130266.

59.       Robinson L.J., Soboloff J., Tourkova I.L., Larrouture Q.C., Onwuka K.M., Papachristou D.J., Gross S., Hooper R., Samakai E., Worley P.F., Liu P., Tuckermann J., Witt M.R.,Blair H.C., The calcium channel orai1 is required for osteoblast development: Studies in a chimeric mouse with variable in vivo runx-cre deletion of orai-1. PLoS One. 18(5): e0264596, 2023. PMID37167218.PMC10174572.

60.       Sartor O., Karrison T.G., Sandler H.M., Gomella L.G., Amin M., Purdy J., Michalski J.M., Garzotto M.G., Pervez N., Balogh A.G., Rodrigues G.B., Souhami L., Reaume M.N., Williams S.G., Hannan R., Jones C.U., Horwitz E.M., Rodgers J.P., Feng F.Y.,Rosenthal S.A., Androgen deprivation and radiotherapy with or without docetaxel for localized high-risk prostate cancer: Long-term follow-up from the randomized nrg oncology rtog 0521 trial. Eur Urol, 2023. PMID37179241.

61.       Schubert L., Elliott A., Le A.T., Estrada-Bernal A., Doebele R.C., Lou E., Borghaei H., Demeure M.J., Kurzrock R., Reuss J.E., Ou S.I., Braxton D.R., Thomas C.A., Darabi S., Korn W.M., El-Deiry W.S.,Liu S.V., Erbb family fusions are recurrent and actionable oncogenic targets across cancer types. Front Oncol. 13: 1115405, 2023. PMID37168365.PMC10164992.

62.       Shrestha J., Santerre M., Allen C.N., Arjona S.P., Hooper R., Mukerjee R., Kaul M., Shcherbik N., Soboloff J.,Sawaya B.E., Hiv-1 gp120 protein promotes hand through the calcineurin pathway activation. Mitochondrion. 70: 31-40, 2023. PMID36925028.

63.       Snyder N.W.,Meier J.L., Metabolic regulation of epigenetic drug resistance. Nat Chem Biol, 2023. PMID37127755.

64.       Soaita I., Megill E., Kantner D., Chatoff A., Cheong Y.J., Clarke P., Arany Z., Snyder N.W., Wellen K.E.,Trefely S., Dynamic protein deacetylation is a limited carbon source for acetyl-coa-dependent metabolism. J Biol Chem: 104772, 2023. PMID37142219.

65.       Somanath P.R., Chernoff J., Cummings B.S., Prasad S.M.,Homan H.D., Targeting p21-activated kinase-1 for metastatic prostate cancer. Cancers (Basel). 15(8)2023. PMID37190165.PMC10137274.

66.       Starmer H.M., Klein D., Montgomery A., Goldsmith T., McCarroll L., Richmon J., Christopher Holsinger F., Beadle B.,Jain P., Head and neck virtual coach: A randomized control trial of mobile health as an adjunct to swallowing therapy during head and neck radiation. Dysphagia. 38(3): 847-855, 2023. PMID35960394.

67.       Strauss D., Kaplunov B., Kutikov A., Geynisman D.M., Lau K.,Smaldone M., Between the hammer and anvil: Resolution of unresectable muscle invasive bladder cancer in a renal transplant patient after cessation of immunosuppressive therapy. Urol Case Rep. 48: 102399, 2023. PMID37193579.PMC10182268.

68.       Tatum A., Rosser B.R.S., Wheldon C.W., Torres M.B., Bates A.J., Haggart R., Konety B.R., Mitteldorf D., Polter E.J., Ross M.W., Talley K.M.C., West W., Wright M.M.,Zhang Z., The effects of prostate cancer treatment on role-in-sex in gay and bisexual men: Mixed methods results from the restore-1 and restore-2 studies. J Sex Res. 60(5): 752-761, 2023. PMID36200951.PMC10076452.

69.       Tetzlaff E.D., Hylton H.M., Ruth K.J., Hasse Z.,Hall M.J., Moral distress, organizational climate, and the risk of burnout among physician assistants in oncology. JCO Oncol Pract. 19(5): e639-e649, 2023. PMID36780593.

70.       Thompson J.F., Hyngstrom J., Caracò C., Zager J.S., Jahkola T., Bowles T.L., Pennacchioli E., Hoekstra H.J., Moncrieff M., Ingvar C., van Akkooi A., Sabel M.S., Levine E.A., Henderson M., Dummer R., Rossi C.R., Kane J.M., 3rd, Trocha S., Wright F., Byrd D.R., Matter M., MacKenzie-Ross A., Kelley M.C., Terheyden P., Huston T.L., Wayne J.D., Neuman H., Smithers B.M., Desai D., Gershenwald J.E., Schneebaum S., Gesierich A., Jacobs L.K., Lewis J.M., O’Donoghue C., Sardi A., McKinnon J.G., Slingluff C.L., Farma J.M., Schultz E., Scheri R.P., Vidal-Sicart S., Testori A.A.E., Scolyer R.A., Elashoff D.E., Cochran A.J.,Faries M.B., Regarding: Predicting regional lymph node recurrence in the modern age of tumor-positive sentinel node melanoma. Ann Surg Oncol, 2023. PMID37149545.

71.       Triggs J.R., Krogh K., Simon V., Krause A., Kaplan J.B., Yang G.Y., Wani S., Kahrilas P.J., Pandolfino J.,Komanduri S., Novel histologic score predicts recurrent intestinal metaplasia after successful endoscopic eradication therapy. Dis Esophagus. 36(5)2023. PMID36446594.PMC10150172.

72.       Ungerleider J.D., Ungerleider R.M., James L., Wolf A., Kovacs M., Cerfolio R., Litle V., Cooke D.T., Jones-Ungerleider K.C., Maddaus M., Luc J.G.Y., DeAnda A., Erkmen C.P., Bremner K.,Bremner R.M., Assessment of the well-being of significant others of cardiothoracic surgeons. J Thorac Cardiovasc Surg, 2023. PMID37160214.

73.       Vekariya U., Toma M., Nieborowska-Skorska M., Le B.V., Caron M.C., Kukuyan A.M., Sullivan-Reed K., Podszywalow-Bartnicka P., Chitrala K.N., Atkins J., Drzewiecka M., Feng W., Chan J., Chatla S., Golovine K., Jelinek J., Sliwinski T., Ghosh J., Matlawska-Wasowska K., Chandramouly G., Nejati R., Wasik M., Sykes S.M., Piwocka K., Hadzijusufovic E., Valent P., Pomerantz R.T., Morton G., Childers W., Zhao H., Paietta E.M., Levine R.L., Tallman M.S., Fernandez H.F., Litzow M.R., Gupta G.P., Masson J.Y.,Skorski T., DNA polymerase θ protects leukemia cells from metabolically induced DNA damage. Blood. 141(19): 2372-2389, 2023. PMID36580665.

74.       Wasik M.A.,Dogan A., Reports from the 2021 sh/eahp workshop on transformation and transdifferentiation in lymphoid malignancies. Am J Clin Pathol, 2023. PMID37170768.

75.       Wheldon C.W.,Spradau J.Z.H., Indoor tanning among sexual and gender minority adolescents and adults: Results from the 2020 pennsylvania lgbt health needs assessment. J Skin Cancer. 2023: 3953951, 2023. PMID37234933.PMC10208760.

76.       Wolczyk M., Serwa R., Kominek A., Klejman A., Milek J., Chwałek M., Turos-Korgul L., Charzyńska A., Dabrowski M., Dziembowska M., Skorski T., Piwocka K.,Podszywalow-Bartnicka P., Tiar and fmrp shape pro-survival nascent proteome of leukemia cells in the bone marrow microenvironment. iScience. 26(4): 106543, 2023. PMID37123244.PMC10140000.

77.       Xu K., Zhang Y., Saaoud F., Shao Y., Lu Y., Jiang X., Wang H.,Yang X., Editorial: Insights in cardiovascular therapeutics 2022-cardiovascular innate immunity. Front Cardiovasc Med. 10: 1184030, 2023. PMID37144060.PMC10151803.

78.       Yeung H.M., Sreekrishnanilayam K., Meeker C., Deng M., Agrawal S., Abdullah H.,Vijayvergia N., Comparative outcomes of second-line topoisomerase-i inhibitor therapies on neuroendocrine carcinoma. J Gastrointest Cancer. 54(1): 73-79, 2023. PMID35006522.PMC9271131.

79.       Yong V., Rostmeyer K., Deng M., Chin K., Graves E.K.M., Ma G.X.,Erkmen C.P., Gender differences in cardiothoracic surgery letters of recommendation. J Thorac Cardiovasc Surg, 2023. PMID37156362.

80.       Yuan H., Wu X., Wu Q., Chatoff A., Megill E., Gao J., Huang T., Duan T., Yang K., Jin C., Yuan F., Wang S., Zhao L., Zinn P.O., Abdullah K.G., Zhao Y., Snyder N.W.,Rich J.N., Lysine catabolism reprograms tumour immunity through histone crotonylation. Nature. 617(7962): 818-826, 2023. PMID37198486.

81.       Zeigler-Johnson C., McDonald A.C., Pinheiro P., Lynch S., Taioli E., Joshi S., Alpert N., Baudin J., Joachim C., Deloumeaux J., Oliver J., Bhakkan-Mambir B., Beaubrun-Renard M., Ortiz A.G.,Ragin C., Trends in prostate cancer incidence among Black men in the Caribbean and the United States. Prostate, 2023. PMID37244749.

Staff Publications Received in April, 2023

1.         Adler F.R., Anderson A.R.A., Bhushan A., Bogdan P., Bravo-Cordero J.J., Brock A., Chen Y., Cukierman E., DelGiorno K.E., Denis G.V., Ferrall-Fairbanks M.C., Gartner Z.J., Germain R.N., Gordon D.M., Hunter G., Jolly M.K., Karacosta L.G., Mythreye K., Katira P., Kulkarni R.P., Kutys M.L., Lander A.D., Laughney A.M., Levine H., Lou E., Lowenstein P.R., Masters K.S., Pe’er D., Peyton S.R., Platt M.O., Purvis J.E., Quon G., Richer J.K., Riddle N.C., Rodriguez A., Snyder J.C., Lee Szeto G., Tomlin C.J., Yanai I., Zervantonakis I.K.,Dueck H., Modeling collective cell behavior in cancer: Perspectives from an interdisciplinary conversation. Cell Syst. 14(4): 252-257, 2023. PMID37080161.

2.         Ajani J.A., D’Amico T.A., Bentrem D.J., Cooke D., Corvera C., Das P., Enzinger P.C., Enzler T., Farjah F., Gerdes H., Gibson M., Grierson P., Hofstetter W.L., Ilson D.H., Jalal S., Keswani R.N., Kim S., Kleinberg L.R., Klempner S., Lacy J., Licciardi F., Ly Q.P., Matkowskyj K.A., McNamara M., Miller A., Mukherjee S., Mulcahy M.F., Outlaw D., Perry K.A., Pimiento J., Poultsides G.A., Reznik S., Roses R.E., Strong V.E., Su S., Wang H.L., Wiesner G., Willett C.G., Yakoub D., Yoon H., McMillian N.R.,Pluchino L.A., Esophageal and esophagogastric junction cancers, version 2.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 21(4): 393-422, 2023. PMID37015332.

3.         Alzobi M., Hurtz C., Mehta H., Thomas S.,Corey S.J., B-cell lymphoblastic leukemia in an adolescent with dravet syndrome. Pediatr Blood Cancer: e30340, 2023. PMID37073671.Letter.

4.         Bachmann M., Su B., Rahikainen R., Hytönen V.P., Wu J.,Wehrle-Haller B., Conferming the role of talin in integrin activation and mechanosignaling. J Cell Sci. 136(8)2023. PMID37078342.

5.         Baishya M.L., Martinasek M., Bell L.,Wheldon C.W., Adverse childhood experiences and adult tobacco use among sexual and gender minority populations: Examining the role of mental, social, and community health. LGBT Health. 10(3): 211-219, 2023. PMID36520611.

6.         Barham D.W., Gross M.S., Lentz A.C., Simhan J.,Yafi F.A., Author reply. Urology. 174: 134, 2023. PMID37030907.

7.         Bodor J.N., Bauman J.R., Handorf E.A., Ross E.A., Clapper M.L.,Treat J., Real-world progression-free survival (RWPFS) and the impact of pd-l1 and smoking in driver-mutated non-small cell lung cancer (NSCLC) treated with immunotherapy. J Cancer Res Clin Oncol. 149(5): 1755-1763, 2023. PMID35708776. NEEDS PMC.

8.         Bukavina L., Isali I., Ginwala R., Sindhani M., Calaway A., Magee D., Miron B., Correa A., Kutikov A., Zibelman M., Ghannoum M., Retuerto M., Ponsky L., Markt S., Uzzo R.,Abbosh P., Global meta-analysis of urine microbiome: Colonization of polycyclic aromatic hydrocarbon-degrading bacteria among bladder cancer patients. Eur Urol Oncol. 6(2): 190-203, 2023. PMID36868921. NEEDS PMC.

9.         Cai K.Q., Shellhamer C., Akiyama T.,Jensen L.E., Pellino1 restricts herpes simplex virus infections in the epidermis and dissemination to sebaceous glands. Journal of Investigative Dermatology. 143(4): 639-+, 2023. WOS:000959697300001. PMC10038864.

10.       Chandramouly G., Jamsen J., Borisonnik N., Tyagi M., Calbert M.L., Tredinnick T., Ozdemir A.Y., Kent T., Demidova E.V., Arora S., Wilson S.H.,Pomerantz R.T., Author correction: Polλ promotes microhomology-mediated end-joining. Nat Struct Mol Biol, 2023. PMID37059901.

11.       Chin S.M., Lepore S.J., Collins B.N., Dumenci L.,Rincon M.A., Validation and psychometric properties of the Tobacco Urge Management Scale (TUMS). Int J Environ Res Public Health. 20(8)2023. PMID37107735.PMC10138592.

12.       Corbett C.B., St Paul A., Leigh T., Kelemen S.E., Peluzzo A.M., Okune R.N., Eguchi S., Haines D.S.,Autieri M.V., Genetic deletion of FXR1 reduces intimal hyperplasia and induces senescence in vascular smooth muscle cells. Am J Pathol. 193(5): 638-653, 2023. PMID37080662.

13.       Corkum M.T., Buyyounouski M.K., Chang A.J., Chung H.T., Chung P., Cox B.W., Crook J.M., Davis B.J., Frank S.J., Henriquez I., Horwitz E.M., Hoskin P., Hsu I.C., Keyes M., King M.T., Kollmeier M.A., Krauss D.J., Kukielka A.M., Morton G., Orio P.F., 3rd, Pieters B.R., Potters L., Rossi P.J., Showalter T.N., Solanki A.A., Song D., Vanneste B., Vigneault E., Wojcieszek P.A., Zelefsky M.J.,Kamrava M., Salvage prostate brachytherapy in radiorecurrent prostate cancer: An international delphi consensus study. Radiother Oncol: 109672, 2023. PMID37059334.

14.       Cotta B.H., Choueiri T.K., Cieslik M., Ghatalia P., Mehra R., Morgan T.M., Palapattu G.S., Shuch B., Vaishampayan U., Van Allen E., Ari Hakimi A.,Salami S.S., Current landscape of genomic biomarkers in clear cell renal cell carcinoma. Eur Urol, 2023. PMID37085424.

15.       Czader M., Amador C., Cook J.R., Thakkar D., Parker C., Dave S.S., Dogan A., Duffield A.S., Nejati R., Ott G., Xiao W., Wasik M.,Goodlad J.R., Progression and transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma and b-cell prolymphocytic leukemia: Report from the 2021 sh/eahp workshop. Am J Clin Pathol, 2023. PMID37052539.

16.       Daly M.B., Rosenthal E., Cummings S., Bernhisel R., Kidd J., Hughes E., Gutin A., Meek S., Slavin T.P.,Kurian A.W., The association between age at breast cancer diagnosis and prevalence of pathogenic variants. Breast Cancer Res Treat, 2023. PMID37084156.

17.       Demidova E.V., Serebriiskii I.G., Vlasenkova R., Kelow S., Andrake M.D., Hartman T.R., Kent T., Virtucio J., Rosen G.L., Pomerantz R.T., Dunbrack R.L., Jr., Golemis E.A., Hall M.J., Chen D.Y.T., Daly M.B.,Arora S., Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing. BMC Genomics. 24(1): 212, 2023. PMID37095444.PMC10123997.

18.       Dotan E., Catalano P., Lenchik L., Boutin R., Yao X., Marques H.S., Ioffe D., Zhen D.B., Li D., Wagner L.I., Simon M.A., Wong T.Z.,O’Dwyer P.J., The giant trial (ecog-acrin ea2186) methods paper: A randomized phase ii study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer – defining a new treatment option for older vulnerable patients. J Geriatr Oncol. 14(3): 101474, 2023. PMID36963200.

19.       Dunbar K.J., Karakasheva T.A., Tang Q., Efe G., Lin E.W., Harris M., Sahu V., Sachdeva U.M., Hu J., Klein-Szanto A.J., Henick B., Diehl J.A., Nakagawa H.,Rustgi A.K., Tumor-derived CCL5 recruits cancer-associated fibroblasts and promotes tumor cell proliferation in esophageal squamous cell carcinoma. Mol Cancer Res, 2023. PMID37027010.

20.       Egleston B.L., Chanda A.K., Bai T., Fang C.Y., Bleicher R.J.,Vucetic S., Using pointwise mutual information for breast cancer health disparities research with SEER-medicare claims. Methodology (Gott). 19(1): 43-59, 2023. PMID37090814.PMC10121207.

21.       Ettinger D.S., Wood D.E., Aisner D.L., Akerley W., Bauman J.R., Bharat A., Bruno D.S., Chang J.Y., Chirieac L.R., DeCamp M., Dilling T.J., Dowell J., Durm G.A., Gettinger S., Grotz T.E., Gubens M.A., Hegde A., Lackner R.P., Lanuti M., Lin J., Loo B.W., Lovly C.M., Maldonado F., Massarelli E., Morgensztern D., Ng T., Otterson G.A., Patel S.P., Patil T., Polanco P.M., Riely G.J., Riess J., Schild S.E., Shapiro T.A., Singh A.P., Stevenson J., Tam A., Tanvetyanon T., Yanagawa J., Yang S.C., Yau E., Gregory K.M.,Hughes M., NCCN guidelines® insights: Non-small cell lung cancer, version 2.2023. J Natl Compr Canc Netw. 21(4): 340-350, 2023. PMID37015337.

22.       Franco-Rocha O.Y., Wheldon C.W., Osier N., Lett E., Kesler S.R., Henneghan A.M.,Suárez-Baquero D.F.M., Cisheteronormativity and its influence on the psychosocial experience of LGBTQ+ people with cancer: A qualitative systematic review. Psychooncology, 2023. PMID37025048.

23.       Fu J., Fu C., Wang R.S., Geynisman D.M., Ghatalia P., Lynch S.M., Harrison S.R., Tagai E.K.,Ragin C., Current status and future direction to address disparities in diversity, equity, and inclusion in prostate cancer care. Curr Oncol Rep: 1-10, 2023. PMID37010786.PMC10068208.

24.       Fuller A.D., Karami A.L., Kabir M.F., Klochkova A., Jackson J.L., Mu A., Tan Y., Klein-Szanto A.J.,Whelan K.A., Eosinophilic esophagitis-associated epithelial remodeling may limit esophageal carcinogenesis. Front Allergy. 4: 1086032, 2023. PMID37064719.PMC10090679.

25.       Geynisman D.M., Broughton E., Hao Y., Zhang Y., Le T.,Huo S., Corrigendum to real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the united states [urologic oncology: Seminars and original investigations 40 (2022) 195.E1-195.E11]. Urol Oncol, 2023. PMID37019763.

26.       Ginsburg K.B., Schober J.P., Bukavina L., Murray N., Chandra A.A., Chen D.Y.T., Greenberg R.E., Viterbo R., Uzzo R.G., Smaldone M.C., Kutikov A., Correa A.F. Oncologic outcomes of CT1 and CT2 micropapillary variant compared with CT1 and CT2 conventional urothelial carcinoma treated with radical cystectomy. Urology Practice. 9(5): 396-404, 2022. WOS:000963165400017.

27.       Goodlad J.R., Xiao W., Amador C., Cook J.R., Happ L., Thakkar D., Dave S., Dogan A., Duffield A., Nejati R., Ott G., Wasik M.,Czader M., Phenotypic and genotypic infidelity in b-lineage neoplasms, including transdifferentiation following targeted therapy: Report from the 2021 SH/EAHP workshop. Am J Clin Pathol, 2023. PMID37085149.

28.       Hallemeier C.L., Moughan J., Haddock M.G., Herskovic A.M., Minsky B.D., Suntharalingam M., Zeitzer K.L., Garg M.K., Greenwald B.D., Komaki R.U., Puckett L.L., Kim H., Lloyd S., Bush D.A., Kim H.E., Lad T.E., Meyer J.E., Okawara G.S., Raben A., Schefter T.E., Barker J.L., Jr., Falkson C.I., Videtic G.M.M., Jacob R., Winter K.A.,Crane C.H., Association of radiotherapy duration with clinical outcomes in patients with esophageal cancer treated in NRG oncology trials: A secondary analysis of NRG oncology randomized clinical trials. JAMA Netw Open. 6(4): e238504, 2023. PMID37083668.PMC10122174.

29.       Heller A., Du F., Liu Y., Yang Y.,Yang Z.J., Generating a mouse model for relapsed sonic hedgehog medulloblastoma. STAR Protoc. 4(2): 102234, 2023. PMID37074909.

30.       Hernandez N.E., Jankowski W., Frick R., Kelow S.P., Lubin J.H., Simhadri V., Adolf-Bryfogle J., Khare S.D., Dunbrack R.L., Jr., Gray J.J.,Sauna Z.E., Computational design of nanomolar-binding antibodies specific to multiple sars-cov-2 variants by engineering a specificity switch of antibody 80r using rosettaantibodydesign (rabd) results in potential generalizable therapeutic antibodies for novel sars-cov-2 virus. Heliyon. 9(4): e15032, 2023. PMID37035348.PMC10069166.

31.       Ioffe D.,Dotan E., Guidance for treating the older adults with colorectal cancer. Curr Treat Options Oncol, 2023. PMID37052812.

32.       Jones R.M., Snead R., Sarwer D.B.,Ibrahim J.K., Mask adherence and the relationship between masking and weather-related metrics. J Community Health: 1-8, 2023. PMID37097507.PMC10126535.

33.       Jordan R.M.,Bleicher R., ASO author reflections: Impact of electromagnetic seed localization on breast-conserving surgery. Ann Surg Oncol, 2023. PMID37067742.

34.       Jordan R.M., Rivera-Sanchez L., Kelley K., O’Brien M.A., Ruth K., Porpiglia A.S., Aggon A.A., Ross E., Sigurdson E.R., Bleicher R.J. The impact of an electromagnetic seed localization device versus wire localization on breast-conserving surgery: A matched-pair analysis. Ann Surg Oncol, 2023. PMID37012435.

35.       Kabir M.F., Jackson J.L., Fuller A.D., Gathuka L., Karami A.L., Conde D.G., Klochkova A., Mu A., Cai K.Q., Klein-Szanto A.J., Muir A.B., Whelan K.A. Diclofenac exhibits cytotoxic activity associated with metabolic alterations and p53 induction in ESCC cell lines and decreases ESCC tumor burden in vivo. Carcinogenesis, 2023. PMID37014121.

36.       Kadariya Y., Sementino E., Shrestha U., Gorman G., White J.M., Ross E.A., Clapper M.L., Neamati N., Miller M.S., Testa J.R. Inflammation as a chemoprevention target in asbestos-induced malignant mesothelioma. Carcinogenesis. 43(12): 1137-1148, 2022. PMID36355620.PMC10122428.

37.       Kharofa J.R., Yothers G., Kachnic L.A., Ajani J., Meyer J.E., Augspurger M.E., Okawara G.S., Garg M.K., Schefter T.E., Swanson T.A., Doncals D.E., Kim H., Zaki B.I., Narayan S., Lee R.J., Mamon H.J., Schwartz M.A., Moughan J.,Crane C.H., Use of the toxicity index in evaluating adverse events in anal cancer trials analysis of RTOG 9811 and RTOG 0529. American Journal of Clinical Oncology-Cancer Clinical Trials. 45(12): 534-536, 2022. WOS:000966780900008. PMC9912479.

38.       Khene Z.E., Kutikov A.,Campi R., Machine learning in renal cell carcinoma research: The promise and pitfalls of ‘renal-izing’ the potential of artificial intelligence. BJU Int, 2023. PMID37005367.

39.       Lin A.,Schmalbach C.E., Surgery in the era of immunotherapy for advanced head and neck non-melanoma skin cancer. Curr Oncol Rep, 2023. PMID37010785.

40.       Magee D.E., Cheung D.C., Hird A.E., Chung P., Warde P., Catton C., Berlin A., Zlotta A., Fleshner N.E.,Kulkarni G.S., Cost of bladder cancer care: A single centre comparison of radical cystectomy and trimodal therapy. Urol Pract: 101097upj0000000000000403, 2023. PMID37103562.

41.       Manley C.J., Kramer T., Kumar R., Gong Y., Ehya H., Ross E., Bonta P.I.,Annema J.T., Robotic bronchoscopic needle-based confocal laser endomicroscopy to diagnose peripheral lung nodules. Respirology. 28(5): 475-483, 2023. PMID36535801. NEEDS PMC.

42.       Nejati R., Amador C., Czader M., Thacker E., Thakkar D., Dave S.S., Dogan A., Duffield A., Goodlad J.R., Ott G., Wasik M.A., Xiao W.,Cook J.R., Progression of hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP workshop. Am J Clin Pathol, 2023. PMID37085150.

43.       Nguyen J., Takebe N., Kummar S., Razak A., Chawla S.P., George S., Patel S.R., Keohan M.L., Movva S., O’Sullivan Coyne G., Do K., Juwara L., Augustine B., Steinberg S.M., Kuhlmann L., Ivy S.P., Doroshow J.H.,Chen A.P., Randomized phase ii trial of sunitinib or cediranib in alveolar soft part sarcoma. Clin Cancer Res. 29(7): 1200-1208, 2023. PMID36302173.PMC10068440.

44.       O’Mahony D.G., Ramus S.J., Southey M.C., Meagher N.S., Hadjisavvas A., John E.M., Hamann U., Imyanitov E.N., Andrulis I.L., Sharma P., Daly M.B., Hake C.R., Weitzel J.N., Jakubowska A., Godwin A.K., Arason A., Bane A., Simard J., Soucy P., Caligo M.A., Mai P.L., Claes K.B.M., Teixeira M.R., Chung W.K., Lazaro C., Hulick P.J., Toland A.E., Pedersen I.S., Neuhausen S.L., Vega A., de la Hoya M., Nevanlinna H., Dhawan M., Zampiga V., Danesi R., Varesco L., Gismondi V., Vellone V.G., James P.A., Janavicius R., Nikitina-Zake L., Nielsen F.C., van Overeem Hansen T., Pejovic T., Borg A., Rantala J., Offit K., Montagna M., Nathanson K.L., Domchek S.M., Osorio A., García M.J., Karlan B.Y., De Fazio A., Bowtell D., McGuffog L., Leslie G., Parsons M.T., Dörk T., Speith L.M., Dos Santos E.S., da Costa A., Radice P., Peterlongo P., Papi L., Engel C., Hahnen E., Schmutzler R.K., Wappenschmidt B., Easton D.F., Tischkowitz M., Singer C.F., Tan Y.Y., Whittemore A.S., Sieh W., Brenton J.D., Yannoukakos D., Fostira F., Konstantopoulou I., Soukupova J., Vocka M., Chenevix-Trench G., Pharoah P.D.P., Antoniou A.C., Goldgar D.E., Spurdle A.B.,Michailidou K., Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2. Br J Cancer, 2023. PMID37076566.

45.       Panetta J.V., Veltchev I., Price R.A.,Ma C.C., 2d imrt qa passing rate dependency on coronal plane. Phys Med. 110: 102594, 2023. PMID37116388.

46.       Pfister D.G., Haddad R.I., Worden F.P., Weiss J., Mehra R., Chow L.Q.M., Liu S.V., Kang H., Saba N.F., Wirth L.J., Sukari A., Massarelli E., Ayers M., Albright A., Webber A.L., Mogg R., Lunceford J., Huang L., Cristescu R., Cheng J., Seiwert T.Y.,Bauml J.M., Biomarkers predictive of response to pembrolizumab in head and neck cancer. Cancer Med. 12(6): 6603-6614, 2023. PMID36479637.PMC10067081.

47.       Pyrgidis N., Barham D.W., Hammad M., Sokolakis I., Hatzichristodoulou G., Lentz A.C., Simhan J., Yafi F.A.,Gross M.S., Synchronous surgical management of erectile dysfunction and stress urinary incontinence: A systematic review and meta-analysis of reoperation rates. Sex Med Rev. 10(4): 782-790, 2022. PMID37051965.

48.       Raddi R.M., Ge Y.,Voelz V.A., Biceps v2.0: Software for ensemble reweighting using bayesian inference of conformational populations. J Chem Inf Model. 63(8): 2370-2381, 2023. PMID37027181.

49.       Rathi N., Attawettayanon W., Yasuda Y., Lewis K., Roversi G., Shah S., Wood A., Munoz-Lopez C., Palacios D.A., Li J., Abdallah N., Schober J.P., Strother M., Kutikov A., Uzzo R., Weight C.J., Eltemamy M., Krishnamurthi V., Abouassaly R.,Campbell S.C., Point of care parenchymal volume analyses to estimate split renal function and predict functional outcomes after radical nephrectomy. Sci Rep. 13(1): 6225, 2023. PMID37069196.PMC10110585.

50.       Ruth A., Rehman U., Stewart P., Moore L.E., Yucel R.,Wilson R.T., Maternal and paternal household pesticide exposure during pregnancy and risk of childhood acute lymphoblastic leukemia. J Occup Environ Med, 2023. PMID37015736.

51.       Sajisevi M., Caulley L., Eskander A., Du Y., Auh E., Karabachev A., Callas P., Conradie W., Martin L., Pasternak J., Golbon B., Rolighed L., Ahmed A.H.A., Badhey A., Cheung A.Y., Corsten M., Forner D., Liu J.C., Mavedatnia D., Meltzer C., Noel J.E., Patel V., Sharma A., Tang A.L., Tsao G., Venkatramani M., Williams M., Wrenn S.M., Zafereo M., Stack B.C., Randolph G.W.,Davies L., Evaluating the rising incidence of thyroid cancer and thyroid nodule detection modes a multinational, multi-institutional analysis. JAMA Otolaryngology-Head & Neck Surgery. 148(9): 811-818, 2022. WOS:000962002600001. PMC9284406.

52.       Serrano C., Bauer S., Gómez-Peregrina D., Kang Y.K., Jones R.L., Rutkowski P., Mir O., Heinrich M.C., Tap W.D., Newberry K., Grassian A., Shi H., Bialick S., Schöffski P., Pantaleo M.A., von Mehren M., Trent J.C.,George S., Circulating tumor DNA analysis of the phase iii voyager trial: Kit mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib. Ann Oncol, 2023. PMID37105265.

53.       Shan G.P., Hu W., Price R.A., Chen L.L.,Ma C.M.C., A new target localization method for image-guided radiation therapy of prostate cancer. Physica Medica-European Journal of Medical Physics. 107: 102550, 2023. WOS:000953138100001.

54.       Shu T.D., Prunty M.C., Pominville R., Omil-Lima D., Castro Bigalli A.A., Kutikov A., Bukavina L., Calaway A.C.,Markt S.C., Bladder and kidney cancer diagnosis and survival increase with medicare eligibility at age 65. Urol Pract. 10(1): 59-65, 2023. PMID37103437.

55.       St Paul A., Corbett C., Peluzzo A., Kelemen S., Okune R., Haines D.S., Preston K., Eguchi S.,Autieri M.V., Fxr1 regulates vascular smooth muscle cell cytoskeleton, vsmc contractility, and blood pressure by multiple mechanisms. Cell Rep. 42(4): 112381, 2023. PMID37043351.

56.       Stockton S., Catalano P., Cohen S.J., Burtness B.A., Mitchell E.P., Dotan E., Lubner S.J., Kumar P., Mulcahy M.F., Fisher G.A., Crandall T.L., Benson A., Paclitaxel with or without cixutumumab as second-line treatment of metastatic esophageal or gastroesophageal junction cancer: A randomized phase ii ecog-acrin trial. Oncologist, 2023. PMID37104870.

57.       Sulibhavi A., Tharmalingam S., McCarroll L.,Soliman A.M.S., Reversible bevacizumab induced vocal fold necrosis. Journal of Voice. 37(2): 257-259, 2023. WOS:000956368500001.

58.       Sultan S., Zucker J.,Weinberg D.S., Mpox: What practicing gastroenterologists need to know. Gastroenterology. 164(4): 505-509, 2023. WOS:000960483200001. PMC9774747.

59.       Tang J.A., McCarroll L.,Schmalbach C.E., Voice restoration and quality of life in larynx cancer. Otolaryngol Clin North Am. 56(2): 361-370, 2023. PMID37030948.

60.       Valdez R., Drevik J., Prunty M., Isali I., Sindhani M., Ponsky L., Bigalli A.C., Chen D., Mishra K., Kutikov A., Calaway A.,Bukavina L., Cost-effectiveness analysis of arterial catheter insertion on robotic-assisted laparoscopic prostatectomy. Can J Urol. 30(2): 11495-11501, 2023. PMID37074749.

61.       Vickers C., Tupchong S.,Aphale A., Validation of contactless smartphone measurement application in clinical context of mohs micrographic surgery patients. Skin Res Technol. 29(4): e13325, 2023. PMID37113096.

62.       Vitale I., Pietrocola F., Guilbaud E., Aaronson S.A., Abrams J.M., Adam D., Agostini M., Agostinis P., Alnemri E.S., Altucci L., Amelio I., Andrews D.W., Aqeilan R.I., Arama E., Baehrecke E.H., Balachandran S., Bano D., Barlev N.A., Bartek J., Bazan N.G., Becker C., Bernassola F., Bertrand M.J.M., Bianchi M.E., Blagosklonny M.V., Blander J.M., Blandino G., Blomgren K., Borner C., Bortner C.D., Bove P., Boya P., Brenner C., Broz P., Brunner T., Damgaard R.B., Calin G.A., Campanella M., Candi E., Carbone M., Carmona-Gutierrez D., Cecconi F., Chan F.K., Chen G.Q., Chen Q., Chen Y.H., Cheng E.H., Chipuk J.E., Cidlowski J.A., Ciechanover A., Ciliberto G., Conrad M., Cubillos-Ruiz J.R., Czabotar P.E., D’Angiolella V., Daugaard M., Dawson T.M., Dawson V.L., De Maria R., De Strooper B., Debatin K.M., Deberardinis R.J., Degterev A., Del Sal G., Deshmukh M., Di Virgilio F., Diederich M., Dixon S.J., Dynlacht B.D., El-Deiry W.S., Elrod J.W., Engeland K., Fimia G.M., Galassi C., Ganini C., Garcia-Saez A.J., Garg A.D., Garrido C., Gavathiotis E., Gerlic M., Ghosh S., Green D.R., Greene L.A., Gronemeyer H., Häcker G., Hajnóczky G., Hardwick J.M., Haupt Y., He S., Heery D.M., Hengartner M.O., Hetz C., Hildeman D.A., Ichijo H., Inoue S., Jäättelä M., Janic A., Joseph B., Jost P.J., Kanneganti T.D., Karin M., Kashkar H., Kaufmann T., Kelly G.L., Kepp O., Kimchi A., Kitsis R.N., Klionsky D.J., Kluck R., Krysko D.V., Kulms D., Kumar S., Lavandero S., Lavrik I.N., Lemasters J.J., Liccardi G., Linkermann A., Lipton S.A., Lockshin R.A., López-Otín C., Luedde T., MacFarlane M., Madeo F., Malorni W., Manic G., Mantovani R., Marchi S., Marine J.C., Martin S.J., Martinou J.C., Mastroberardino P.G., Medema J.P., Mehlen P., Meier P., Melino G., Melino S., Miao E.A., Moll U.M., Muñoz-Pinedo C., Murphy D.J., Niklison-Chirou M.V., Novelli F., Núñez G., Oberst A., Ofengeim D., Opferman J.T., Oren M., Pagano M., Panaretakis T., Pasparakis M., Penninger J.M., Pentimalli F., Pereira D.M., Pervaiz S., Peter M.E., Pinton P., Porta G., Prehn J.H.M., Puthalakath H., Rabinovich G.A., Rajalingam K., Ravichandran K.S., Rehm M., Ricci J.E., Rizzuto R., Robinson N., Rodrigues C.M.P., Rotblat B., Rothlin C.V., Rubinsztein D.C., Rudel T., Rufini A., Ryan K.M., Sarosiek K.A., Sawa A., Sayan E., Schroder K., Scorrano L., Sesti F., Shao F., Shi Y., Sica G.S., Silke J., Simon H.U., Sistigu A., Stephanou A., Stockwell B.R., Strapazzon F., Strasser A., Sun L., Sun E., Sun Q., Szabadkai G., Tait S.W.G., Tang D., Tavernarakis N., Troy C.M., Turk B., Urbano N., Vandenabeele P., Vanden Berghe T., Vander Heiden M.G., Vanderluit J.L., Verkhratsky A., Villunger A., von Karstedt S., Voss A.K., Vousden K.H., Vucic D., Vuri D., Wagner E.F., Walczak H., Wallach D., Wang R., Wang Y., Weber A., Wood W., Yamazaki T., Yang H.T., Zakeri Z., Zawacka-Pankau J.E., Zhang L., Zhang H., Zhivotovsky B., Zhou W., Piacentini M., Kroemer G.,Galluzzi L., Apoptotic cell death in disease-current understanding of the NCCD 2023. Cell Death Differ: 1-58, 2023. PMID37100955.PMC10130819.

63.       Wasserman J.S., Feiser F., Palacio S., Patel K., Gonzalez J., Fowle H.,Graña X., Protocol to assess substrate dephosphorylation by serine/threonine phosphoprotein phosphatases in vitro. STAR Protoc. 4(2): 102148, 2023. PMID37074907.

64.       Wei X., Schultz K., Pepper H.L., Megill E., Vogt A., Snyder N.W.,Marmorstein R., Allosteric role of the citrate synthase homology domain of ATP citrate lyase. Nat Commun. 14(1): 2247, 2023. PMID37076498. PMC10115795.

65.       Xiao W., Amador C., Cook J.R., Czader M., Dave S., Dogan A., Duffield A., Goodlad J., Nejati R., Ott G.,Wasik M., B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic cell neoplasms: Diversity, differentiation lineage, genomic alterations, and therapy: Report from the 2021 SH/EAHP workshop. Am J Clin Pathol, 2023. PMID37040587.

66.       Yip W., Ghoreifi A., Gerald T., Lee R., Howard J., Asghar A., Khanna A., Cai J., Aron M., Gill I., Thompson R.H., Uzzo R., Margulis V., Singla N.,Djaladat H., Perioperative complications and oncologic outcomes of nephrectomy following immune checkpoint inhibitor therapy: A multicenter collaborative study. Eur Urol Oncol, 2023. PMID37005212.

67.       Zainol Abidin Q.H., Ida T., Morita M., Matsunaga T., Nishimura A., Jung M., Hassan N., Takata T., Ishii I., Kruger W., Wang R., Motohashi H., Tsutsui M.,Akaike T., Synthesis of sulfides and persulfides is not impeded by disruption of three canonical enzymes in sulfur metabolism. Antioxidants (Basel). 12(4)2023. PMID37107243.PMC10135671.

Staff Publications Received in March, 2023

1.        Albiges L., Tannir N.M., Burotto M., McDermott D., Plimack E.R., Barthelemy P., Porta C., Powles T., Donskov F., George S., Kollmannsberger C.K., Gurney H., Grimm M.O., Tomita Y., Castellano D., Rini B.I., Choueiri T.K., Leung D., Saggi S.S., Lee C.W., McHenry M.B.,Motzer R.J., First-line nivolumab plus ipilimumab versus sunitinib in patients without nephrectomy and with an evaluable primary renal tumor in the checkmate 214 trial. Journal of Urology. 209(2): 442-443, 2023. PMIDWOS:000928267800067.Editorial.

2.        Atkins M.B., Jegede O.A., Haas N.B., McDermott D.F., Bilen M.A., Stein M., Sosman J.A., Alter R., Plimack E.R., Ornstein M.C., Hurwitz M., Peace D.J., Signoretti S., Denize T., Cimadamore A., Wu C.J., Braun D., Einstein D., Catalano P.J.,Hammers H., Phase ii study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (hcrn gu16-260-cohort b). J Immunother Cancer. 11(3)2023. PMID36948504.PMC10040058.

3.        Bakhos C., Petrov R.,Abbas A., Adopting the robotic platform for anatomic lung resections: Real life lessons for the tech enthusiast. J Thorac Dis. 15(2): 232-234, 2023. PMID36910091.PMC9992593.

4.        Baldwin D.A., Gigli C.R., Kwok T., Connelly S., Helstrom J.L., Ebersole B., Ross E.A., Araten M., Glickman J., Glickman R.,Horwitz E.M., Clinical validation of an alternative specimen collection kit for sars-cov-2 testing at fox chase cancer center. J Biomol Tech. 33(3)2022. PMID36910578.PMC10001927.

5.        Barham D.W., Gross M.S., Lentz A.C., Simhan J.,Yafi F.A., Aua-recommended antibiotic prophylaxis for primary penile implantation results in a higher, not lower, risk for postoperative infection: A multicenter analysis. Reply. J Urol: 101097ju0000000000003385, 2023. PMID36893356.

6.        Bauman J.E., Saba N.F., Roe D., Bauman J.R., Kaczmar J., Bhatia A., Muzaffar J., Julian R., Wang S., Bearelly S., Baker A., Steuer C., Giri A., Burtness B., Centuori S., Caulin C., Klein R., Saboda K., Obara S.,Chung C.H., Randomized phase ii trial of ficlatuzumab with or without cetuximab in pan-refractory, recurrent/metastatic head and neck cancer. J Clin Oncol: Jco2201994, 2023. PMID36977289.

7.        Bergerot C.D., Malhotra J., Bergerot P., Philip E.J., Castro D.V., Hsu J., Mota A.C.A., Cardoso de Azeredo A., Neto J.N.M., Hutson T., Grünwald V., Bex A., Psutka S.P., Rini B., Plimack E.R., Master V., Albiges L., Choueiri T.K., Pal S.,Powles T., Patients’ perceptions regarding the relevance of items contained in the functional assessment of cancer therapy kidney symptom index-19. Oncologist, 2023. PMID36917626.

8.        Brown J.C., Sturgeon K., Sarwer D.B., Troxel A.B., DeMichele A.M., Denlinger C.S.,Schmitz K.H., The effects of exercise and diet on oxidative stress and telomere length in breast cancer survivors. Breast Cancer Res Treat, 2023. PMID36933050.

9.        Bukavina L., Isali I., Ginwala R., Sindhani M., Calaway A., Magee D., Miron B., Correa A., Kutikov A., Zibelman M., Ghannoum M., Retuerto M., Ponsky L., Markt S., Uzzo R.,Abbosh P., Global meta-analysis of urine microbiome: Colonization of polycyclic aromatic hydrocarbon-degrading bacteria among bladder cancer patients. Eur Urol Oncol, 2023. PMID36868921.

10.      Cai K.Q., Shellhamer C., Akiyama T.,Jensen L.E., Pellino1 restricts herpes simplex virus infections in the epidermis and dissemination to sebaceous glands. J Invest Dermatol. 143(4): 639-647.e2, 2023. PMID36216205.PMC10038864.

11.      Campbell K.S., Murine cytomegalovirus encodes a specific cell surface marker that can trigger attack by nk cells. J Immunol. 210(5): 519-520, 2023. PMID36881870.

12.      Dotan E., Catalano P., Lenchik L., Boutin R., Yao X., Marques H.S., Ioffe D., Zhen D.B., Li D., Wagner L.I., Simon M.A., Wong T.Z.,O’Dwyer P.J., The giant trial (ecog-acrin ea2186) methods paper: A randomized phase ii study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer – defining a new treatment option for older vulnerable patients. J Geriatr Oncol. 14(3): 101474, 2023. PMID36963200.

13.      Egleston B.L., Bleicher R.J., Fang C.Y., Galloway T.J.,Vucetic S., Benefits versus drawbacks of delaying surgery due to additional consultations in older patients with breast cancer. Cancer Rep (Hoboken): e1805, 2023. PMID36943210.

14.      Golovine K., Abalakov G., Lian Z., Chatla S., Karami A., Chitrala K.N., Madzo J., Nieborowska-Skorska M., Huang J.,Skorski T., Abl1 kinase as a tumor suppressor in aml1-eto and nup98-pmx1 leukemias. Blood Cancer J. 13(1): 42, 2023. PMID36959186.PMC10036529.

15.      Granillo L., Iosif A.M., Goodrich A., Snyder N.W.,Schmidt R.J., Maternal androgens and autism spectrum disorder in the marbles prospective cohort study. Res Autism Spectr Disord. 992022. PMID36938498.PMC10022653.

16.      Hasan A., Khamjan N., Lohani M.,Mir S.S., Targeted inhibition of hsp90 in combination with metformin modulates programmed cell death pathways in a549 lung cancer cells. Appl Biochem Biotechnol, 2023. PMID37000353.

17.      Haslam D.E., John E.M., Knight J.A., Li Z., Buys S.S., Andrulis I.L., Daly M.B., Genkinger J.M., Terry M.B.,Zhang F.F., Diet quality and all-cause mortality in women with breast cancer from the breast cancer family registry. Cancer Epidemiol Biomarkers Prev, 2022. PMID36857773.PMC10066732.

18.      Huda A., Arakawa H., Mazzucco G., Galli M., Petrocelli V., Casola S., Chen L.,Doksani Y., The telomerase reverse transcriptase elongates reversed replication forks at telomeric repeats. Sci Adv. 9(12): eadf2011, 2023. PMID36947627.PMC10032592.

19.      Jang H.J., Hostetter G., MacFarlane A.W., Madaj Z., Ross E.A., Hinoue T., Kulchycki J.R., Burgos R.S., Tafseer M., Alpaugh R.K., Schwebel C.L., Kokate R., Geynisman D.M., Zibelman M.R., Ghatalia P., Nichols P.W., Chung W., Madzo J., Hahn N.M., Quinn D.I., Issa J.J., Topper M.J., Baylin S.B., Shen H., Campbell K.S., Jones P.A.,Plimack E.R., A phase ii trial of guadecitabine plus atezolizumab in metastatic urothelial carcinoma progressing after initial immune checkpoint inhibitor therapy. Clin Cancer Res, 2023. PMID36928921.

20.      Johnson C.K., Leung M.M., Ma G.X.,Ogunwobi O.O., Effective recruitment strategies utilized to examine dietary practices of blacks in new york city in the midst of the covid-19 pandemic. J Racial Ethn Health Disparities: 1-9, 2023. PMID36929490.PMC10019415.

21.      Johnston W., Rosier B.T., Carda-Diéguez M., Paterson M., Watson P., Piela K., Goulding M., Ramage G., Baranyia D., Chen T., Al-Hebshi N., Mira A.,Culshaw S., Longitudinal changes in subgingival biofilm composition following periodontal treatment. J Periodontol, 2023. PMID36960491.

22.      Kashani-Sabet M., Leachman S.A., Stein J.A., Arbiser J.L., Berry E.G., Celebi J.T., Curiel-Lewandrowski C., Ferris L.K., Grant-Kels J.M., Grossman D., Kulkarni R.P., Marchetti M.A., Nelson K.C., Polsky D., Seiverling E.V., Swetter S.M., Tsao H., Verdieck-Devlaeminck A., Wei M.L., Bar A., Bartlett E.K., Bolognia J.L., Bowles T.L., Cha K.B., Chu E.Y., Hartman R.I., Hawryluk E.B., Jampel R.M., Karapetyan L., Kheterpal M., Lawson D.H., Leming P.D., Liebman T.N., Ming M.E., Sahni D., Savory S.A., Shaikh S.S., Sober A.J., Sondak V.K., Spaccarelli N., Usatine R.P., Venna S.,Kirkwood J.M., Early detection and prognostic assessment of cutaneous melanoma: Consensus on optimal practice and the role of gene expression profile testing. JAMA Dermatol, 2023. PMID36920356.

23.      Kottschade L.A., Pond G.R., Olszanski A.J., Zakharia Y., Domingo-Musibay E., Hauke R.J., Curti B.D., Schober S., Milhem M.M., Block M.S., Hieken T.,McWilliams R.R., Salvo: Single arm trial of ipilimumab and nivolumab as adjuvant therapy for resected mucosal melanoma. Clin Cancer Res, 2023. PMID37000165.

24.      Laderman L., Sreekrishnanilayam K., Pandey R.K., Handorf E., Blumenreich A., Sorice K.A., Lynch S.M., Cheema K., Nagappan L., Sosa I.R., Dotan E.,Vijayvergia N., Venous thromboembolism in metastatic pancreatic cancer. Eur J Haematol, 2023. PMID36941225.

25.      Luo S., Kong C., Zhao S., Tang X., Wang Y., Zhou X., Li R., Liu X., Tang X., Sun S., Xie W., Zhang Z.R., Jing Q., Gu A., Chen F., Wang D., Wang H., Han Y., Xie L.,Ji Y., Endothelial hdac1-zeb2-nurd complex drives aortic aneurysm and dissection through regulation of protein s-sulfhydration. Circulation, 2023. PMID36951067.

26.      Ma C.M.C., Shan G., Hu W., Price R.A.,Chen L., A new target localization method for image-guided radiation therapy of prostate cancer. Phys Med. 107: 102550, 2023. PMID36870203.

27.      Magarinos J., Lutzow L., Dass C., Ma G.X.,Erkmen C.P., Feasibility of single – encounter telemedicine lung cancer screening: A retrospective cohort study in an underserved population. Cancer Control. 30: 10732748221121391, 2023. PMID36935556.PMC10028660.

28.      Miller A.L., Nicastro L.K., Bessho S., Grando K., White A.P., Zhang Y., Queisser G., Buttaro B.A.,Tükel Ç., Nitrate is an environmental cue in the gut for salmonella enterica serovar typhimurium biofilm dispersal through curli repression and flagellum activation via cyclic-di-gmp signaling. mBio. 13(1): e0288621, 2021. PMID35130730.PMC8822344.

29.      Moses K.A., Sprenkle P.C., Bahler C., Box G., Carlsson S.V., Catalona W.J., Dahl D.M., Dall’Era M., Davis J.W., Drake B.F., Epstein J.I., Etzioni R.B., Farrington T.A., Garraway I.P., Jarrard D., Kauffman E., Kaye D., Kibel A.S., LaGrange C.A., Maroni P., Ponsky L., Reys B., Salami S.S., Sanchez A., Seibert T.M., Shaneyfelt T.M., Smaldone M.C., Sonn G., Tyson M.D., Vapiwala N., Wake R., Washington S., Yu A., Yuh B., Berardi R.A.,Freedman-Cass D.A., Nccn guidelines® insights: Prostate cancer early detection, version 1.2023. J Natl Compr Canc Netw. 21(3): 236-246, 2023. PMID36898362.

30.      Prunty M., Rhodes S., Sun H.L., Psutka S.P., Mishra K., Kutikov A., Chen D.V., Ponsky L., Calaway A.,Bukavina L., Redefining the gender gap in urology authorship: An 18-year publication analysis. European Urology Focus. 8(5): 1512-1519, 2022. PMIDWOS:000922586200046.

31.      Reza J.A., Raman V., Vekstein A., Grau-Sepulveda M., Burfeind W.P., Chin K., Petrov R.,Erkmen C.P., Implementation of screening guidelines in early esophageal cancer: A study of the society of thoracic surgeons general thoracic surgery database. Ann Surg, 2023. PMID36912032.

32.      Saad A., Loren A., Bolanos-Meade J., Chen G., Couriel D., Di Stasi A., El-Jawahri A., Elmariah H., Farag S., Gundabolu K., Gutman J., Ho V., Hoeg R., Horwitz M., Hsu J., Kassim A., Dabaja M.K., Magenau J., Martin T., Mielcarek M., Moreira J., Nakamura R., Nieto Y., Ninos C., Oliai C., Patel S., Randolph B., Schroeder M., Tzachanis D., Varshavsky-Yanovsky A.N., Vusirikala M., Algieri F.,Pluchino L.A., Hematopoietic cell transplantation, version 3.2022 featured updates to the nccn guidelines. Journal of the National Comprehensive Cancer Network. 21(2): 108-115, 2023. PMIDWOS:000946526600003.

33.      Salami A.C., Stone J.M., Greenberg R.H., Leighton J.C., Miick R., Zavala S.R., Zeitzer K.L.,Bakhos C.T., Early prophylactic gastrectomy for the management of gastric adenomatous proximal polyposis syndrome (gapps). ACS Case Rev Surg. 3(7): 62-68, 2022. PMID36909251.PMC9997706.

34.      Schuler B.R., Collins B.N., Scheuermann T.S., Baishya M., Kilby L.,Lepore S.J., Translating pediatric primary care best practice guidelines for addressing tobacco in the wic system. Transl Behav Med. 13(2): 57-63, 2023. PMID36434752.PMC9972351.

35.      Scott A.J., Basu Mallick A., Dotan E., Cohen S.J., Gold P.J., Hochster H.S., Subramaniam S., Barzi A., Watts G.S., Blatchford P.J.,Messersmith W.A., A phase ii study investigating cabozantinib in patients with refractory metastatic colorectal cancer (agicc 17crc01). Cancer Res Commun. 2(10): 1188-1196, 2022. PMID36969746.PMC10035393.

36.      Shields P.G., Bierut L., Arenberg D., Balis D., Cinciripini P.M., Davis J., Edmondson D., Feliciano J., Hitsman B., Hudmon K.S., Jaklitsch M.T., Leone F.T., Ling P., McCarthy D.E., Ong M.K., Park E.R., Prochaska J., Sandoval A.J., Sheffer C.E., Spencer S., Studts J.L., Tanvetyanon T., Tindle H.A., Tong E., Triplette M., Urbanic J., Videtic G., Warner D., Whitlock C.W., McCullough B.,Darlow S., Smoking cessation, version 3.2022, nccn clinical practice guidelines in oncology. J Natl Compr Canc Netw. 21(3): 297-322, 2023. PMID36898367.

37.      Shrestha J., Santerre M., Allen C.N., Arjona S.P., Hooper R., Mukerjee R., Kaul M., Shcherbik N., Soboloff J.,Sawaya B.E., Hiv-1 gp120 protein promotes hand through the calcineurin pathway activation. Mitochondrion. 70: 31-40, 2023. PMID36925028.

38.      Siegel S.D., Brooks M.M., Berman J.D., Lynch S.M., Sims-Mourtada J., Schug Z.T.,Curriero F.C., Neighborhood factors and triple negative breast cancer: The role of cumulative exposure to area-level risk factors. Cancer Med, 2023. PMID36916687.

39.      Strauss A.L., Triggs J.R., Tewksbury C.M., Soriano I., Wernsing D.S., Dumon K.R., Williams N.N.,Shao J.M., Conversion to roux-en-y gastric bypass: A successful means of mitigating reflux after laparoscopic sleeve gastrectomy. Surg Endosc, 2023. PMID36997653.

40.      Sufian M.A., Zamanova S., Shabana A.M., Kemp B., Mondal U.K., Supuran C.T.,Ilies M.A., Expression dynamics of ca ix epitope in cancer cells under intermittent hypoxia correlates with extracellular ph drop and cell killing by ureido-sulfonamide ca ix inhibitors. Int J Mol Sci. 24(5)2023. PMID36902027.PMC10002582.

41.      Sulibhavi A., Tharmalingam S., McCarroll L.,Soliman A.M.S., Reversible bevacizumab induced vocal fold necrosis. J Voice. 37(2): 257-259, 2023. PMID33358072.

42.      Sultan S., Zucker J.,Weinberg D.S., Mpox: What practicing gastroenterologists need to know. Gastroenterology. 164(4): 505-509, 2023. PMID36539015.PMC9774747.

43.      Voelz V.A., Pande V.S.,Bowman G.R., Folding@home: Achievements from over 20 years of citizen science herald the exascale era. Biophys J, 2023. PMID36945779.

44.      Wheldon C.W., Sykes K.J., Ramaswamy M., Bass S.B.,Collins B.N., Integrating hpv vaccination within prep care delivery for underserved populations: A mixed methods feasibility study. J Community Health, 2023. PMID36894796.

45.      Wiese D., Islami F.,Henry K.A., Changes in geographic accessibility to mammography by state and rural-urban status, united states, 2006-2022. J Natl Cancer Inst. 115(3): 337-340, 2023. PMID36515214.PMC9996203.

46.      Wiese D., Stroup A.M., Islami F., Mattes M., Baylor E., Boscoe F.P.,Henry K.A., Geographic diffusion of digital mammography in the united states. Cancer, 2023. PMID36988982.

47.      Yin C., Zhang T.,Balachandran S., Detecting z-rna and z-DNA in mammalian cells. Methods Mol Biol. 2651: 277-284, 2023. PMID36892774.

48.      Zhang L., Wang G., Zhu L., Wei W.,Zhang J., Editorial: Gynecological and gastrointestinal cancers: Recent advances in molecular diagnosis and targeted therapy. Front Mol Biosci. 10: 1167337, 2023. PMID36936994.PMC10020627.